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Abstract
Diabetic retinopathy (DR) is a chronic, progressive and possibly vision-threatening
eye disease. Early detection and diagnosis of DR, prior to the development of any le-
sions, is paramount for more efficiently dealing with it andmanaging its consequences.
This thesis investigates and proposes a number of candidate geometric and haemody-
namic biomarkers, derived from fundus images of the retinal vasculature, which can be
reliably utilised for identifying the progression from diabetes to DR. Numerous stud-
ies exist in literature that investigate only some of these biomarkers in independent
normal, diabetic and DR cohorts. However, none exist, to the best of my knowledge,
that investigates more than 100 biomarkers altogether, both geometric and haemody-
namic ones, for identifying the progression to DR, by also using a novel experimental
design, where the same exact matched junctions and subjects are evaluated in a four
year period that includes the last three years pre-DR (still diabetic eye) and the onset
of DR (progressors’ group). Multiple additional conventional experimental designs,
such as non-matched junctions, non-progressors’ group, and a combination of them
are also adopted in order to present the superiority of this type of analysis for reti-
nal features. Therefore, this thesis aims to present a complete framework and some
novel knowledge, based on statistical analysis, feature selection processes and classi-
fication models, so as to provide robust, rigorous and meaningful statistical inferences,
alongside efficient feature subsets that can identify the stages of the progression. In
addition, a new and improved method for more accurately summarising the calibres of
the retinal vessel trunks is also presented.
The first original contribution of this thesis is that a series of haemodynamic fea-
tures (blood flow rate, blood flow velocity, etc.), which are estimated from the retinal
vascular geometry based on some boundary conditions, are applied to studying the
progression from diabetes to DR. These features are found to undoubtedly contribute
to the inferences and the understanding of the progression, yielding significant results,
mainly for the venular network.
The second major contribution is the proposed framework and the experimental
design for more accurately and efficiently studying and quantifying the vascular alter-
ations that occur during the progression to DR and that can be safely attributed only
to this progression. The combination of the framework and the experimental design
lead to more sound and concrete inferences, providing a set of features, such as the
central retinal artery and vein equivalent, fractal dimension, blood flow rate, etc., that
are indeed biomarkers of progression to DR.
The third major contribution of this work is the new and improvedmethod for more
accurately summarising the calibre of an arterial or venular trunk, with a direct appli-
cation to estimating the central retinal artery equivalent (CRAE), the central retinal
vein equivalent (CRVE) and their quotient, the arteriovenous ratio (AVR). Finally, the
improved method is shown to truly make a notable difference in the estimations, when
compared to the established alternative method in literature, with an improvement be-
tween 0.24% and 0.49% in terms of the mean absolute percentage error and 0.013 in
the area under the curve.
I have demonstrated that some thoroughly planned experimental studies based on
a comprehensive framework, which combines image processing algorithms, statistical
and classification models, feature selection processes, and robust haemodynamic and
geometric features, extracted from the retinal vasculature (as a whole and from specific
areas of interest), provide altogether succinct evidence that the early detection of the
progression from diabetes to DR can be indeed achieved. The performance that the
eight different classification combinations achieved in terms of the area under the curve
varied from 0.745 to 0.968.
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Chapter 1
Introduction
This thesis presents a framework for the study of multiple geometric and haemody-
namic biomarkers of progression from diabetes to diabetic retinopathy (DR), derived
from the retinal vasculature. In addition, an improved estimation of the calibres of the
parent vessel trunks with an application to the estimation of the central retinal artery
equivalent(CRAE), the central retinal vein equivalent (CRVE) and their quotient, arte-
riovenous ratio (AVR), is also presented. All of the above studies and implementations
aim to identify whether early alterations are indeed present in the retinal vasculature
prior to the onset of diabetic retinopathy (DR) and the appearance of any lesions, when
still dealing with a diabetic eye. This is paramount, given that the earlier a disease is
identified, themore efficient the treatment plan can be (WHO, 2016; AmDiabAss et al.,
2010).
DR is a vision-threatening eye disease that affects the retinal blood vessels and
is primarily a consequence of the systemic disease of diabetes (WHO, 2016; Group
et al., 2004). Diabetes is a chronic disease that occurs when the pancreas does not
produce adequate insulin, or when the body cannot actually make use of the insulin it
produces. Insulin is an important hormone that regulates the blood sugar (WHO, 2016;
Alberti & Zimmet, 1998). Uncontrolled diabetes leads to hyperglycaemia, which is
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the raise of the blood sugar above a normal level, and over a period of time can cause
severe damage to various body’s systems, including kidneys, nerves and blood vessels
(Creager et al., 2003). There are two types of diabetes, Type 1 and Type 2. Type 1
diabetes, previously known as insulin-dependent childhood-onset is not preventable
with today’s knowledge and also requires a daily administration of insulin (Alberti &
Zimmet, 1998). Type 2 diabetes, formerly known as non-insulin dependent or adult-
onset is a consequence of the body’s incapability of effectively using insulin. The
majority of people that suffer from diabetes fall into this category and is linked to the
lifestyle (body weight, physical inactivity, etc.). Recently this type of diabetes is also
found in children (WHO, 2016; Alberti & Zimmet, 1998).
Some important epidemiological facts from the world health organisation (WHO)
suggest that between 1980 and 2014 the number of people with diabetes has risen from
108 million to a massive 422 million. Similarly the prevalence of diabetes has risen
from 4.7% to 8.5% during the above same period. In 2012, 1.5 million deaths were
directly associated with diabetes and another 2.2 million deaths were linked to high
blood glucose levels. Moreover, 2.6% of global blindness can be attributed to diabetes
(WHO, 2016; Alberti & Zimmet, 1998).
DR is one of the most common causes of preventable blindness and of moderate
to severe visual impairment (Bourne et al., 2013). According to 2010 estimations,
more than a third of diabetic patients have signs of DR and a third of those suffer from
vision-threatening DR (severe non-proliferative DR, or proliferative DR (PDR)), or
presents signs of diabetic macular oedema (Lee et al., 2015b).
1.1 Motivation and Objectives
It is imperative to point out, that throughout this thesis, the purpose is to use and com-
bine state of the art computer vision, image processing, machine learning and statistical
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analysis techniques, in order to conduct a comprehensive, detailed, robust and com-
plete study, with scientific, technical and clinical importance.
More specifically, the main aim and novelty of this thesis is to utilise and develop
different tools, in the areas of image processing, statistical analysis and machine learn-
ing, in order to thoroughly investigate the alterations that occur to the retinal vascu-
lature during the progression from diabetes to DR, and also present a framework that
accomplishes that. In literature, there is a vast and endless number of implemented
algorithms for segmenting the retinal vessels (Oliveira et al., 2016; Li et al., 2016;
Christodoulidis et al., 2016; Soares et al., 2006; Staal et al., 2004; Al-Diri et al., 2009)
and/or extracting different kind of vascular measurements (Lowell et al., 2004b; Perez-
Rovira et al., 2011; Al-Diri et al., 2009, 2010; Grisan et al., 2008; Hart et al., 1999).
All of these algorithms justify their existence by stressing the importance that they
might have in providing a way of studying different pathological disorders. However,
to the best of my knowledge, no previous work exists, that investigates at the same
time and in multiple experimental designs, many candidate biomarkers of progression
to DR, as well as estimating haemodynamic features from the vascular geometry and
also evaluating them both statistically and by using classification models. An addi-
tional novelty is that different areas of the retina, as described in (Hove et al., 2004),
are also separately investigated in order to find out whether they can offer us more
powerful biomarkers. Having said that, all the biomarkers presented in this thesis are
evaluated in two complementary ways. First, statistically, in order to understand how
each of them changes across the investigated periods of time, and secondly, for their
discrimination potential, when utilised for diagnosing the different stages of the dis-
ease.
Finally an alternative, more accurate method for summarising the calibre of the
parent vessel trunk is also presented (Leontidis et al., 2016b) and compared with the
established method in literature (Knudtson et al., 2003), with an application to esti-
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mating the arteriovenous ratio (AVR). It should be stressed that the work of the thesis
deals with the estimation of the candidate biomarkers and with the evaluation of the
changes in the measured biomarkers among the different populations at risk, given the
covariates and the condition of the patient, rather than the prediction/assignment of a
person to a particular sub-population to stratify its risk of developing retinopathy.
The main objectives of this thesis are the following:
• To provide complete, detailed and valid studies, which evaluate for their statis-
tical significance and robustness more than 100 candidate biomarkers that are
extracted from different areas of the retina. In addition a feature selection pro-
cess will be conducted and classificationmodels will be built, in order to evaluate
the discrimination potential of these biomarkers.
• To investigate, primarily from a technical perspective but with keeping in mind
the clinical implications as well, whether the retinal vasculature significantly and
distinctly changes prior to the onset of DR, as a consequence of the progression
of diabetes.
• To present a framework that accommodates the proposed way of analysis, where
the same exact segments are studied over a period of time, and also compare
it against alternative experimental designs. The proposed framework offers a
pipeline that is able not only to automate the process of analysing retinal images
and extracting features for studying DR and other retinal diseases, but to also
ascertain that the bifurcations are correctly matched (progression studies), the
areas of interest are properly identified and the analysis is valid and therefore
meaningful.
• To estimate various haemodynamic features, directly from the vascular geometry
and to apply them in the study of the progression to DR. This process includes
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some constraints, imposed by the boundary conditions, which are used to make
these estimations.
• To propose an alternative and more accurate method for summarising the calibre
of the parent vessel trunk, separately for healthy, diabetic and DR groups, for
estimating the central retinal artery equivalent (CRAE), the central retinal vein
equivalent (CRVE) and their quotient, the arteriovenous ratio (AVR). More ac-
curate estimates can help build better performing classification systems, both for
the earlier diagnosis of the progression of the disease and the overall improve-
ment of the classification accuracy.
1.2 Statement of Originality
The primary contributions of this thesis are presented below, with all of them elabo-
rated in the chapters to come.
1. The first major contribution is the proposed framework and the experimental de-
sign that offer an efficient and accurate way tomore robustly study the alterations
in the retinal vasculature, for identifying and diagnosing early the progression
from diabetes to DR. This has an important clinical implication, because the pro-
liferation of the disease can sometimes be rapid, leading to irreversible damages
in the retinal tissue. Providing a framework of automated analysis and diagnosis
could help clinicians monitor the progression of the disease more closely and/or
adjust the treatment plans of the patients.
To achieve all these, many different methods already proposed in literature will
be combined and some key parts will be implemented, in order to create the fea-
ture set that will be used to conduct the statistical analysis, the feature selection
process and the multiple binary classifications. In addition, all the classifica-
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tion models will include solely geometric and haemodynamic features, with no
information extracted from the images per se.
2. The secondmajor original contribution is to introduce a pilot estimation of haemo-
dynamic features, directly from the retinal vascular geometry, and more impor-
tantly to evaluate them as candidate biomarkers for identifying the progression
to DR. Haemodynamic features’ calculation is possible by utilising devices, like
laser doppler flowmeter and colour doppler imaging, that can provide in-vivo
measurements. However, this is a demanding process, not easily applicable,
and it also requires prospective studies, given that these data cannot be retro-
spectively found. Therefore, in this study, a number of haemodynamic features
are estimated, such as blood flow rate, blood flow velocity, wall shear stress,
pressures and Reynolds number, by utilising a 0-D mathematical model with
some boundary conditions. The estimations are made possible by a combina-
tion of image analysis techniques and mathematical modelling, with the former
used for extracting geometric parameters needed for the estimations (lengths and
widths of the vessel segments), and the latter for simulating some of the condi-
tions that are governed by the functionality of the retina.
3. The third major contribution is the new and more improved method for sum-
marising the width of the parent vessel trunk, with a direct application to the
more accurate estimation of the AVR. This method does not only improve the
general estimation of the AVR, but also proposes adjusted equations, specifically
for healthy, diabetic and DR groups. Any improvement in the above biomark-
ers, which are vastly used in many studies of different disorders (Golpe et al.,
2016; Leontidis et al., 2016a; Triantafyllou et al., 2014; Heitmar et al., 2010;
Chew et al., 2016), can lead to more accurate analyses and inferences. The su-
periority of the proposed method is proven both in terms of the mean absolute
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percentage error and the classification performance of the newly estimated fea-
tures (CRVE, CRAE and AVR), and is also compared with the gold standard
method in literature.
1.3 Thesis Overview
The thesis is organised as follows; Chapter 2 gives an overview of the medical back-
ground and previous studies. This chapter presents the necessary background infor-
mation to understand the functionality and importance of the retina and what happens
during the proliferation of diabetes and DR. It also discusses various previous studies,
establishing the necessary basis for the subsequent chapters. Chapter 3 is devoted
on describing the proposed framework, with details about its parts, the methods and
the techniques that were adopted and combined. It also describes the different areas
of interests and how the vessel segments are matched and assigned to each of these
areas. Finally it gives important information about the biomarkers under investigation
and also the fundamentals for the estimation of the haemodynamic features. Chapter
4 focuses on the statistical analysis methods, the feature selection processes and the
classification models. All the metrics that were utilised to evaluate and validate the
models are also elaborated, followed by the feature selection and classification tech-
niques that were adopted, and finishing with the binary classification combinations
that were conducted. Chapter 5 is solely devoted on the new method of summarising
the width of the parent vessel trunk, which is also compared with the gold standard
method in literature, using statistical and classification approaches for the validation.
Chapter 6 will present the novel results of the statistical analyses of the six different
data categories and also the results of the eight different classification combinations.
Finally, some critical and concluding remarks are given in Chapter 7.
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Chapter 2
Medical Background and Previous
Studies
2.1 Introduction
This chapter is focusing on providing the necessary background information in order
to understand how the human retina is functioning, how is affected by diabetes and
diabetic retinopathy (DR) and what impact this has to the retinal vascular geometry
and haemodynamics. Diverse and comprehensive research is being conducted in this
field, both by clinicians and computer scientists that creates the need for a deeper
understanding of the mechanisms underneath the development of diabetic retinopathy
(DR). This fact enhances the necessity for a comprehensive approach in quantifying
the functional impairments and the retinal vascular alterations (objective of this thesis)
during the development and progression of diabetes, until the first lesions appear in the
retina (onset of DR). Since DR can be managed upon early diagnosis, it is useful to
focus on finding and categorising all the changes that are triggered by the progression
of diabetes.
The first part of this chapter is devoted on providing some medical background
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information about the retinal tissue, and also how diabetes and DR is affecting its
functionality. The second part presents the findings of some key previous studies,
with the third part addressing how this thesis is aiming to contribute to this research
field with some novel elements.
2.2 Anatomy of the Retina
The vertebrate retina, or simply the retina, is composed by ten distinct layers, which
are categorised from closest to farthest from the vitreous body (Villegas, 1960). The
retina of the eye is a light-sensitive layer of tissue, which is located in the inner surface
of the eye and enables the conversion of the incoming light into a neural signal for fur-
ther processing in the visual cortex of the brain (Dowling, 1987). It is easily accessible
nowadays with many different methods (ophthalmoscope, fluorescein angiogram, op-
tical coherence tomography etc.), to both scientists and clinicians (Ciulla et al., 2003).
Its importance is highlighted by the fact that, according to estimations, around 80% of
all sensory information in humans originates from the retina (Hildebrand & Fielder,
2011; Oyster, 1999; Riordan-Eva & Whitcher, 2008). Figure 2.1 shows where the
retina stands in respect to some of the other anatomical parts of the eye.
Figure 2.1: A schematic representation of some of the anatomical parts of the eye, includ-
ing the retina. The diagram shows the position of the retina into this complex organ, the eye.
Source:http://www.thomasutton.com/about-your-eyes/eye-anatomy-diagram.html.
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As described above, retina is a layered structure of neurons interconnected with
synapses with only the photoreceptors cells being light sensitive. There are two main
types of photoreceptors: rods, which are responsible for black-and-white vision, mainly
in dark light, and cones, which make the eye perceive colour and support daytime vi-
sion. A third one is also found, which is a much more rare type of photoreceptor, the
intrinsically photosensitive ganglion cell, which responds to light in the absence of all
rod and cone photoreceptors (Do & Yau, 2010).
In humans, the entire retina is approximately 24 mm in diameter (Riordan-Eva &
Whitcher, 2008). It contains 7 million cones and 75–150 million rods. An important
part of the retina is the optic disc or optic nerve head, which is often called the blind
spot, since it has no photoreceptors. It is found at the optic papilla, a nasal zone where
the optic nerve fibres leave the eye (Navarro, 2009; Oyster, 1999). In a fundus image,
figure 2.2, this can be found as a white oval area, extending in an area of 3 mm2.
Temporal to the optic disc is the macula, a small and highly sensitive part of the retina
responsible for detailed central vision. In the very centre of the macula is the fovea,
which is responsible for sharp central vision, necessary in humans for activities that
require visual details (Provis et al., 2005).
In section, the size of the retina is approximately 0.25 mm in thickness, which
varies with age (Alamouti & Funk, 2003). It has three layers of nerve cells and two
of synapses including the ribbon synapse. The connection between brain and retina is
made via the optic nerve head, which carries the ganglion cell axons in the brain, and
the blood vessels that are spread inside the retina (Riordan-Eva & Whitcher, 2008).
2.3 Diabetic Retinopathy
Diabetic retinopathy is a complication of diabetes, characterised by lesions and vas-
cular anomalies in the retina, which include micro-aneurysms, haemorrhages, cotton
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wool spots, exudates (bright spots), venous beading, intra-retinal microvascular ab-
normalities, neovascularisation, loop and fibrous proliferation (Donnelly & Horton,
2008). Figure 2.2 shows a normal retina with the blood vessels, the macular area
and the optic nerve head, and also a diabetic retinopathy retina one with some appar-
ent lesions. Diabetic maculopathy occurs when diabetic retinopathy starts affecting
the central macula, which may also cause loss of vision (Antcliff & Marshall, 1999).
Making a proper assessment of the stage of retinopathy requires the ability to be able
Figure 2.2: Normal retina on the left, showing the blood vessels, the macula and the optic disc.
On the right the same retina can be seen, which now includes haemorrhages and micro-aneurysms.
Source:http://www.silversteineyecarenj.com/diabetic-eye-care.php.
to successfully identify all of the the following (Donnelly & Horton, 2008; Wilkinson
et al., 2003):
Micro-aneurysms represent the earliest visible change of diabetic retinopathy.
They appear as round, red dots, mainly in the posterior part of the eye, and
usually increase with the progression of DR. It is also common to appear in
clusters (Wilkinson et al., 2003).
Haemorrhages usually accompanymicro-aneurysms in the retina, but they may
take different shapes, such as a dot or blot (mostly in the inner layer), and also
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flame-shaped (mostly within the superficial layer in the nerve fibre layer), de-
pending on their depth within the retina (Donnelly & Horton, 2008).
Vitreous haemorrhage refers to the bleeding within the vitreous cavity. When
the macula is obscured, the incidence of vision loss rises sharply (Donnelly &
Horton, 2008).
Preretinal or subhyaloid haemorrhage is bleeding found anterior to the retina
and under the posterior vitreous face; it often appears as a capsized shape(Ramsay
et al., 1986).
Hard exudates are formed by leaked cellular lipids from abnormal intra-retinal
capillaries. They appear as shiny yellow-white deposits with sharp margins,
which vary from small spots to larger patches. They may also evolve into rings
known as circinates. In case the leaked lipids coalesce into the fovea, then vision
can be compromised (Wilkinson et al., 2003).
Cotton wool spots are greyish or white patches of discolouration in the nerve
fibre layer, which have indistinct edges. They result from local ischaemia, so
multiple cotton wool spots might indicate generalised retinal ischaemia - a fea-
ture of pre-proliferative retinopathy(Donnelly & Horton, 2008) .
Venous beading refers to the localised dilation of veins. The degree of venous
beading can be a useful sign of proliferative diabetic retinopathy as well as dif-
fuse retinal ischaemia (Wilkinson et al., 2003).
Intraretinal microvascular abnormalities are regions where capillaries appear
dilated with new tortuous vessels formed within the retinal layers (Lee et al.,
2015a).
Neovascularisation refers to the process of abnormally growing new vessels.
These new vessels stem from large veins or major arcade vessels. They initially
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appear as fine tussocks on the surface of the retina. These newly formed vessels
are fragile and bleed easily (Wilkinson et al., 2003).
Loop is the sudden deviation of a vein from its normal course. The deviation
varies from a gentle curve to a nearly omega shaped one (Cogan et al., 1961).
Retinal detachment is an outcome of the neovascular traction. It usually occurs
slowly and may remain stable for years, when laser treatment has been applied
to control the neovascular process (Wilkinson et al., 2003; Donnelly & Horton,
2008).
DR may progress through four stages (Watkins, 2003; Frank, 1995):
1. Background or mild non-proliferative retinopathy, where small balloon-like
swellings appear in the retina’s blood vessels called micro-aneurysms.
2. Moderate non-proliferative retinopathy, where swelling and distortion of the
vessels might occur, as well as possibly losing their ability to transport blood.
3. Severe non-proliferative retinopathy, where evenmore blood vessels get blocked,
depriving of the blood supply to various areas of the retina. These areas can stim-
ulate the production of growth factors that signal the retina to start growing new
blood vessels.
4. Proliferative retinopathy. At this stage, the proliferation of new blood vessels
occurs, which grow along the inner surface of the retina and the vitreous gel.
These vessels are fragile, which makes them more likely to leak and start bleed-
ing. It is also possible that the scar tissue will contract and cause the retina to be
detached from the underlying tissue.
An example of the four stages can be seen in figure 2.3.
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Figure 2.3: Four different fundus images, representing a different stage of DR. Image 1: mild non-
proliferative DR, image 2: moderate non-proliferative DR, image 3: severe non-proliferative DR and
image 4: proliferative DR. Source: http://sdhawan.com/eye-diseases-diabeteseye.htm.
Although DR is a very common complication of diabetes, still many cases are
observed at a late stage, where visual acuity is impaired and irreversible damage has
already occurred (Aiello, 2003; Ruta et al., 2013). The prevalence of DR is found
to increase with the duration of diabetes. According to some very interesting results
from the Australian Diabetes, Obesity and Lifestyle study in patients with diabetes
with less than 5 years in diabetic state, the prevalence of DR is less than 10%, but this
number becomes more than 50% in those patients having diabetes for 20 or more years
(Nguyen et al., 2008a; Tapp et al., 2003).
The main risk factors of DR remain hypertension and hyperglycaemia, but hy-
perlipidaemia should not be excluded as well (Nguyen et al., 2007). A number of
epidemiological studies have highlighted the importance of hyperglycaemia in DR,
in addition to two pivotal studies: UK Prospective Diabetes Study in patients with
Type 2 diabetes (UKPDS, 1998a) and the Diabetes Control and Complications Trial
in patients with Type 1 diabetes (Ohkubo et al., 1995; DiabConCompTr, 1993). In
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the UK Prospective Diabetes Study, there is another interesting part, which shows that
controlling the blood pressure level reduces the risk of retinopathy regardless of the
glycaemic level (UKPDS, 1998b).
An important thing to keep in mind is that the isolated retinopathy signs (micro-
aneurysms, haemorrhages and cotton wool spots) are found to be more common now
in subjects without diabetes and hypertension, in comparison with what had been pre-
viously believed (Nguyen et al., 2008a).
At an early stage, DR affects the endothelial cells and the structure of muscle cells,
leading to the loss of pericytes (Eva & Mansour, 1998). The proliferation of the en-
dothelial cells and the thickening of the membrane cause vascular occlusion, whereas
pericyte loss is responsible for the formation of micro-aneurysms. The big challenge
remains to detect and understand the microvascular haemodynamic abnormalities at a
stage when there are no morphological alterations in the retina. In this stage, the clin-
icians could possibly be able to intervene and manage to some extent the progression
of the disease.
Unfortunately, the pathogenesis of DR is not yet fully understood both at the cel-
lular and molecular level, limiting the options for effective therapeutic interventions
early, while the disease still develops (Stitt et al., 2005; Stitt & Curtis, 2005). The
exact mechanism that triggers the formation of the microvascular lesions remains to
be fully understood.
In general, hyperglycaemia appears to be sufficient to initiate the development of
DR as revealed by some experiments in animals, which were made hyperglycaemic in
the laboratory (Engerman &Kern, 1984; Kador et al., 1990; Kern & Engerman, 1996).
At the same time, similar studies have shown that by intensively and sufficiently con-
trolling hyperglycaemia leads to the inhibition of the development of DR (Engerman
& Kern, 1993).
Possible geometric alterations in the retina might indicate the existence of a sys-
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temic disease. Functional changes can be depicted in the retina vasculature and also be
measured using devices such as flow velocity meters, oximeters etc. Assessing these
functional and haemodynamic changes in a qualitative way might help to bypass the
limitations of studying only the morphological features. Moreover, it can help dif-
ferentiate between diseases that their structural effect on the retina is ambiguous and
prone to misinterpretation.
2.4 Blood Supply
The retinal circulation is directly observable and has its own blood supply, which
comes from behind the eye and enters the retina through the optic nerve head. It is
an end arterial system without anastomoses. The central retinal artery brings the blood
into the retina and the central retinal vein drains the blood out of the eye, leading the
blood back to the heart for re-oxygenation (Funk, 1997; Hayreh, 1969).
2.5 Screening of the Retina
Retinal imaging is a non-invasive way of viewing human vessels. Using proper tech-
niques, retina is visible from the outside, which assists in the imaging of the retina
and brain tissue non-invasively (Lupascu, 2010; Terai et al., 2014). Moreover, as the
retina is a highlymetabolically active tissue with a double blood supply, it allows direct
non-invasive observation of the circulation (Rice et al., 2002; Kim et al., 2011).
The reason why the retina is so extensively studied is due to the fact that both eye-
and other- diseases that affect the circulation and the brain can be illustrated in the
retina (Wong et al., 2001, 2006). Macular degeneration and glaucoma are among the
most prominent diseases and together with DR the most important causes of blindness
in the developed world (Williams et al., 2004).
In addition to the eye diseases, a number of systemic diseases also affect the retina.
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Complications of such diseases include DR from diabetes mellitus, hypertension from
cardiovascular disease and multiple sclerosis (Hayreh et al., 2001). During the last
decade, advances in non-invasive techniques utilised for measuring several features
in the retina, have led to the exploration of different aspects about the haemodynamic
and geometric features of the retina and blood flow regulation, both in normal and
diseased human eyes. Some examples of these techniques are the following: The
retinal vessel analyser (Polak et al., 2000), dye dilution technique for arteriovenous
passage time (Wolf et al., 1989), blue field simulation for the velocity and the number
of leukocytes (Riva & Petrig, 1980), bidirectional laser Doppler velocimetry (LDV)
for the red blood cell velocity (Sullivan et al., 1990), laser Doppler flowmetry for the
blood flow in the tissue of the optic disc (Nilsson et al., 1980) and colour Doppler
imaging for the central retinal arterial blood velocity (Williamson & Baxter, 1994).
Regarding the measurement of retinal blood flow, another methodology is the video
fluorescein angiography, which relies on the rapid injection of a small bolus fluorescein
dye and recording the retinal images with a scanning laser ophthalmoscope in order
to distinguish the resultant vascular fluorescence from the passage of fluorescent dye
through the retinal circulation (Wolf et al., 1989).
2.6 Blood Flow Mechanisms in Diabetes
Impairment in retinal blood flow is one of the earliest abnormalities to occur in the
human body in diabetes (Cunha-Vaz et al., 1978). Only 4% of the blood flow delivered
to the eye is distributed into the retina (Besharse & Bok, 2011). Impairment of retinal
circulation results in blood flow alterations, which consequently affect the delivery of
oxygen and metabolic substrates to the tissue. The maintenance of the function and
structure of the retina is highly affected from these abnormalities (Clermont & Bursell,
2007).
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Grunwald et al. stressed the importance of the blood flow, especially in compar-
ison with perfusion pressure (Grunwald et al., 1996). In their initial study in diabetic
patients, they found that both the mean blood pressure and perfusion pressure in all pa-
tients who were normotensive were significantly higher in five patients, whose blood
flow did not decrease after 5 days and whose retinopathy deteriorated at 6 months.
Another observation shows evidence that increased blood pressure is correlated with
increased prevalence of retinopathy (Knowler et al., 1980; Klein et al., 1989, 1995).
In the Wisconsin study, the authors found that systolic blood pressure is a significant
predictor of the incidence of DR, while diastolic blood pressure can be an important
predictor of the progression of the disease (Klein et al., 1989).
Perfusion pressure can also be of importance in the early screening of DR, since
the normal auto-regulatory response mechanism of the vessels is impaired. Perfusion
pressure can be calculated by subtracting the intraocular pressure from the two-thirds
of the mean arterial pressure (Sinclair et al., 1982). In another study, using light stim-
ulation in patients with well-controlled Type 1 diabetes and no signs of retinopathy,
showed that the functional abnormalities consist of reduced or no dilation of retinal
vessels, as well as reduced or no constriction of retinal arteries, as a response to the
increase of intraluminal pressure (Garhofer et al., 2004b; Mandecka et al., 2007). A
very interesting finding (Hill et al., 2009; Lorenzi et al., 2010) was that flickering light
stimulates and activates auto-regulatory mechanisms that dilate the retinal blood ves-
sels and affect the blood flow by enhancing the circulation. In healthy subjects, the
response relates to the increase of the calibre of the retinal vessels by 2–4%, whereas in
diabetic patients, there is slight or no response to the stimuli at all. An observation of
the response of the retinal vessels to increased intraluminal pressure and how the vas-
cular mechanisms manage to regulate this suggests that in normal arteries, an elevation
in intraluminal pressure leads to the constriction of the vessels or to the dilation under
pressure reduction. All of these occur by using the inherent mechanisms in the vas-
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cular smooth muscles cells that are independent of any hormonal, neural or metabolic
influences. This mechanism is termed myogenic response (Hill et al., 2009).
It can be inferred from the above studies that blood flow is an important window for
understanding and measuring the changes during the progression of the disease. Every
single change, either in the vessel structure or in the microcirculation, directly affects
the blood flow inside the vessels. It is a fact that most of the studies use different
methods to take such measurements and different metric systems. It still remains a
very difficult task to associate changes in blood flow with the progression of a disease,
since many other factors might influence the blood flow, which have to be excluded in
the first place.
2.7 Introduction to Biomarkers
A few tests were run to evaluate the response of the retinal vessel structure to different
stimuli, measuring at the same time the changes in the vascular diameter, either with the
laser Doppler flowmetry or with the dynamic retinal vessel analyzer (Garhofer et al.,
2004a; Lorenzi et al., 2010). In addition, some retinal vascular width changes were
identified and associated with early consequences of diabetes, making them candidates
to become biomarkers of risk for diabetic complications.
A biomarker can be defined as a feature that is accurately and objectively measur-
able and is evaluated as an indicator of regular biological and pathogenic processes or
responses in a specific drug treatment or disease (Steyerberg et al., 2012). It is clear
that some systemic markers such as blood pressure, duration of diabetes, glucose level
and lipid levels are definitely relevant factors, but on the other hand, they cannot be
used to identify the proliferation of DR (Hove et al., 2006). It is observed that even
patients under good glycaemic control can worsen rapidly, in contrast to patients with
poor control that might remain in stable condition (Ribeiro et al., 2013). This led to
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the identification of different phenotypes of progression, taking into account the char-
acteristics of the retinal lesions.
Time of testing plays a crucial role in accurately and reliably measuring the haemo-
dynamic features at fixed state. Diverse indications of the abnormalities in diabetic
patients are observed, which are assumed to be attributed to the influence of blood
glucose level during the testing (Ikram et al., 2013; Pournaras et al., 2008). Applying
some stimuli in the retina can cause abnormal auto-regulation of the blood flow in DR
patients, with a simultaneous increase of the flow, in parallel with the proliferation
of DR (Kohner et al., 1995). Changes in the retinal architecture may result in im-
paired space filling and microcirculatory transport of non-uniform shear distribution
in branches and bifurcations. Moreover, it might cause reduced energy efficiency in
blood flow, giving a strong indication of early disease state (Ikram et al., 2013).
2.8 Pathology in the Diabetic Retina
The pathological processes during diabetes are initially subtle but affect the whole
haemodynamic functionality of the retina. During normal state, the auto-regulation
mechanisms keep the blood flow constant in the whole range of systemic blood pres-
sures and intraocular ones (Riva et al., 1981). The vessel responses are locally regu-
lated, by targeting the smoothmuscle cells in arterioles and capillary pericytes (Burgansky-
Eliash, 2012; Sims, 1986). On the other hand, during diabetes, there are changes in
local vasoactive factors, and the response of pericytes to these factors is altered as well
(Joussen et al., 2002; King et al., 1994; Bursell et al., 1997).
Tight junction complex proteins help in the creation of the blood–retinal barrier.
In order to maintain normal neural function, the tight junction is responsible for the
connection of the endothelial cells in the brain and retina (Harhaj & Antonetti, 2004).
In some diseases such as DR, the actions of the vascular endothelial growth factor
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(VEGF) and cytokines on the tight junction proteins affect the vascular permeability
and cause changes in the blood–retinal barrier. The importance of blood–retinal barrier
can be highlighted from the fact that it is responsible for preventing certain substances
from entering the tissues of the retina. The blood–retinal barrier is formed from tight
junctions between retinal epithelial cells and non-fenestrated capillaries of the retinal
circulation (Harhaj & Antonetti, 2004).
According to emerging evidence, neurodegeneration has been found to occur early
in the pathogenesis of DR. In addition to neural apoptosis, some changes in glial cells
(non-neurons) occur as well, with the process known as reactive gliosis. It is still un-
clear, which of the two processes occurs first in the degeneration process. Themost im-
portant mechanisms that mediate the neurodegeneration process are: oxidative stress,
extracellular glutamate accumulation and reduction of neuroprotective factors (Simo
& Hernandez, 2014).
The term oxidative stress, describes the imbalance that occurs between the reac-
tive oxygen species and the antioxidant defenses of a living system (Baynes, 1991).
Tissue damage and patho-physiology is triggered by oxidants such as reactive oxy-
gen species and reactive nitrogen species. The oxidative stress, which is caused by
hyperglycaemia, is considered an important pathway of diabetic microvascular com-
plications (Cui et al., 2005). There is strong evidence that the correlation between
hyperglycaemia, redox homoeostasis and oxidative stress is responsible for the patho-
genesis of DR (Kowluru & Chan, 2007; El-Remessy et al., 2005).
The Hoorn study reported the significance of subclinical inflammation to the de-
velopment of DR (Van Hecke et al., 2005). DR is also considered a low-grade inflam-
matory disease affecting the rolling and adhesion of leukocytes (Miyamoto & Ogura,
1999). Nowadays, the role of inflammation has been highlighted and it is considered
very important, though complex and unclear. Inflammation is triggered by factors such
as hyperglycaemia, oxidative stress, hypertension etc., but this creates a chain reaction
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since inflammation propagates these pathways further through cytokines, VEGF sig-
nalling, adhesion molecules, enhanced receptors for advanced glycation end- products
expression, nitric oxide regulation andNF-kb signalling. The subclinical inflammation
via endothelial nitric oxide synthase leads to increased intraocular pressure (Adamis,
2002).
2.9 Effect of Diabetes in Vessel Structure
Hyperglycaemia leads to intramural pericyte death and thickening of the basement
membrane, which contributes highly to the alterations in the integrity of the retinal
blood vessels. This fact causes changes to the blood–retinal barrier and vascular per-
meability (Kitabchi et al., 2009; Qaum et al., 2001). During the hyperglycaemic state,
the endothelial cells align and elongate in the direction of shear stress, modifying some
of their functions at the same time. Shear stress is defined as the component of stress
coplanar with a material cross-sectionally (Libby P, 2002). The endothelial cells re-
spond to the increased shear stress and producemore a vasodilator (nitric oxide), which
causes the expansion/dilation of the blood vessels. This homoeostatic reaction of the
vessels occurs in order to restore the normal shear stress by decreasing the blood flow
velocity (Gross et al., 2003; Beckman et al., 2001).
Another major issue is the development of atherosclerotic plaque, namely the hard-
ening and thickening of arterial wall due to the reactive oxygen species and inflamma-
tion. These two factors can be suppressed by the nitric oxide. If the endothelial cells
do not produce enough nitric oxide in response to shear stress in a diabetic state, it can
lead to the development of atherosclerosis in diabetic patients (Creager et al., 2003).
The pulsatile flow of the blood through the vessels activates the endothelial nitric
oxide (Lu & Kassab, 2004). The shear stress, caused by the blood pressure in every
heartbeat, makes the vessels stretch and relax, since the blood flow inside the vessels
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is not steady. The role of the endothelial nitric oxide is to maintain the diameter of
the blood vessels so as to preserve the perfusion of tissues at optimal levels. VEGF
mediates the release of nitric oxide from human umbilical venous endothelial cells
(Toda et al., 2010; Calles-Escandon & Cipolla, 2001).
Metabolic abnormalities are a main characteristic of diabetes, which include hyper-
glycaemia, free fatty acids and insulin resistance. These three factors provoke molec-
ular mechanisms, which in turn alter the function and the structure of the vessels. Ox-
idative stress is one of those affected, in addition to the malfunction of the intracellular
signal transduction (Hartnett et al., 2000; Beckman et al., 2002).
One very important concept defines that hyperglycaemia-induced oxidative stress,
very common in DR, mediates the endothelial malfunction in diabetic patients. This is
proven by the observations that intra-arterial infusion of ascorbic acid restores endothelium-
dependent vasodilation in healthy subjects, exposed to a hyperglycaemic clamp as well
as in patients with Type 1 and Type 2 diabetes (O’Driscoll et al., 1997).
Vascular muscle cell apoptosis in atherosclerotic lesions is also increased in such
a way that patients with diabetes are prone to having fewer smooth muscle cells in
the arterial lesions, which increases the tendency of plaque rupture. The signalling
pathways in the cells are affected by the way the cells adhere to the substrate proteins.
Moreover, since the cells attach to the glycated collagen in a completely different way
than normal collagen, it leads to a different way of responding to themechanical forces.
Although the high blood sugar state is more frequent, the cell response to blood flow
is altered even in low blood sugar levels (Creager et al., 2003).
The arterial walls tend to become stiffer with age, but diseases such as diabetes can
accelerate this natural process. The arterial muscle cells contraction and relaxation are
affected by the impaired endothelial cells, which in turn affect the wall stiffness by the
modification of the isometric tone (Bank et al., 1995).
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2.10 Oxygen Perfusion
The exact cause of the elevated oxygen saturation in DR is still uncertain and unclear,
but it is evident that the normal response of the retinal circulation in preventing hyper-
oxygenation is impaired by hyperglycaemia (Khoobehi et al., 2013).
Oxygen distribution is another major factor in the vessel wall oxygen perfusion.
The process of the oxygen distribution can be affected by some factors, including cap-
illary non-perfusion and shunting, thickening of capillary basement membranes and
oxygen affinity of haemoglobin in diabetic patients (Konno et al., 1996).
If the capillary network is shunted at some point, the blood may bypass it through
dilated channels. During this state, some of the capillaries are closed and some di-
lated. Some studies in the retina, using fluorescein angiography, have shown that di-
lated capillaries force the blood to pass from arterioles to venules, leading to capillary
non-perfusion (Hardarson & Stefánsson, 2012). This ”unhealthy” process makes the
transport of blood faster than normal, making the venular blood hyperoxic and the rest
of the blood hypoxic in these non-perfused areas. The capillary non-perfusion in addi-
tion to shunting disturbs the normal blood flow, altering the normal oxygenation that
may lead to different pathologies. As a consequence, the non-perfused areas do not
extract oxygen from the haemoglobin, making the tissues hypoxic and thus ischemic.
One of the observations during DR is the thickening of capillary walls, which can
lower oxygen delivery levels. It is assumed that in this situation oxygen is inhibited
from efficiently diffusing and perfusing vessels, contributing probably to the elevated
oxygenation of the blood. Knowing the high importance of the oxygen for the func-
tionality and preservation of tissues, it can be inferred that the mal-distribution during
the disease state makes the tissues hypoxic, elevating the demand of oxygen, and thus
increasing the blood flow to deliver more oxygen. The above way is one of the reasons
that total blood flow can be increased in DR (Hardarson & Stefánsson, 2012) .
It is easily understood that dead tissue cannot consume oxygen. Tissue degenera-
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tion lowers the total amount of oxygen extracted by blood vessels, increasing simul-
taneously the venous oxygen saturation, as mentioned in (Khoobehi et al., 2013). It is
speculated that the affected microcirculation in diabetes has an effect on retinal ves-
sel saturation (Hammer et al., 2009). Pathogenesis in DR has been linked to retinal
hypoxia, which triggers neovascularization and retinal oedema (Cai & Boulton, 2002).
Khoobehi et al. conducted a comprehensive experiment in order to determine the
retinal oxygen saturation trendwith the onset of diabetes and increasing severity of DR,
by comparing diabetic groups with and without retinopathy (Khoobehi et al., 2013).
For this purpose, they used a fundus camera-based dual-wavelength snapshot oximeter
to take images of the retina for the whole recruited group and analyse them to deter-
mine oxygen saturation in the major arteries and veins. It was found that in normal
subjects, the saturation was 92.3 ± 4.2% in arteries and 57.2 ± 6% in veins; in dia-
betic patients without DR, it was 96.3 ± 8.6% in arteries and 58.7 ± 7.5% in veins;
in diabetic patients with mild-to-moderate non-proliferative DR, it was 97.7 ± 5.8%
in arteries and 61.1 ± 7.6% in veins. The saturation in patients with diabetes with se-
vere non-proliferative DR was 102 ± 10.2% in arteries and 66.8 ± 8.4% in veins; in
patients with proliferative DR, it was 103.6 ± 8.7% in arteries and 66.6 ± 10.2% in
veins; and finally, in all diabetics with DR combined, it was 100.4 ± 7.6% in arteries
and 64.2 ± 8.4% in veins. From this study, it is clear that there is a trend of increasing
retinal oxygen saturation from healthy subjects to non-DR group and to DR patients.
In DR, the oxygen perfusion might be influenced by the impaired blood flow. In a
study by Jorgensen et al., 156 diabetic patients were recruited, 48 with Type 1 and
108 with Type 2 diabetes, in addition to 80 age-matched normal subjects (Jorgensen
et al., 2014). For the normal controls, any other diseases such as ocular diseases, di-
abetes or hypertension were excluded. They used a retinal oximetry device in order
to measure the oxygen saturation in veins and arteries. As observed in proliferative
DR patients, the arterial saturation was significantly higher than normal subjects and
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diabetic patients with retinopathy not requiring treatment, whereas there was no sig-
nificant difference in diabetic patients without retinopathy. Regarding the veins, the
diabetic patients with or without retinopathy presented significantly higher saturation
than normal subjects. Another important observation indicates that the oxygen extrac-
tion decreases with increasing severity of retinopathy, i.e. from normal subjects until
the last stage of proliferative DR.
2.11 Haemodynamic and Geometric Alterations in Di-
abetes &DR – Experimental Results in Literature
A vast number of studies have focused on the vascular changes in healthy, diabetic
and/or DR subjects. Studies since 1921 can be found introducing the vascular changes
due to DR (Wagener &Wilder, 1921), with also other studies (Wagener &Keith, 1939;
Scheie, 1953; Leishman, 1957; Stokoe & Turner, 1966) introducing general vessel ap-
pearance, such as tortuosity, branching patterns and general retinal features (Ashton,
1949). Regarding the more recent and comprehensive studies, Burgansky et al. stud-
ied the effect of DR on the arterial blood flow velocity in 42 diabetic patients and 38
healthy subjects and found that the velocity was slower in DR patients than healthy
subjects (3.74 mm/s ± 1.09 for DR and 4.19mm/s ± 0.99 for healthy) (Burgansky-
Eliash et al., 2012, 2010). Moreover, they investigated the early haemodynamic al-
terations in patients with diabetes before the first lesions appear in the retina. In this
study, the blood flow velocity in the retinal vasculature of adult-onset diabetic patients
with no signs of DR (23 eyes) was compared with that of age-matched healthy subjects
(51 eyes). For all the participants, measurements of blood glucose level, glycosylated
haemoglobin (HbA1c), body mass index, intraocular pressure, systemic blood pres-
sure and heart rate were taken. According to their results, the blood flow velocity in
arteries was 4.7 ± 1.7 mm/s in the diabetic group, which is significantly higher than
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that of the healthy group 4.1 ± 0.9mm/s. The velocity in the veins in both groups was
slower than arteries (3.8 mm/s in diabetes mellitus group and 2.9 mm/s in healthy
group). It is worth mentioning that in the diabetic group, the velocity values in both
arteries and veins were not correlated with the duration of diabetes, the level of glu-
cose, HbA1C or body mass index (Burgansky-Eliash, 2012; Burgansky-Eliash et al.,
2010).
It is apparent that the increased velocity in diabetic patients compared to healthy
subjects is opposed to the findings in DR patients (Libby P, 2002). This means that the
relationship between the disease and healthy blood flow velocity reverses during the
development of morphological alterations in the retina, as arteries reach their limits
and capillary resistance defines the flow volume. In two studies (Rimmer et al., 1989;
Konno et al., 1996), it was found that blood flow velocity decreases over time in some
but not all diabetic patients.
Takahiko et al. assessed the blood flow in the bilateral central arteries in 50 insulin-
dependent diabetic patients without any signs of DR and they used 20 sex- and age-
matched normal subjects as a comparison. For the measurements, they used duplex
Doppler sonography (Kawagishi et al., 1995). The parameters that they measured
were peak-systolic velocity, end-diastolic velocity, time-averaged velocity, resistance
index (RI) and pulsatility index. As was expected, the results were different between
diabetic patients and normal subjects. Peak-systolic velocity, end-diastolic velocity
and time-averaged velocity were lower in diabetic patients than in normal subjects.
Regarding the RI index, it appeared to be higher in diabetic patients than in normal
subjects. Finally, for the pulsatility index, there was no significant difference between
diabetic patients and normal subjects. Another interesting finding is that RI is corre-
lated with the levels of glucose (r = 0.310) but not with haemoglobin levels (r = 0.184),
blood pressure or duration of diabetes. The outcome shows that retinal artery blood
flow velocities were decreased, whereas vascular resistance was increased in diabetic
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patients without clinical signs of DR.
Grunwald et al. recruited 19 diabetic patients with less than 4 years of diabetes and
16 age-matched normal subjects. In their experiment, they measured different venous
segments in diabetic patients and normal subjects respectively. Haemodynamic pa-
rameters such as blood glucose, mean blood pressure, intraocular pressure, perfusion
pressure, haemoglobin and the duration of diabetes were taken into account. The total
measured blood flow rate in the diabetic patients was 43.3 (SD8.9)ml/min, which is
significantly higher than normal subjects 38.5 (SD 4.7)ml/min by about 12% (Grun-
wald et al., 1996). A positive correlation was also observed between blood flow and
disease duration. The total venous cross-section in diabetic patients was much higher
than that of normal subjects by about 12%. Again a correlation was observed be-
tween the total venous cross-section and duration of diabetes (r = 0.34). The blood
flow velocity in the largest retinal vein in both eyes appeared not to be significantly
different between normal subjects and diabetic patients and no significant correlation
was observed between the velocity and duration of the disease(r = 0.05). A very in-
teresting part of this experiment was the measurement of the retinal-vascular regula-
tory response in hypoxia, which was defined as the percentage decrease in blood flow
rate, blood flow velocity and large venous diameter between normal room air breath-
ing and 100% oxygen breathing provided externally. This magnitude was found to
be –11.6% (SD 4.5%) for venous diameter, –35.2% (SD 8.4%) in blood flow veloc-
ity and –49.2% (SD 7.8%) in blood flow rate but showing no significant difference
from those of the normal subjects (-12.6%(SD 4.1%), -38.2 (SD 10%) and -53% (SD
8.8%) respectively). Finally they found no significant correlation between any of the
haemodynamic variables measured.
In another study (Grunwald et al., 1992), 12 normal subjects and 18 diabetic pa-
tients with background retinopathy were used for taking measurements of the total
retinal volumetric blood flow and venous diameter in a similar way as the above-
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mentioned experiment, using the same haemodynamic parameters. They found a pos-
itive correlation between the venous diameter measurements and the maximum ery-
throcyte velocity in four to five major retinal veins, both in normal subjects and in
diabetic patients, measured by using bidirectional laser Doppler. The results showed
a significantly larger blood flow and venous cross-section in the diabetic patients than
normal subjects. Blood flow was found significantly larger in temporal retina than in
nasal retina in normal subjects and diabetic patients. The measured blood flow was
also significantly different between the superior and inferior retina in diabetic patients
but not in normal subjects.
Bursell et al. conducted a comprehensive experiment investigating the retinal
blood flow changes in patients with Type 1 diabetes and age-matched normal sub-
jects (Bursell et al., 1996). It was also investigated whether blood glucose levels can
alter the retinal blood flow and also whether this can influence blood flow data in
cross-sectional studies. Fluorescein angiography was used and blood glucose levels
were adjusted in three levels using a glucose clamp in order to achieve values at 100,
200 and 300 mg/dl, taking blood flow measurements in each of these levels. Retinal
blood flow was found to be significantly decreased in diabetic patients in comparison
with the blood flow in normal subjects. During the glucose clamp in diabetic patients,
the retinal blood flow increased at 200mg/dl and 300mg/dl in comparison with the
100mg/dl level. In addition to the blood flow, they took measurements of arterial and
venous diameters but the results presented no significant differences across the three
glucose clamps and between the two groups.
The rate of retinal blood flow depends on several factors, which determine the
perfusion pressure and the vascular resistance. Perfusion pressure is the pressure that
drives the blood into the retinal vasculature. Vascular resistance is generated by the
combination of the retinal vessels and the blood viscosity (Pournaras et al., 2008).
Blood flow rate using laser doppler velocimetry (LDV) method has been found to
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vary with a junction exponent x = 2.76 (SD 0.16) in the arteries (values of diameter (D)
between 39 and 145 µm) and x = 2.84 (SD 0.12) for the veins (values of D between 64
and 177 µm) (Riva et al., 1985). These values are in close agreement with Murray’s
law (Murray, 1926b), which calculates a junction exponent value of 3 for a vascular
system that seeks an optimum compromise between blood volume and vascular resis-
tance or in other words that minimises its resistance for a given volume. Feke et al.
found an exponent of 4.1 for D >100 µm (Feke et al., 1989) and Garcia et al. 3.35
for D between 84–177 µm (Garcia Jr et al., 2002). Another study using dye delivery
technique found an exponent of 2.9 for retinal arterioles and arteries with D between
20 and 80 µm (Guran et al., 1990).
In literature, as far as normal subjects are concerned, the values of the blood flow
rate between studies vary between 30 and 38 µl/min (Grunwald et al., 1992; Riva
et al., 1985) and from 65 to 80 µl/min (Konno et al., 1996; Feke et al., 1989; Garcia Jr
et al., 2002). These differences in measurements are attributed to the fact of different
methodological approaches.
As outlined in (Burgansky-Eliash, 2012), the correlation of blood flow velocity
to physiological parameters is very important in order to understand the effects that
diabetes can have to the human body functionality. In figure 2.4, it is shown that for a
healthy group the flow velocity in arterioles, but not in veins, is positively correlated
withmean arterial pressure (r = 0.29) (Burgansky-Eliash, 2012). The interesting part in
this is that there was no significant correlation observed between blood flow velocity
and mean arterial pressure in both pre-retinopathy and DR patients. This indication
does not exclude the fact that there might be reduced correlation since it could be
impaired by other factors as well, while diabetes develops and progresses.
In the epidemiologic study of Wisconsin (Klein et al., 1984a,b,c,d, 1998, 2008),
which spans across a twenty five year period, they are focusing on the prevalence of
progression and regression to diabetic retinopathy. For that purpose they recruited
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Figure 2.4: Blood flow velocity correlation with the mean arterial pressure using the Retinal Function
Imager. Plot taken from (Burgansky-Eliash, 2012).
more than 1000 young and old diabetic patients, for conducting a prospective study.
A number of medical, demographic, ocular and other covariates were investigated, e.g.
duration of diabetes, glycosylated haemoglobin, body mass index, vessel widths and
arteriovenous ratio (AVR). Their studies foundmultiple associationswith the above co-
variates, regarding the progression risk and incidence of diabetic retinopathy, like du-
ration of diabetes and age. In the particular study that targeted the geometric biomark-
ers, they found that within four years from the baseline examination the central retinal
artery and vein equivalents were associated with greater progression of retinopathy.
In addition, larger CRVE and smaller AVR were strongly associated with greater 4-
,10- and 14-year incidence of proliferative retinopathy. Larger arteriolar and venular
widths, independent of the retinopathy severity level, is associatedwith the progression
of retinopathy and also larger venular caliber is associated with the 4-year incidence
of proliferative retinopathy. In contrast, according to (Yang et al., 2016) wider venu-
lar but not arteriolar widths were found to be associated with the development and
increase severity of diabetic retinopathy in a chinese population. Similarly in (Kifley
et al., 2007) they observed that an increasing severity of DR in persons with diabetes
is associated with the widening of retinal venular width. In (Tsai et al., 2011) was also
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suggested that wider retinal arteriolar width is associated with diabetes and hypergly-
caemia, whereas wider retinal venular width is associated with diabetic retinopathy. In
(Islam et al., 2009) was found that arteriolar calibre was significantly wider in persons
with diabetes compared to DR (p<0.0001), but not for venular widths. Other findings
in (Nguyen et al., 2008b) suggest that both CRVE and CRAE are larger in individuals
with diabetes compared to normal subjects, observing also further dilation of veins
with increasing severity of diabetic retinopathy.
In (Habib et al., 2014) they compared subjects with different stages of diabetic
retinopathy, including subjects that progressed to proliferative DR and subjects with
only diabetes. They investigated only the vessel widths and branching angles. They
observed significant changes among no-DR, mild-DR, severe-DR and PDR indepen-
dent groups for both venular and arterial widths. In their predictive study, which in-
cluded the same subjects in three periods, i.e. first, penultimate and final visit, with the
first being no-DR and the other twomild- and Proliferative- DR respectively, no signif-
icant results were observed whatsoever. Tortuous or twisted vessels are regularly seen
in humans (Weibel & Fields, 1965); mild tortuosity is usually a common anomaly with
no clinical symptons, but severe tortuosity may lead to serious symptoms. Not specif-
ically in the retina, tortuosity has been linked to ageing, atherosclerosis, hypertension,
genetic defects and diabetes (Del Corso et al., 1998; Hiroki et al., 2002; Pancera et al.,
2000; Callewaert et al., 2008; Owen et al., 2008). The underlying mechanisms that
provoke the vessels to become tortuous are poorly understood (Han, 2012). In (Lotmar
et al., 1979) vessel tortuosity quantification passed into a more objective assessment,
where they subdivided a tortuous vessel into single arcs and measured the chord length
and the arrow height (Kalitzeos et al., 2013). A few studies have observed a significant
increase of tortuosity in diabetic and DR subjects (Sasongko et al., 2011; Weiler et al.,
2015; Cheung et al., 2012; Leontidis et al., 2015b), suggesting that tortuosity might
be one of the early signs of vascular changes during the proliferation and progression
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of diabetes and DR.
In addition to the above, another investigated candidate biomarker is fractal di-
mension (FD), which is a measure of the complexity of a pattern (more in chapter 3).
Increased FD in proliferative diabetic retinopathy patients in comparison to normal
subjects has been observed (Daxer, 1993). In (Kunicki et al., 2009) no statistical dif-
ference was found between a diabetic and DR eye, suggesting that the complexity of
the retina vessel network remains statistically the same. Moreover higher FD in dia-
betic subjects compared to normal ones has also been observed, and the associations
remained the same even after adjusting for the presence of retinopathy (Yau et al.,
2010). It needs to be stressed that FD can be affected from the quality of the seg-
mentation and the amount of segmented vessels, supporting the main approach of the
studies of this thesis of comparing the same retinas over a period of time (progressors’
group, i.e. subjects with diabetes that progressed to DR and whose retrospective data
are available).
Unfortunately, when it comes to reviewing, comparing and summarising studies
like the previously presented ones, some problems arise that make the interpretations
problematic. Most of the studies do not use the same techniques for measurements
and they do not follow the same protocol for selecting participants. The results can-
not be directly compared when the cohorts have different demographic background
and/or different medical records (other diseases etc.). On the other hand, these re-
sults are enough to give a good indication of what is happening in the retina, from a
hemodynamical and a geometrical perspective. This helps in planning future studies,
which can be based on the previous findings, trying at the same time to include and
consider more factors that are taken into account, in order to enhance the robustness
and reliability of the analyses and the results.
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2.12 Connection of Previous Studies with this Thesis
It is crucial to emphasise that to the best of my knowledge, all of the above studies
and others in literature involve non-progressed cohorts (subjects with diabetes vs dif-
ferent subjects with advanced stages of diabetic retinopathy) or progressed ones with
wide and unstandardised periods of time, in which they try to identify or exclude any
associations between the disease and the vascular changes. The Wisconsin study was
held over a large period of time, but it did not focus on the changes that occur during
the last stages of the diabetic eye and the immediate onset of DR, but on the long-term
changes. Besides, in such a long period of time many factors might have changed that
could affect the associations.
Therefore the main novel study of this thesis, the progressors’ study (the three
year period pre-DR and the onset of DR, i.e. four years of investigations within the
same subjects), and the comparisons with the non-progressors’ one (four consecutive
years of the same subjects with diabetes but no DR), aim to bridge the gap that exists
in literature, quantifying the vascular changes, by taking into account many different
candidate biomarkers, that some of them, in one way or another, have not ever been
evaluated before. General impressions and knowledge exists about what happens to
the retinal vasculature during the transition from normal to the diabetic eye and/or to
the severe non-proliferative or proliferative diabetic retinopathy eye. However it still
remains unknown, how the vasculature behaves during the time period that the work
of this thesis investigates, and also whether the biomarkers follow the general trends
described previously.
In addition, a novel framework and extensive evaluation of the investigated fea-
tures is presented, by designing and conducting various classification combinations,
within the progressors’ and non-progressors’ groups, and also between them. In this
way, the purpose is to evaluate both the discriminative power of the investigated fea-
tures, as well as how this can be used in predicting different stages of the disease. Tak-
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ing into account that all of the studies that will be presented in the upcoming chapters
are focusing on the late stages of the diabetic eye, as well as the early and still manage-
able stages of DR, the importance of the outcome of these studies is vastly amplified.
Any possible important findings can be used for further investigations and/or clini-
cal applications, since focusing on the advanced or proliferative retinopathy, where
the changes are already extensive and more difficult to reverse or manage, is not an
objective or part of this thesis’s studies. It has to be emphasised that it is important
to understand how the progression of diabetes affects the retinal vasculature at these
crucial last stages of the diabetic eye, but always inside a controlled and accurately
specified period. Duration of diabetes, as commonly reported, is a factor that cannot
be accurately defined, because the date that a subject was diagnosed with diabetes can
be significantly different from the actual date that diabetes occurred. Undoubtedly,
duration of diabetes still remains a very important indicator of the progression when
reliably estimated, however it cannot give an accurate indication in which stage of
diabetes a patient is.
Finally any comparisons with the results of other studies in literature shall therefore
be made with caution, given that this thesis includes studies of a specific period of time
andwith data extracted from the same subjects (follow-up) during the transitional years
from diabetic- to diabetic retinopathy- eye. More reliable comparisons can be made
between the non-progressors’ group and the progressors’ DR group, which include
independent subjects with diabetes andDR. This last combination ismore similar to the
approaches of the other studies in literature. However, as it is going to be stressed more
extensively later, more accurate and representative results can be obtained when one
compares the same retinas over a period of time, and also when, instead of conducting
a cross-sectional experiment, one includes follow-up examinations, in order to define
a more accurate and meaningful trend.
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Proposed Framework and Biomarkers
3.1 Introduction
Retinal image analysis remains a very challenging and versatile field of study. Dif-
ferent regions of the retina, starting from the optic nerve head (large vessels) until
the precapillaries (small vessels), include vessels of dissimilar size, having different
properties (Gariano et al., 1996). As already shown, most of the previous studies in
literature that investigate the retinal pathologies, in regards to the changes in the retinal
vasculature, present a few deficiencies; a) they are only focusing on limited number of
features, b) the measurements within each retina are averaged prior to the analysis (no
mixed effects model then), c) the analysis is made across independent groups, letting
other factors that cannot be standardised to contribute to the errors, d) ignore the more
localised changes in different areas of the retina and e) they do not account for the di-
versity of the retina, which includes many small and large vessels. This latter situation
leads to collecting measurements that might show differences that cannot be safely
attributed to the investigated pathologies, but rather to the inconsistency in selecting
vessels of the same order, hence creating inflated unjustified differences.
The purpose of this chapter is to present a novel framework and methodology for
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studying the retinal vasculature, for identifying the progression from diabetes to dia-
betic retinopathy, that also addresses the issues that were previously described. In ad-
dition, multiple geometric and haemodynamic features are introduced and described,
which will be investigated and evaluated in the next chapters, in a manner that no other
previous study has ever attempted.
3.1.1 Proposed Approach
Despite the many studies in literature, which try to make associations of mainly ge-
ometric alterations with a number of different pathologies, still no comprehensive
framework and/or guidelines exist that combine a series of robust image processing
approaches, statistical analysis tailored to the specific requirements and also a com-
prehensive evaluation of the discriminative power of the candidate biomarkers.
For the first time, in this thesis, such a framework and methodology are proposed,
in order to shed some light on the vascular changes that occur during the progres-
sion and proliferation of diabetes. To achieve that, given the complexity of the retinal
functionality and structure, a series of algorithms that either have been proposed in
literature or were implemented as part of this thesis, are used. As a novel outcome, a
total number of 101 geometric and haemodynamic features are measured or derived,
analysed and evaluated as candidate biomarkers of progression to DR, extracted from
the retina as a whole, as well as from some predefined areas of interest (Hove et al.,
2004).
The first major novel contribution is that a series of haemodynamic features are
estimated, following the segmentation and connection of vascular trees, using both
haemodynamic principles and the retinal geometry. These features are also anal-
ysed and evaluated as candidate biomarkers of progression from diabetes to diabetic
retinopathy, by studying the same vascular trees in a four year period of time that
includes the last three years of the diabetic eye and the onset of diabetic retinopathy
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(progression study). In addition to the above the same exact procedure and analysis are
followed for the non progression study, as well as for the various geometric features
that come from different areas of the retina.
The second major contribution is that a novel framework for studying the reti-
nal vasculature is presented, following a new methodology that aims to minimise the
errors of the analysis, by building and comparing suitable and robust statistical and
classification models. In addition, a tool is implemented that automatically matches
the bifurcations across the different images of the same patient, handling the data in
a way that lets us study the progression and the effects on specific segments over a
period of time and on a large scale basis. The retina is also partitioned into predefined
areas of interest, in order to be separately evaluated.
3.1.2 Chapter Overview
In the studies that follow, many algorithms are utilised for accommodating the needs
of this thesis, e.g. for the segmentation and registration of the retinal images, for ex-
tracting features, etc., but it is also totally out of the scope of this thesis to implement
any such algorithms. There are numerous algorithms in literature doing the above
or purely focusing on the technical aspects, but no studies, to the best of my knowl-
edge, exist that estimate haemodynamic features, combined with various image-level,
bifurcation-level and localised (areas of interests) geometric ones, for studying the
progression of the disease.
The first part of this chapter will give details about the data collection process,
fulfilled in two phases. The second part will be devoted on describing the proposed
framework, which can be used to conduct complete and comprehensive studies for
identifying the retinal vascular alterations during the progression of a disease. At the
third part, an introduction of all the geometric and haemodynamic features will be
made alongside the processes that were involved for measuring and extracting them.
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Finally the last part will conclude the chapter.
3.2 Data Collection and Studies
Prior to commencing any of the studies, an ethical approval was obtained by the ethical
committee of the University of Lincoln in the United Kingdom. The most important
part of all the studies presented in this thesis is the data collection process, which is
driven by the planned experiments. In order to investigate and study the progression
of the disease over a few year period, eliminating any errors coming from factors that
cannot be taken care of in advance, like age, gender, lifestyle, other unknown diseases
or the diversity of different retinas, a retrospective study was planned. To accomplish
that, data coming from patients that progressed from diabetes to DR were needed, in
order to be able to study the exact same segments over a period of time, identifying
vascular changes that one can be confident enough that they can be attributed to the
effects that diabetes has to the retinal vasculature. Therefore, in all of the studies of
this thesis, only retinal fundus images and the age of each subject were used. No other
information was extracted or utilised whatsoever.
The data were collected in two phases. At the initial phase, during which different
methods and techniques were investigated and explored, ninety two macula-centred
(temporal) and ninety two optic disc centred (nasal) digitised colour fundus images
were utilised, coming from twenty three patients with Type 2 diabetes and no other
known diseases, over a period of time that includes the last three years of diabetic eye
and the onset of DR. This set of images came from a UK diabetic screening database,
kindly provided to me by the Health Intelligence company in the UK.
The second phase, during which the proposed framework was developed and all
the utilised methods were finalised (focus of this thesis), was conducted after obtain-
ing additional data and hence extending the available images that were provided dur-
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ing the first, exploratory phase. This was achieved by myself visiting the diabetic eye
screening service of the Pilgrim hospital in Boston, UK, in order to carefully extract
additional data. The selection of the images was very careful and thorough, reviewing
every single of them, in order to make sure that the quality is high enough and con-
sistent, for measuring all the features in an equally reliable manner within the same
patient and across the whole image set. The images are graded (R0: Subject with
diabetes but no DR, R1: Subject with diabetes and background retinopathy) by the
DR graders of the hospital that the screening is taking place, according to the stan-
dards and protocols defined by the UK national health system (RCOphth, 2012). In
addition, more than 5.000 patients’ data were reviewed by myself, in order to finally
extract the images from 104 of them, which had a full history of four consecutive years
and the quality of the images was decent enough with minimal to no artefacts, so that
all the vessels appear clearly (figure 3.1). This was also made possible by the fact that
in the UK, diabetic patients are urged to monitor their retinas annually, albeit in prac-
tice many of them neglect it. This last fact made it very difficult and time consuming
to personally extract all the images and go through so many patients’ data to identify
the suitable ones that follow the strict requirements. In fact, the vast majority of these
data were inadequate, because either some images were missing, or the quality was not
high enough or due to other factors, such as suffering also from other diseases (e.g.
hypertension, glaucoma, etc.) or having cataract that blurs part of the image, which
made them ineligible. Figure 3.2 shows two examples of how bad quality some of the
retinal images can be, hence the careful selection of them. On the other hand, figure
3.1 shows an example of two qualified images, coming from the dataset that was used
in the studies of this thesis.
In addition, a control group of 27 patients was also extracted, that had not pro-
gressed to diabetic retinopathy at the time of the data collection. For that group also
the last four consecutive years of the disease were chosen and eight images for each
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Figure 3.1: Two good quality and gradeable retinal images can be seen. In both images, all the areas
of interest inside the retina can be seen clearly, without artefacts or blurriness whatsoever.
patient were extracted, just like with the other group. This group was used in order to
make some additional analyses, beyond the progression study, both within this non-
progressors’ group and also in conjunctionwith the progressors’ group, for comparison
purposes.
For all of the above data, both the temporal (macula centred) and nasal (optic disc
centred) images were extracted, with the latter category to be used for estimating the
AVR, and the former for all the other studies. Moreover, the average group age for both
the non-progressors and progressors groups was very close (mean age 54.5 (±7.8) and
53.4 (±8.4) for progressors and non-progressors, respectively). All the studies and
results presented in this thesis were conducted using the final unified dataset with reti-
nal images, which includes all the images that were collected during the two separate
phases.
In addition, for implementing the proposed method of summarising the calibre
of the parent vessel trunk (healthy group, chapter 5), another set of images, coming
from an experiment organised by the School of Computer Science at the University of
Lincoln, UK, was used. This set includes 25 images only from healthy subjects and
was exclusively used for extracting bifurcations, utilising them for implementing the
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Figure 3.2: Two very low quality and ungradeable retinal images can be seen. The image on the left
is a quite common situation, where the macula area is of acceptable quality, but the periphery is blurry.
On the other side, the image on the right is a very bad one that cannot be used for DR grading or any
other study whatsoever.
Table 3.1: Overview of the retinal image datasets used in the studies of this thesis
Datasets
collection
Source Number of
Images
(Subjects)
Resolution
(FOV)
Nasal or
Temporal
Studies
Initial
Phase
Health Intelligence,
Cheshire, UK
184 (23) 2352X1568
(45◦)
Both All, excluding
non-progressors
Second
Phase
Pilgrim hospital,
Boston, UK
1048 (131) 3216X2316
(45◦)
Both All
Healthy
Group
University of
Lincoln, UK
25 (12) 3888X2592
(45◦)
Temporal Summarising calibre
of parent vessel
healthy group part of the proposed method in chapter 5. A summary of the datasets
can be found in Table 3.1.
All of the above data were used to create the six categories of experiments, as seen
in Table 3.2, that will be analysed later, in order to identify any vascular changes during
different stages of both diabetes and DR, evaluating at the same time all the candidate
biomarkers.
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Table 3.2: Summary of the studies of this thesis
Studies Experimental Design Description Particulars
Category 1 Progressors’ group -
four year period of pro-
gression with matched
segments (four groups -
main study)
• Four years of progres-
sion, starting from the
three years pre-DR until
the onset of DR
• Exact same segments
and subjects are included
over the whole four year
period
Truly identify and as-
sociate any vascular
changes with the pro-
gression of the disease,
given that the same
exact segments are
investigated
Category 2 Progressors’ group - four
year period of progres-
sion with non-matched
segments (four groups)
• Similar to category 1,
but the bifurcations are
not matched, so no mea-
surements are discarded
• Imbalanced groups
Direct comparison with
category 1 to figure out
whether matching the bi-
furcations affects the re-
sults
Category 3 Non-Progressors’ group
- four year period of pro-
gression with matched
segments without DR
(four groups)
• Same subjects and seg-
ments across a four year
period, which does not
include DR
• Subjects with diabetes
but have not progressed
DR
Evaluate to what extent
diabetes affects the reti-
nal vasculature in a four
year period and compare
with the progression to
DR, as outlined in cate-
gory 1
Category 4 Non-Progressors’ group
- four year period
of progression with
non-matched segments
without DR (four
groups)
• Similar to category 3,
but the bifurcations are
not matched, so no mea-
surements are discarded
• Imbalanced groups
Direct comparison with
category 3 to figure out
whether matching the
bifurcations affects the
analysis and the results
whatsoever
Category 5 Averaged non-
progressors’ group
(one group) versus
averaged progressors’
group (one group) versus
DR-only group (one
group)
• Does not include the
same subjects, but com-
pares the three different
independent groups of
the disease’s stage (mile-
stones of progression)
The purpose is indeed
to find out, if any
significant vascular
changes occur, during
the transition from the
non-progressed level
to the progressed and
finally to DR
Category 6 Progressors’ group - four
year period of progres-
sion with independent
groups (different indi-
viduals in each group)
• Similarly to category
2, this category intends
to show whether there
is any notable reason to
prefer the more demand-
ing and sensitive analysis
of category 1
• Different subjects and
segments across the dif-
ferent groups
The stages of the dis-
ease are similar to cat-
egory 1, but the sub-
jects are independent and
non-matched across the
four year period. Direct
comparisons with the re-
sults of category 1will be
made, given that the data
reflect the same period of
progression, but within
independent groups
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3.3 Proposed Framework
One of the main objectives of this thesis is to provide a complete framework for the
analysis of the retinal vasculature, in order to show how more robust the statistical
inferences can be that way. Some of the processes involved are automated and other
could possibly become automated in the future, when some unsolved problems in reti-
nal imaging are addressed, e.g. vessel connectivity and vessel labelling (Arteries vs
Veins). However, it is worth pointing out, that the purpose of this thesis is not to
implement the methods that automate the framework (e.g. image registration, image
segmentation, etc.), rather to take all the necessary steps in order to conclude with
more accurate, precise and meaningful statistical inferences and classification models.
The pipeline of the framework that is proposed includes the following general
steps, which are going to be elaborated next.
1. Image registration
2. Image segmentation and junction measurements
3. Extraction of the areas of interest
4. Automated matching of bifurcations
5. Extraction of candidate biomarkers
6. Statistical analysis and inferences
7. Feature selection and classification
Mathworks Matlab software (Matlab, 2014) was utilised for all the algorithms that
were used or developed for steps 1-5, and will be addressed in this chapter. Regarding
steps 6 and 7, the open source language R (R Core Team, 2013) and Rstudio (RStudio
Team, 2015) with some core packages were used, and they will be discussed in details
during the next chapter.
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It is worth noticing, that at the initial exploratory phase, until the proposed frame-
work was conceived and developed, no framework existed and none of the above steps
was included in any process whatsoever. The features were manually extracted, us-
ing a tool developed by (Al-Diri et al., 2010) that will be described in details in the
next sections, and only statistically evaluated. However, during the main (second)
phase, in which this thesis and contributions are based on, the proposed framework
was developed. In this framework, which is applied in practice to all the studies of
the progression of the diseases (diabetes and DR, chapter 6), all 7 steps are automated,
with the only manual intervention being the labelling of the vessels as arteries or veins.
Detailed information and technical aspects about all these processes are given in the
next sections.
3.3.1 Image Registration
3.3.1.1 General Approach
When studying the progression of a disease, it is paramount to be able to compare the
same segments over a period of time, primarily for two reasons. Firstly, for eliminat-
ing, as far as possible, the errors due to other conditions that affect the measurements,
e.g. age, gender, lifestyle, other unknown conditions etc., and secondly for being con-
fident enough that any measured differences can be attributed to the effects of the
disease, with all of these being conditional to a large enough amount of observations
and subjects. Doing the opposite, i.e. comparing independent groups and unmatched
measurements, requires a much larger sample, and that is because one can inconsis-
tently include and measure large and small vessels across the whole cohort, leading
to inflated unreal differences. An efficient and practical way to resolve some of these
issues is to register the bifurcations that come from the same subjects, in order to auto-
matically identify and include only the matched bifurcations across the images of the
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same patient.
3.3.1.2 Registration Technique Adopted in this Thesis
For the purpose of my studies, the open source library VLFeat (Vedaldi & Fulkerson,
2008) was used, implemented in Matlab, created by Vedaldi and Fulkerson, which
offers a complete registration algorithm, based on the Scale-Invariant Features Trans-
form (SIFT) and homography estimation with Random sample consensus (Ransac).
Following the above processes, the images can be registered prior to segmenting them,
in order the bifurcations to approximately be aligned, letting us automatically match
the segmented bifurcations, based on their individual coordinates.
In brief, SIFT combines together a feature detector and a feature descriptor (Lowe,
1999). The detector extracts from the image a number of attributed regions in a way
that is consistent with some variations of the illumination, the viewpoint and other
viewing conditions. The descriptor associates to these regions a signature, which iden-
tifies their appearance in a compact and robust way. Then a regular Euclidean distance
is used, i.e. the distance between descriptor i from image A and descriptor j from im-
age B (Vedaldi & Fulkerson, 2008). For each descriptor in image A, the algorithm
calculates the distance to all the descriptors in image B, matching it with the closest
one from B; otherwise the descriptor in A is not matched at all. Following that, a
homography is estimated that describes the transformation between the two images
(equation 3.1) (Kriegman, 2007).
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Since the homography is defined up to scale, it has 8 degrees of freedom, hence re-
quiring four point correspondences to estimate (Dubrofsky, 2009). At this point, since
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Figure 3.3: Four registered images and the fused one. a: Reference image. b,c,d: Subsequent registered
images. e: Fused image. The bifurcations are now adequately aligned, in order to be reliably matched.
not all correspondences are correct, Ransac is used to find a set of good matches (in-
liers). This is achieved by randomly choosing 4 matches, estimating the homography
by using these matched pairs, and counting how many other matches agree. A match
between the point of image A = (Xa,Ya) and the point of image B = (Xb,Yb) agrees
with the transformation, if the transformed point H(A)=(X’a, Y’b) is close to point B
(Fischler & Bolles, 1981).
The VLfeat algorithm (Vedaldi & Fulkerson, 2008) adjusts the resolutions of the
images, for creating amosaic. Inmy case, since the four images of the four consecutive
years need to be aligned altogether, I parametrised the way that the algorithm creates
the vectors for each image, in order to preserve the same resolution, and also each of
them to be aligned with the unaltered reference image. In this way, the same coordinate
system is applied in all the images and the resolutions remain the same across all of
them. In figure 3.3 an example can be seen that shows four registered images both
separately and fused together.
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3.3.2 Image Segmentation and Junction Measurements
3.3.2.1 General Approach
The main step for studying every retinal disease is the image segmentation. This pro-
cessmust follow the image registration, otherwisematching the bifurcations and study-
ing the progression of any disease within the same patients will be impossible. It is an
indispensable part that is needed in order to obtain the vascular trees and bifurcations,
which will allow any type of vascular measurements. Every candidate biomarker, ei-
ther geometric or haemodynamic, requires an accurate segmentation with profiles of
the vessel segments, before making any estimations. Any segmentation algorithm that
can provide binary trees, profiles of the vessel segments and geometric measurements
can be used in the pipeline of this framework.
3.3.2.2 Image Segmentation Techniques Used in this Thesis
Following the image registration, the registered images are then segmented, using a
segmentation algorithm, implemented by Bashir et al., whose accuracy, reliability
and robustness has been evaluated in literature (Al-Diri et al., 2009). This algorithm
works by growing a ”Ribbon of Twins” active contour model, which uses two pairs
of contours to capture each vessel’s edge, while maintaining width consistency. The
algorithm starts using a generalised morphological order filter to identify approximate
centrelines. After identifying the vessel segments, the network topology is also deter-
mined, using an implicit neural cost function, defined by using self-organising feature
maps, in order to resolve junction configurations. The output of these neural networks
is a “novelty signal”, which indicates whether the input vector is similar to the vectors
presented during the training stage; they are therefore ideal to provide an implicit cost
function, characterising whether a configuration is consistent with normal expecta-
tions. The local junction measurements, such as vessel widths, angles and derivatives
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of those, are also estimated by this algorithm. In addition the lengths of the vascular
trees are also returned, which is one of the parameters, together with the vessel widths,
that are used for the estimation of the haemodynamic features.
A second segmentation algorithm (Hunter et al., 2005), which was used for the
fractal dimension calculation and tortuosity measurements, is the one proposed by
Hunter et al. It is based on a non linear tram-line filter, which is applied at a num-
ber of orientations, rotating the kernel by 22.5◦ and selecting the strongest response
at each pixel. This process calculates the contrast between a central line and satel-
lite tram-lines (two short parallel segments). Order statistics filtering was also used,
where the response values within the inner and outer filters are sorted. Finally the
differences between the third darkest and third lightest values are obtained, and the
resulting strength map is thresholded in order to receive the segmentation. The noise
and the false positive segments that occur are sorted out a) by doing some morpholog-
ical thinning to reduce vascular segments to a single-pixel ones, b) by removing small
segments and c) by a clean-up of the remaining segments, including hole-filling and
pruning of small side-spurs.
The segmentation algorithm in (Hunter et al., 2005) was preferred over the one
in (Al-Diri et al., 2009) for the above estimations (fractal dimension and tortuosity),
because it provides a) binary vessel segmentations needed for the fractal dimension
estimations, and b) the profiles of the vessel segments are returned in a single file
(in contrast to the other segmentation algorithm), as required by the algorithm that
calculates the tortuosity metrics. Figure 3.4 shows an example of the segmentation of
two images used in this thesis, as obtained from the two algorithms.
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Figure 3.4: On the left, a segmentation from the algorithm proposed in (Al-Diri et al., 2009) can be
seen. On the right is an example of the segmentation based on the method proposed in (Hunter et al.,
2005).
3.3.3 Extraction of the Areas of Interest
3.3.3.1 General Approach
An important part and novelty of the studies presented in this thesis is the examination
and exploitation of the possible importance of different areas of the retina, in addition
to the retina as a whole. Different regions inside the retina include different sizes
of vessels, which can be larger in the periphery (E3) and near the optic nerve head,
and finer around the macular area (E1 and E2). Therefore, it is likely the disease to
be affecting the vasculature differently, depending on the size of the vessels, as was
explained in chapter 2. To make sure that all these possible scenarios are taken into
account, it is recommended to include in every study of any retinal disease the areas
that are described next, as an additional step in order to identify possible localised
alterations.
3.3.3.2 Recommended Approach for the Areas of Interest
To do so, the areas that Hove et al. proposed were adopted in this study, which were
defined based on previously published knowledge of the development of retinopathy.
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This included information about the early lesions that develop temporally from the
fovea (Dobree, 1970; Taylor & Dobree, 1970), the correlation between blood pres-
sure and the location of the lesions around the arcades (Bek & Helgesen, 2001), about
how the occurrence of lesions in the periphery is associated with the retinopathy grade
(Group et al., 1991), and also how the severity of retinopathy is connected to the dis-
tance of the lesions from the fovea area (Group et al., 1987). To come up with these
areas, they also studied 11 Type 2 patients with diabetes, who had developed visual
loss secondary to DR. They took into account the total number and area of all the haem-
orrhages and exudates located inside the three ellipses (E1, E2 and E3) and circles (C1
and C2), as seen in figure 3.5 (Hove et al., 2004). The two circles, with their centre
in the fovea area, have a diameter of one and two diameters of the optic disc. The
ellipse E1 includes the retinal area temporal from the fovea, the ellipse E2 includes the
macular area and the ellipse E3 includes the upper and lower vascular arcades.
Following up the patients (Hove et al., 2004), they also observed an increase in the
total number and area of the haemorrhages inside E1 and outside E3, only an increase
in the area of the haemorrhages between E1 and E2 and an increase in the number of the
haemorrhages between E1 and E2; no significant changes were observed around the
arcades whatsoever. The number and area of haemorrhages and exudates were found
to be significant to the later development of vision-threatening diabetic maculopathy.
All of these observations they made (Hove et al., 2004), support the evidence
that retinal hyperperfusion co-occurs with diabetic retinopathy, due to malfunctions
in tone regulation of smaller arterioles that supply the microcirculation (Kohner et al.,
1995; Grunwald et al., 1996; Bek, 1999). On the other hand, increased arterial blood
pressured and impaired autoregulation facilitate the apprearance of lesions around the
larger arterioles near the arcades (Bek & Helgesen, 2001; Rassam et al., 1995).
Finally, in definining these areas, no information about the vascular geometry was
taken into account. Therefore, our purpose is to find out whether the vessel widths,
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angles and tortuosity are affected in these areas, given that the location of the lesions
seems to be connected to the later development of vision-threatening disorders. The
Figure 3.5: Two examples of how the areas of interest are defined. E1, E2 and E3 are the ellipses, C1
and C2 are the two circles around the fovea, and Zone A and Zone B are the excluded and included areas
for the AVR estimation respectively. The arcade is a parabola with its vertex at the optic disc centre. The
perpendicular lines, which cross the arcade in various points, help to standardise the selection of arteries
and veins for the estimation of the local arteriovenous ratio. All these areas, across all the images, are
either semi-automatically or automatically generated.
ellipses were generated based on the general ellipse equations and according to the
methodology in (Hove et al., 2004), adjusting however the distance and dimension
parameters to account for the difference in the resolution of the images. Similarly,
the circles C1 and C2 are generated according to the general circle equation. In our
studies, the values of the two radii of each ellipse, a and b, are 227 and 450, 530 and
750, and 750 and 880 pixels, for E1, E2 and E3, respectively.
In addition to the above areas, in figure 3.5, some additional areas can be seen.
Zone A and Zone B are the two areas that were proposed in (Knudtson et al., 2003;
Hubbard et al., 1999), in order to estimate the central retinal artery (CRAE) and vein
(CRVE) equivalent, as well as their quotient the arteriovenous ratio (AVR). The region
of interest (Zone B) is defined as shown in figure 3.5, and includes the region where
the edges of the vessels course through at 0.5 to 1.0 disc diameters from the optic disc
margin. The region between this area and the optic disc is excluded, as not having the
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vessels attained their status inside the retina yet. Within this area, the six largest veins
and the six largest arteries are measured, following an iterative procedure of pairing up
the largest vessels with the smallest ones, until a final single number is obtained. More
information about this is provided in the next sections and even more details about the
methodology is given in chapter 5.
An important step that was corrected for this thesis’s studies, which improves the
accuracy of the estimation of the areas, is the correction of the rotation. In figure 3.5,
especially in the image on the right, it can be clearly seen, that the centre of OD and
the centre of fovea are not in the same horizontal line, having a small offset of 6.66
degrees. This is estimated, by calculating the angle that is created between the line
parallel to the x axis that crosses the centre of the OD, and the line that connects the
centres of OD and fovea. For visualisation purposes, the lines and the angles appear on
both images of figure 3.5. Following that, all three ellipses are then rotated according
to this offset, in order to finally include the correct areas, which are consistent across
the consecutive years. Finally, the algorithm is adjusted so as to account for both left
and right eyes, since some of the equations for the estimations of the areas need a
change of sign (minus to plus and vice versa). That is achieved by comparing the
estimated coordinates of the OD with the x axis, i.e. whether the coordinates are in
the first half, e.g. between 0 and x/2, or in the other half, between x/2 and x (x is the
horizontal dimension of the image in pixels).
In addition, the arcades/parabolas that can be seen in the two images in figure 3.5
follow approximately the main vein and artery that exit the optic disc and head towards
the retinal periphery. Their vertex point is on the centre of OD and they are symmetric
in respect to the x axis. In various points along the arcades, the tangents and then the
slopes are calculated, in order to draw the perpendicular lines that cross this point,
at both sides of the arcade. The arcade has its vertex at the centre of the OD and its
curvature is empirically selected so as to approximately follow the arteries and veins
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that span towards the periphery on the side of the macula area.
Optic Disc and Fovea Localisation
As can be inferred, the important part for defining all these areas is the optic disc
and fovea localisation. There are two steps involved in this process. At the first step,
both fovea and optic disc are automatically estimated, based on an implementation
provided by Andrew Hunter, University of Lincoln (Lowell et al., 2004a), for which
more details will follow. Given that here the priority is not the accurate and automated
localisation of the fovea and OD, but the areas of interest and the arcade, the process
involves an extra step. After the algorithms estimate the coordinates of the centres of
the OD and the fovea across the whole image set, and before any areas are defined, the
user is prompted to confirm that both the fovea and OD are correctly estimated. If so,
the process continues; if not, then the user manually clicks and draws the margins of
the OD and fovea, overpassing the automated process. In that way the goal is achieved,
which is to estimate as accurately as possible the areas, in order to reliably extract the
features needed for the progression and non-progression studies.
As aforementioned, in order to automate the process of defining the areas of in-
terest, OD and fovea localisation algorithms were incorporated, which precede the
execution of the algorithm that defines the areas. The method, developed by (Lowell
et al., 2004a), provides us with the initial coordinates needed to proceed with the whole
estimations. As far as the OD localisation is concerned is based on the correlation with
a specialised filter, which matches key elements of the structure of the optic disc. The
correlation peak gives the approximate centre of the optic disc. The template consists
of a Laplacian of Gaussian with a vertical channel in the middle to correspond to a
major vessel band (Lowell et al., 2004a). This template is correlated with the intensity
component of the retinal image. The different values of the optic disc radius that the
authors tried are based on estimates of the pixel to micrometer ratio, using an average
value of 1850µm for the OD diameter (Bertelsen et al., 2013; Patton et al., 2006b).
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Figure 3.6: A very illustrative example, showing the dimensions and the exact areas that cor-
respond to the macula and OD inside the retina. Source: Danny Hope from Brighton & Hove, UK -
https://en.wikipedia.org/wiki/Macula_of_retina/media/File:Macula.svg.
Regarding the fovea localisation, this relies on the OD one. As can be seen in figure
3.6, the positions of the macula lutea and the OD inside the retina are anatomically re-
lated. Based on that fact, the fovea localisation starts with a given starting position for
the OD centre. Similarly to the OD, a Laplacian of Gaussian filter is used to match the
fovea, assuming macula-centred images. Given an initial offset from the OD, which is
trimmed according to the maximum and minimum OD diameters, a correlation search
is conducted for finding the best foveal match on a fixed granularity, based on the OD
centre. The sampling is made on a wide spaced grid around the estimated position that
is more or less anatomically defined. If the best correlation is below a global thresh-
old, the expected position is used instead, followed by firstly resampling on a finer grid
around the peak of the first search, and then on a single pixel granularity grid, which
gives us the final position (Lowell et al., 2004a).
It is worth pointing out that all of the specific techniques that are adopted in this
thesis to implement the framework (SIFT and RANSAC for image registration, active
contours for image segmentation, etc.) could be replaced with alternative ones, as long
57
3.3. PROPOSED FRAMEWORK
as they can accommodate the requirements and the purpose of this framework.
3.3.4 Matching of the Bifurcations
Just like the optic disc and fovea, bifurcations are also anatomical landmarks inside
the retina. The position of each bifurcation is more or less fixed, with only negligible
changes occurring, just like with the retinal vessels, mainly due to the dynamic nature
of the retina. Given that the vast majority of the candidate biomarkers in this thesis
are extracted in reference to the bifurcations, then a clever way to make sure that the
automated system will select and compare the same segments during the investigated
periods of time, is matching the bifurcations. In that way, we make sure that the same
exact vessel segments are compared, minimising the chances of making wrong com-
parisons. Therefore, although the bifurcations themselves, or more precisely the bifur-
cation points, do not have any particular value as candidate biomarkers, their almost
fixed spatial location and the vessels that form the bifurcation are highly important and
indispensable part of the studies of this thesis.
The purpose of the previously presented areas is to finally be able, in conjunction
with suitable segmentation and vascular measurements’ algorithms, to extract each
feature, matched across the whole period of time, and at the same time group them
according to the area they are coming from. The algorithm is also checking whether a
bifurcation or a given segment belongs to this area, i.e. if it is inside, on, or outside of
it. Therefore, each point’s coordinates are checked against the equations of each area
(ellipses, circles, arcade and perpendicular lines). At the end, all the bifurcations can
be organised in accordance with the area they belong to, store the measurements and
create the relevant feature. The same exact thing occurs and in the case of matching
the junctions across the whole investigated period. The condition defines to firstly
identify the same junction in all four images of the progression, and if successful, to
check in which area they have to be assigned to.
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To clarify the process further, the area of ellipse 1 includes everything that is inside
or on the ellipse 1; the area of ellipse 2 includes everything that lies between ellipse
1 and ellipse 2; and likewise, the area of ellipse 3 includes the enclosed area that lies
between ellipse 2 and ellipse 3, including Zones A and B. It is also worth pointing out
that Zones A and B, the arcade and the perpendicular lines are not exclusive, as the
ellipses are among themselves, because they serve a different purpose, i.e. to calculate
the CRVE, CRAE, AVR and the local arteriovenous ratio. For instance, a point can
both belong to Zone B and ellipse 2 (or ellipse 3), given the different purpose that these
two areas serve. In particular, the perpendicular lines help both to visually identify the
vein and artery that serve the same area of the retina and also, alongside the segmenta-
tion algorithm, to return the widths of the two points; the one on the vein and the one
on the artery.After that, the local arteriovenous ratio is calculated, near the OD, and
after one and two branchings of both vein and artery.
Regarding the process of the local arteriovenous ratio, the first measurement
(near OD) is used as a reference, which does not have any importance, since the value
can be affected by the possible different order of branching of the vein and the artery
before they extrude the OD. However the second and third measurements can be con-
trolled, and are indeed selected after the vein and artery branch once and twice, towards
the same direction. Therefore, it will be later evaluated, whether the local arteriove-
nous ratios’ differences (point 2 minus reference, point 3 minus reference and point 3
minus point 2), present any significant differences across the years of progression.
Regarding the final iterative process for matching all the segments across the four
year period, this is based on multiple conditionings.
1. Firstly, a segment is manually labelled as artery or vein. All the labellings were
fulfilled by two raters, ending up with a 97,5% Kappa inter-rater agreement,
hence keeping only the mutually agreed segments and discarding the rest.
2. Secondly, the images that come from the same patient are identified, by search-
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ing and matching their unique identification numbers.
3. Following that, only a vein or artery (A or V in our data) is selected at a time,
and thus restricting the search to the respective type of segment, until all of them
have been identified.
4. The process initially commences with the x and y coordinates of e.g. arteries,
and continues with the selection of the first pair of coordinates of the first image
of the first subject. The search is only conducted around the same coordinates
of the other 3 images of the same patient, in a 5x5 window, which is adequate
in order not to miss a not perfectly registered bifurcation, but at the same time
not mistakenly include another different nearby bifurcation (unlikely to have an-
other bifurcation of the same vessel type, A/V, that close though. In any case the
algorithm will prompt the user to choose one of them). If both x and y coor-
dinates are within the margins of the defined windows in all the four images,
then the geometric measurements (widths, angles and derivatives of them), that
correspond to the four matched bifurcations are saved in the respective matrix,
including both the type of feature and the period they are coming from (e.g. for
the progression study: three years pre-DR, two years pre-DR, one year pre-DR
or onset of DR).
5. Finally, the identified entries are replaced with zero values and the previous steps
are repeated. After the process has finished, the remaining, non-zero values are
returned, which correspond to the non-matched bifurcations, for possible further
investigations. The matched bifurcations are now correctly stored. The same
process is also repeated for the veins.
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3.3.5 Candidate Biomarkers
As was previously stressed, this is the first time that such a comprehensive study is
conducted, investigating such a great deal of geometric and haemodynamic features.
This section will give information regarding the investigated features and the tools that
were used to extract them, prior to describing the experiments and the findings.
In the previous chapters, it was shown how complicated the retinal functionality is
and how previous studies have investigated the effects of hyperglycaemia and oxida-
tive stress to the retinal tissue, with the consequences being observed in the geometry
and the heamodynamics.
The retinal vascular network is non-uniform, including both symmetrical and assy-
metrical bifurcations. Although retina is curved in space, its vascular network mostly
lies on a two-dimensional surface, therefore the angle δ, which the parent makes with
the plane, is either zero or near zero (Zamir, 1978; Al-Diri, 2008).
The vascular branching is a main characteristic of the cardiovascular system. The
simplest and most common form of branching is that in which a single stream of blood
is divided into two distinct streams. These two streams may differ significantly, in
terms of size and direction (Al-Diri, 2008).
In the beginning of the 20th century the first attempts to understand the branching
angles are found (Thompson, 1917), with the comprehensive and extensive studies
arriving in 1926 (Murray, 1926b,a). Since that, by the mid of 70s, many more stud-
ies were conducted, dealing with the measuring of the properties of the vascular net-
work and its patterns (Kamiya & Togawa, 1972; Kassab & Fung, 1995; Schreiner &
Buxbaum, 1993; Zamir, 1976, 1999).
Murray’s Law
The two main early papers of Murray (Murray, 1926b,a) focused on defining the
principles of minimum work, for predicting the relationship between radii and blood
flow, applying them to predict the branching angles. The vascular system with a uni-
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formly larger vessel radii will require a larger volume of blood and a higher metabolic
rate, while requiring less pumping power for circulating the blood. These facts led to
the hypothesis that the radii of vessels in the cardiovascular system are the result of a
compromise between the pumping powerHp (equation 3.2) and the cost of maintaining
the blood volume u (equation 3.3).
Hp =
8ρlQ2
πr4
, (3.2)
where ρ is the viscosity of the blood, Q is the flow of the blood in the vascular
system and r is the segment radius.
u = Kπr2l, (3.3)
where K is a constant.
3.3.5.1 Geometric Features
In this chapter, much of the focus goes to the bifurcations and the vascular measure-
ments that can be extracted from them. In figure 3.7 (Al-Diri et al., 2010), the main
configuration of a bifurcation can be seen.
As shown in chapter 2, there are numerous studies in literature, having investigated
the importance of the retinal geometry in studying different pathologies, however some
of the underlying biological processes that might trigger these alterations, are still not
well-known (Stitt & Curtis, 2005; Stitt et al., 2013; Singh et al., 2014).
This sectionwill provide details about the general concepts of the candidate biomark-
ers that appear in Table 3.3 and the methods that were used to measure and/or extract
them.
Widths & Angles
The vessel widths (or interchangeably calibres, or diameters) and angles (1-24,
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Table 3.3: Investigated features as used in the statistical analysis
Features (Short form)
1. Alpha value of arteries (AlphaA) 50.Parent’s arterial width in ellipse 3(Ellipse3parA)
2. Branching coefficient of arteries (BetaA) 51.Small child’s arterial width in ellipse 3(Ellipse3ch1A)
3. Bifurcation index of arteries (LambdaA) 52.Large child’s arterial width in ellipse 3(Ellipse3ch2A)
4. Diameter ratio λ1 of arteries(Lambda1A) 53.Arterial branching angle in ellipse3(Ellipse3ThetaA)
5. Diameter ratio λ2 of arteries(Lambda2A) 54.Central Retinal Artery Equivalent(CRAE_LEON)
6. Arterial branching angle(ThetaA) 55.Central Retinal Vein Equivalent(CRVE_LEON)
7. Adjusted Gamma ratio of arteries (Adj.GammaA) 56.Arteriovenous ratio(AVR_LEON)
8. Parent’s arterial width(Width_parentA) 57.Central Retinal Artery Equivalent(CRAE_KNUD)
9. Large child’s arterial width(Width_child1A) 58.Central Retinal Vein Equivalent(CRVE_KNUD)
10.Small child’s arterial width(Width_child2A) 59.Arteriovenous ratio Knudtson(AVR_KNUD)
11.Average junction’s arterial widths(Width_allA) 60.Average tortuosity (Chandrinos et al., 1998) (mean_phi)
12.Arterial Angle to Branching coefficient 61.Median tortuosity(median_phi)
ratio(Angle.BC_A) 62.Third quartile tortuosity(75th_phi)
13.Alpha value of veins (AlphaV) 63.Standard deviation of tortuosity(sd_phi)
14.Branching coefficient of veins (BetaV) 64.Average tortuosity (Hart et al., 1999)(mean_tau)
15.Bifurcation index of veins (LambdaV) 65.Median tortuosity(median_tau)
16.Diameter ratio λ1 of veins(Lambda1V) 66.Third quartile of tortuosity(75th_tau)
17.Diameter ratio λ2 of veins(Lambda2V) 67.Standard deviation of tortuosity(sd_tau)
18.Branching angle of veins (ThetaV) 68.Average tortuosity(Grisan et al., 2008)(mean_psi)
19.Adjusted Gamma ratio of veins (Adj.GammaV) 69.Median tortuosity(median_psi)
20.Parent’s venular width(Width_parentV) 70.Third quartile tortuosity(75th_psi)
21.Large child’s venular width(Width_child1V) 71.Standard deviation tortuosity(sd_psi)
22.Small child’s venular width(Width_child2V) 72.Combined tortuosity(Poletti et al., 2011)(Tort_blend)
23.Average junction’s widths of veins(Width_allV) 73.Combined tortuosity in ellipse 1(Tort_ellipse1)
24.Venular Angle-to-Branching coefficient 74.Combined tortuosity in ellipse 2(Tort_ellipse2)
ratio(Angle.BC_V) 75.Combined tortuosity in ellipse 3(Tort_ellipse3)
25.Fractal dimension(Fractal) 76.Parent’s arterial wall shear stress(wssparentA)
26.Lacunarity(Lacunarity) 77.Arterial pressure in the whole junction(pressureA)
27.Local arteriovenous ratios’ difference between the 78.Parent’s arterial velocity(vparentA)
second and the reference values(AVmid_AVbeg) 79.Parent’s arterial Reynolds number(ReparentA)
28.Local arteriovenous ratios’ difference between the 80.Large child’s arterial wall shear stress(wsschild1A)
third and the reference values(AVmid_AVbeg) 81.Large child’s arterial flow rate(qchild1A)
29.Local arteriovenous ratios’ difference between the 82.Large child’s arterial flow velocity(vchild1A)
third and the second values(AVmid_AVbeg) 83.Large child’s arterial Reynolds number(Rechild1A)
30.Parent’s venular width in ellipse 1(Ellipse1parV) 84.Small child’s arterial wall shear stress(wsschild2A)
31.Small child’s venular width in ellipse 1(Ellipse1ch1V) 85.Small child’s arterial flow rate(qchild2A)
32.Large child’s venular width in ellipse 1(Ellipse1ch2V) 86.Small child’s arterial flow velocity(vchild2A)
33.Venular branching angle in ellipse1(Ellipse1ThetaV) 87.Small child’s arterial Reynolds number(Rechild2A)
34.Parent’s arterial width in ellipse 1(Ellipse1parA) 88.Arterial pressure according to PinQout(PinQoutA)
35.Small child’s arterial width in ellipse 1(Ellipse1ch1A) 89.Parent’s venular wall shear stress(wssparentV)
36.Large child’s arterial width in ellipse 1(Ellipse1ch2A) 90.Venular pressure in the whole junction(pressureV)
37.Arterial branching angle in ellipse1(Ellipse1ThetaA) 91.Parent’s venular flow velocity(vparentV)
38.Parent’s venular width in ellipse 2(Ellipse2parV) 92.Parent’s venular Reynolds number(ReparentV)
39.Small child’s venular width in ellipse 2(Ellipse2ch1V) 93.Large child’s venular wall shear stress(wsschild1V)
40.Large child’s venular width in ellipse 2(Ellipse2ch2V) 94.Large child’s venular flow rate(qchild1V)
41.Venular branching angle in ellipse2(Ellipse2ThetaV) 95.Large child’s venular flow velocity(vchild1V)
42.Parent’s arterial width in ellipse 2(Ellipse2parA) 96.Large child’s venular Reynolds number(Rechild1V)
43.Small Child’s arterial width in ellipse 2(Ellipse2ch1A) 97.Small child’s venular wall shear stress(wsschild2V)
44.Large child’s arterial width in ellipse 2(Ellipse2ch2A) 98.Small child’s venular flow rate(qchild2V)
45.Arterial branching angle in ellipse2(Ellipse2ThetaA) 99.Small child’s venular flow velocity(vchild2V)
46.Parent’s venular width in ellipse 3(Ellipse3parV) 100.Small child’s venular Reynolds number(Rechild2V)
47.Small child’s venular width in ellipse 3(Ellipse3ch1V) 101.Venular pressure according to PinQout(PinQoutV)
48.Large child’s venular width in ellipse 3(Ellipse3ch2V)
49.Venular branching angle in ellipse3(Ellipse3ThetaV)
Table 3.3) were estimated using two methods. At the initial phase of my studies, the
semi-automatic computerised method was used (Al-Diri et al., 2010). This algorithm,
proposed by Bashir et al., creates a graphical user interface that gives the observer the
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Figure 3.7: A schematic drawing of the configuration of a bifurcation. the symbols represent the
diameters (d), the lengths (l) an the angles of the bifurcations (θ, θ1 and θ2). The subscripts 0, 1 and
2 are used throughout this thesis to denote the parent vessel, the larger branch and the smaller branch,
respectively. The points (x0,y0), (x1, y1) and (x2, y2) are the coordinates of the end points of each
segment, whereas the point (x, y) is the position of the bifurcation. Diagram taken from (Al-Diri, 2008).
ability to label specific junctions inside the retina and then mark them manually. The
observer firstly selects two points along the approximate centreline and then a third
one on one of the segment edges. Finally, an aligned rectangle is drawn, whose width
and direction can easily be adapted, until the observer is confident that the rectangle
is properly aligned. This method is effective as the width is defined along a part of
the vessel, without needing segment profiles. This is assisted by the fact that the tool
presents the image junction zoomed up, allowing taking measurements with sub-pixel
accuracy. The angle in turn, is calculated by firstly clicking to place an intersection
point, followed by clicking to select the ends of the three vessel centrelines. The final
drawn lines can be adjusted until the observer is satisfied with the result.
At the second phase, for the main study, a fully automatic tool was used (Al-Diri
et al., 2009), which is a subpart of the segmentation algorithm (section 3.3.2). This
active contour algorithm provides precise widths and angles measurements with sub-
pixel average width errors.
For every image that was used in these studies, the diameter of the optic nerve head
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was also estimated with the semi-automatic tool. Although the images are rescaled to
have the same resolution (1700X1700 pixels), in order to compensate for possible
magnification errors, each width measurement was standardised, dividing by the OD
diameter of the respective image. However, the measurements of the widths across all
the images, did not suggest the existence of important outliers, which would highlight
possible measurement or calibration errors. In fact, the standardisation (versus non-
standardised values) did not affect the direction of the results.
Another comparison was also made, between a small sample (210 widths, 70 an-
gles) of pre-registered and post-registered semi-automatically measured bifurcations.
The purpose was to find out whether the two-dimensional registration algorithm affects
or not the estimation of the branching angles and/or vessel widths. A paired t-test did
not suggest any significant differences (p-values equal to 0.35 and 0.48 for widths and
angles respectively).
In addition to the above direct measurements, some additional relative ones have
also been proposed in literature and are adopted in theses studies.
• The bifurcation index λ, or otherwise degree of asymmetry (Zamir, 1978). The
value of λ is defined by diving the diameter of the smaller child d2, by the di-
ameter of the larger one, d1. Therefore the value of λ is greater than 0 and less
or equal to 1.
λ =
d2
d1
(3.4)
• The asymmetry ratio α, which is the cross-sectional area of the smaller branch
divided by the larger one. The final value of α is greater than 0 and less or equal
to 1 (Zamir, 1978).
α =
d22
d21
(3.5)
Both λ and α are indexes of the degree of asymmetry. The bifurcation is sym-
metrical when the values of λ or α equal unity, meaning that the two branches
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have the same diameter. As the values converge towards zero, the bifurcation is
considered to be asymmetric or non symmetric.
• The diameter ratios, λ1 and λ2, are the diameters of the children branches di-
vided by the diameter of the parent vessel (Karch et al., 2000).
λ1 =
d1
d0
, λ2 =
d2
d0
(3.6)
• The area ratio or branching coefficient β, is the sum of the cross-sectional areas
of the two children branches divided by the one of the parent vessel (Zamir,
1978; Knudtson et al., 2003).
β =
d21 + d
2
2
d20
(3.7)
• Branching angle θ (defined by the points (x0,y0), (x1, y1) and (x2, y2) in figure
3.7) is the one I will be measuring and evaluating throughout this thesis.
cos(θ0) =
x− x0
((x− x0)2 + (y − y0)2)1/2 (3.8)
Fractal Dimension & Lacunarity
Fractal dimension (FD) and lacunarity (25-26, Table 3.3) are another two impor-
tant features that are included in these studies. The former can give us a measure of
complexity of a structure, as long as it can be considered a fractal, just like the retinal
network (Mainster, 1990). The latter is a measure of heterogeneity of a fractal structure
(Tolle et al., 2008).
Fractality
Fractals present various degrees of self-similarity of different scales. Human retina
has been found to almost be a self-similar structure, thus being possible to be analysed
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as such, giving us a measure of complexity, and letting us also investigate, whether
it changes at different periods of time (Family & Vicsek, 1991). Its discriminatory
power was also evaluated within the classification system, in conjunction with the
other features. Higher values of FD indicate more complex structure.
For the calculation of FD, the well established method of box-counting algorithm
(Minkowski - Bouligand dimension)was used (Mandelbrot, 1983; Foroutan-Pour et al.,
1999; Mandelbrot, 1977), based on equation 3.9 (Li et al., 2009). For this purpose, all
the images were segmented using the segmentation algorithm described previously
(Hunter et al., 2005), obtaining the binary vascular trees, in order to apply the box-
counting and gliding box methods.
FractalDim. = lim
r→0
LogN(r)
Log1/r
, (3.9)
in which N(r) refers to the number of boxes of side length r that has to be used to cover
a given area in the Euclidean n-space, by using a sequential number of descending size
boxes. This occurs in multiple orientations. The final dimension in the 2D space is
between 1 and 2 (1 ≤ D ≤ 2) (Li et al., 2009).
Lacunarity
Complementary to the FD, lacunarity was also evaluated, which is a counterpart of
FD, describing the gappiness between the structures, or alternatively how the fractals
fill the space.
Lacunarity was estimated using the gliding-box algorithm, for different grid ori-
entations (Tolle et al., 2008). A unit box of size r is randomly chosen and the number
of set points p are counted i.e. the mass. The procedure is repeated with the box
centred consecutively for each point within the set, creating a distribution of masses
B(p, r). Finally, we get the probability, by converting the distribution into probability
distribution Q(p, r), dividing by the total number of boxes (B) of size r. Finally, the
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gliding box equation can be written in terms of the accumulated sum of the mean and
the second moments of all boxes (equation 3.10).
LGB(r) =
B(r)
∑B(r)
i=1 p(i, r)
2
[
∑B(r)
i=1 p(i, r)]
2
, (3.10)
where the denominator is the square of the total number of elements in the data set
(Tolle et al., 2008).
Arteriovenous ratio
Chapter 5 of this thesis describes in details the current methodology for estimating
the AVR, including both the widely-used approach in literature, as proposed in (Knudt-
son et al., 2003) and an alternative method proposed as part of this thesis (Leontidis
et al., 2016b). The area of interest is defined as shown in figure 3.8, and includes the
region where the edges of the vessels course through at 0.5 to 1.0 disc diameters from
the optic disc margin. The vessels are labelled and measured using the semi-automatic
tool described previously. The region between this area and the optic disc is excluded,
Figure 3.8: On the left, we can see the original, macula centred image. On the right, the processed
image is shown, which includes only the area, where the vessels are labelled and measured; optic disc
is only shown for reference purposes.
as not having the vessels attained their status inside the retina yet. Within this area,
the six largest veins and the six largest arteries are measured, following an iterative
procedure of pairing up the largest vessels with the smallest ones, until a final single
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number is obtained.
The final value for the vein is termed central retinal vein equivalent and the respec-
tive final value for the artery is termed central retinal artery equivalent. Their quotient
is known as arteriovenous ratio (54-59, Table 3.3).
Local arteriovenous ratio
The local arteriovenous ratio (27-29, Table 3.3) was estimated in three points along
the arcades, starting from near the OD until two branchings apart. An example of
two successive points can be seen in figure 3.9. The included images were carefully
selected in order the branchings to be clear. The first point works as a reference point,
therefore its absolute value does not provide any information, given that one cannot
know the actual branching order, i.e. the number of times a vessel splits into two
smaller ones within a vascular tree, as they come off the OD.
Figure 3.9: The two blue circles show the first two points, where the local arteriovenous ratio is taken.
The first one is near the OD, whereas the second one is after one branching that both the artery and vein
have made.
Tortuosity
Tortuosity (60-72, Table 3.3) is another very important candidate biomarker, con-
sidered to be among the first indicators of the alterations in the retinal vascular network
to appear in retinal pathologies (Nguyen et al., 2007). Tortuosity measures lack of an
official clinical definition; nevertheless, in practice, it refers to the state or quality of
being tortuous, i.e. twisted, having many turns.
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As Grisan et al. describes it (Grisan et al., 2008), a vessel can be considered as a
curve
s(l) = [x(l), y(l)] : D ⊂ R→ R2, (3.11)
where s ∈ C1(R) and l being the curvilinear coordinates defined on an interval D of
R. The cord length Lx is defined as the distance between the curve end points
Lx = ∥s(max(D))− s(min(D))∥ (3.12)
and the curve length Lc as:
Lc =
∫ max(D)
min(D)
∥∥∥∥∥∂s∂l
∥∥∥∥∥dl (3.13)
Finally, the curvature κ(l) of s(l) is defined as follows:
κ(l) =
dx
dl
d2y
dl2
− d2x
dl2
dy
dl((
dx
dl
)2
+
(
dy
dl
)2) 32 (3.14)
In the present studies, specifically for the image-level (whole retina) tortuosity - three
main different methods were utilised, for calculating the local tortuosity. The image
level tortuosity was expressed in terms of mean, median, standard deviation and third
quartile values. In addition, a fourth measure proposed by Poletti et al. was also used,
which is a supervised approach that provides a tortuosity index capable to reproduce
the clinical experts’ assessment (Poletti et al., 2011). This index is a linear, weighted
combination of the other three.
The expertise and algorithms were provided by a research group I am collaborating
with at theDepartment of Information Engineering, at theUniversity of Padova in Italy.
The first method was proposed and elaborated by Grisan et al. (Grisan et al.,
2008). It starts with defining the curvature of the curve as in equation 3.15, and then a
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subsegment si of a vessel segment s is also defined as a turn curve if:
[κ(l) ≤ 0, ∀l ∈ Di] ∨ [κ(l) ≥ 0, ∀l ∈ Di] (3.15)
with Di a compact subset of D. In order to account for the possible issues arising from
straight segments, which affects the tortuosity measures, the authors split the straight
segments into two halves, assigning one to the previous and one to the following turn
curve. After diving the curve s(l) into n turn curves,
si : s = s1 ⊕ s2 ⊕ ...⊕ sn (3.16)
they propose a vessel tortuosity measure as follows:
τ(s) =
n− 1
n
1
Lc
n∑
i=1
[
Lcsi
Lxsi
− 1
]
(3.17)
The second method, is a curve-based measure proposed by Hart et al. (Hart et al.,
1999). This method suggests the use of the ratio between the integral of the absolute
curvature (tc) (or the squared absolute curvature (tsc)) and the chord length Lx (or the
vessel length Lc). The rationale behind this is that integral measures of κ along the
domain D give a measure of the variability of vessel direction.
tc =
∫ max(D)
min(D)
|κ(l)|dl, (3.18)
tsc =
∫ max(D)
min(D)
|κ(l)|2dl (3.19)
The third method is an angle-based method proposed by Chandrinos et al. (Chandri-
nos et al., 1998). Tortuosity is estimated by averaging the change of angle at discrete
points along the vessel’s length, which is independent of scale. For each pixel X that
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belongs to a specific track, they consider two additional centrelines, creating two vec-
tors ui+n and ui−n. At the final step, they take the inverse cosine of the dot product
that form these two vectors.
θ(i) = arccos(ui+n · ui−n) (3.20)
The mean tortuosity is then given by:
T =
1
N − 2n
n∑
i=1
θ(i) (3.21)
The fourth method is a linear supervised combination of the previous three meth-
ods, aiming to provide a tortuosity index capable of reproducing the clinical experts
assessment (Poletti et al., 2011).
Because of the few segments that could be chosen out of the three ellipses (E1, E2,
E3), the employed tortuosity in this case is the simplest and widely used Arc Length
over Chord Length ratio. This vessel tortuosity measure is simply the ratio between
its length Lc and the length of the underlying chord Lx (Lotmar et al., 1979; Heneghan
et al., 2002). In addition to this tortuosity measure, the widths and angles of two
bifurcations were extracted out of each of the previously described three areas (30-53
& 73-75, Table 3.3).
A detailed list of all the 101 investigated features is given in Table 3.3.
3.3.5.2 Haemodynamic Features
The haemodynamic features (76-101, Table 3.3) were estimated in cooperation with a
colleague at the University of Lincoln, Francesco Caliva, based on some of his current
work on modelling of the haemodynamics of the retinal vasculature. In order to avoid
any overlap and conflict with his future doctoral thesis, I will succintly define my
contribution on this specific part of the thesis.
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In order to conduct this part of the study, the segmented images were carefully
selected by myself, in order to make sure that the same vascular trees can be selected in
all four successive images of each patient. This was fulfilled for both the progressors’
and non-progressors’ studies. Using a semi-automatic tool, developed by Caliva et al.
(Calivá et al., 2015), each bifurcation that was not properly connected, due to errors
during the segmentation process, was corrected in order to form a proper vascular tree
(figure 3.10). This process, which gives us all the vascular trees across the whole
image set, is then followed by the estimation of the haemodynamic features that are
described in details in the next section. Similar to the geometric features, all of the
analyses and evaluations of these features were conducted as part of the contributions
of this thesis.
Figure 3.10: Two connected bifurcations, in which the segments were initially disconnected. The cyan
segments are the properly segmented ones; the yellow ”Y” junction is the onewemanually drawwith the
tool in order to define the connectivity and therefore make sure that the vessels are properly connected.
The retinal network is a hydraulic system, which can be studied by applying Kir-
choff’s circuit laws in lumped element models (Rashid, 2010). According to Ohm’s
law, current I is given by the difference in voltage ∆V divided by the electric resis-
tanceR (Hayes &Horowitz, 1989). Relating Ohm’s law to fluid dynamics, the electric
current I is the electric analogue of blood flow rate Q, the voltage difference ∆V is
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the analogue of pressure difference∆P and the electrical resistance R is the analogue
of blood resistance R to flow (Hubbert et al., 1956; Sherman, 1981; Sutera & Skalak,
1993). A schematic representation of the above can be seen in figure 3.11.
Figure 3.11: Schematic representation of the pressure drop in a vessel. Q is the inlet flow, L is the
length, r is the diameter, and P1 and P2 are the pressures in the inlet and outlet of the vessel, respec-
tively.
The features were estimated based on haemodynamic principles and boundary con-
ditions, separately for arterial and venular trees. As we are dealing with vessels with
a diameter less than 200 µm, then microcirculation principles are applicable (Wong
et al., 2003; Pournaras et al., 2008). In such small vessels, Fåhræus-Lindqvist effects
and plasma skimming are paramount in determining the distribution of the hematocrit
and the blood flow velocity profile (Pries et al., 1992, 1989). The purpose of this study
is to see how the variations in the geometry of the vessels affect the haemodynamics
without deepening into the rheology or haematocrit’s distribution within the network,
hence assuming a Newtonian fluid (Aletti et al., 2015). To achieve that, a zero dimen-
sional model (0-D) is designed to estimate the fluid dynamics within the network.
In the present study, all the vascular trees include one bifurcation, with the inlet
(root of the tree) in the parent vessel and the outlets in the two children ones. At the
branching points, the fluid dynamic conditions were estimated under the assumptions
of Hagen-Poiseuille’s law: stiff, straight and uniform tube; Newtonian fluid; laminar,
steady, non-pulsatile and fully developed flow with null velocity at the walls. Blood
flow velocity (V), blood flow rate (Q), Reynolds number (Re), pressure (P) and wall
shear stress (WSS) were estimated, for both arteries and veins.
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Each vascular segment (S) consists of two end-sides (E1 and E2); at each bifurca-
tion (B), the parent vessel (F) splits into two children (C1, C2) vessels, and the blood
flow (Q) is driven from the F to the C1 and C2. Blood viscosity (µ = 0.04poise),
tube’s length (L) and diameter (D), were used to compute the fluid resistance to flow
through each vessel.
R =
128µL
πD4
(3.22)
whereµ is the blood viscosity,L is the length andD is the diameter of the vessel (Kirby,
2010). The flow rate (Q), following the conservation of mass (Qparent = Qch1+Qch2)
was calculated by applying Hagen- Poiseuille’s law Q = (P1 − P2)/R, where P1
and P2 refer to the values of the pressure at E1 and E2 (Zamir, 2016). In literature
different values of the pressure (P) at the central retinal artery and vein (CRA, CRV)
are reported that range from 10 to 90mmHg (Pemp et al., 2013; Kim et al., 2015). In
other studies theymeasured (in-vivo) blood flow velocity with colour doppler imaging,
getting a wide range of values (Keyser et al., 1994; Pemp et al., 2013). For this study,
the adopted values are VCRA = 6.4 cm/S (Fuchsjäger-Mayrl et al., 2001) and VCRV =
3.6 cm/S, selected within the values reported at (Kaiser et al., 1997; Gobel & Lieb,
1995). Accordingly, the diameters of the CRA and CRV are DCRA = 166µm (Pemp
et al., 2013) and DCRV = 210µm, based on a value of AVR = 0.79 (average values in
healthy subjects (Triantafyllou et al., 2014; Heitmar et al., 2010)).
In this thesis the aim is to estimate how fluid dynamics vary at the branching points,
and not to simulate the behaviour of the retinal vasculature. Wall shear stress at the
vessel wall (WSS) was computed as
WSS =
32µQ
D3
(3.23)
where µ is the blood viscosity,Q is the Blood flow andD is the diameter of the vessel
(Papaioannou & Stefanadis, 2005).
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Reynolds number was calculated as
Re =
V Dρ
µ
(3.24)
where ρ = 1.06gr/mL is the value of blood density adopted, V is the velocity and
D is the width of the vessel (Reynolds, 1883).
Boundary conditions
Some necessary boundary conditions were adopted to solve the haemodynamic
problem.
The pressure in CRA = pressure in CRV = 45mmHg; blood flow (Qa) in CRA and
blood flow (Qv) in CRV were derived from the velocity in the central retinal artery
VCRA and the diameter DCRA, and the velocity in the central retinal vein VCRV and
the diameter dCRV , respectively, by using the formula Q = V A, where V is the flow
velocity and A is the cross-sectional area of the blood vessel. Two different boundary
conditions were imposed in this network. In the first one (Qin - Flow boundary
condition), the pressure is directly estimated from the blood flow (Qin) of the system at
the bifurcation point, according to P = QR, whereR is the hydraulic resistance of the
tube according to the Hagen-Poiseuille’s law. The inlet flow rateQin equals to 0.0014
cm3/s and 0.0012 cm3/s for arteries and veins respectively, based on equation 3.25
(Riva et al., 1985) and the values of blood flow velocity reported previously. Across
the parent vessels this value does not change, but it does in the children vessels.
Qin =
πD2
4
V (3.25)
where D and V are the diameter and velocity of the CRV and CRA, respectively.
The boundary conditions at the outlet were enforced applying Murray’s law (Murray,
1926b), according to which the blood flow distribution at the bifurcation depends only
on the vessels’ calibre. In the second one (Pin - pressure boundary condition), a spe-
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cific inlet pressure is forced into the system, through the parent vessel (P=45mmHg
for both arteries and veins), which was chosen as an average of the values mentioned
previously. This estimation reflects the hydrostatic and frictional pressure losses from
the aorta to the Central Retinal Artery (CRA). At the outlet of the network, a pressure
of 15 mmHg is considered, which is equivalent to the intraocular pressure under nor-
mal conditions (Causin et al., 2016). After that the pressure is estimated according to
the pressure drop at the bifurcation point (figure 3.11). Finally all the selected trees
were chosen to be as near to the optic disc as possible.
All of the above estimations are based on the boundary conditions that were adopted
in this thesis, with whatever limitations these impose. However the conditions are ad-
equate to provide an estimate of the relative haemodynamic changes that occur during
different stages of the disease.
Some of the core work of Francesco Caliva will elaborate on the above methodolo-
gies, therefore, in order to avoid any overlap, only essential information was provided,
given that this thesis is focusing on the evaluation of the above features as candidate
biomarkers. In figure 3.12, three examples of the estimation of the haemodynamics
can be seen.
Figure 3.12: Three examples of how the heamodynamic features in a given bifurcation are estimated.
All images come from the same subject and include the same connected bifurcation. On the left, the
image refers to the pressure; on the centre refers to blood flow rate; on the right refers to blood flow
velocity.
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3.4 Conclusion
This chapter presents all the necessary information about the data, the proposed frame-
work and the investigated biomarkers. A detailed introduction was made about the
areas of interest, including how the junctions are being matched, and also the way the
geometric and haemodynamic features are measured and estimated. All of these are
going to be used in conjunction with the techniques that follow in chapter 4 and 5, in
order to conclude with the results of all the studies in chapter 6.
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Chapter 4
Statistics, Feature Selection and
Classification
4.1 Introduction
After providing the description of all the features that are under investigation, the cru-
cial part remains the proper evaluation, in order the results to be as comprehensive,
meaningful and conclusive as possible. In statistics and machine learning it is impor-
tant to identify the optimum feature subset that gives the best performance. In addition,
a simplified and more interpretable model is preferred to a more complicated one.
The purpose of this chapter is to give a detailed description of the evaluation meth-
ods used in this thesis, including the statistical analysis, the feature selection process,
the classification and the validation process. The first aim is to find out whether the
retinal vascular geometry and haemodynamics can provide us with robust biomarkers
of progression to DR, and also quantify their discriminative power in multiple differ-
ent occasions. The second aim is to find the minimal feature set that can differentiate
between multiple combinations of binary classifications.
The chapter is organised as follows. The first section includes the background
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information and the type of statistics that were used in the present studies, followed by
the second section, which will be dedicated to the feature selection and classification
process. The third sectionwill describe the different experiments that were conducted
and the corresponding models that were designed for making the inferences for each of
them. Finally, the fourth sectionwill be the conclusion and discussion of this chapter.
4.2 Statistical Analysis
In every statistical analysis process it is paramount to decide the correct way of analysing
the collected data at the moment of designing the experiments and/or studies. In addi-
tion, the selection of the proper methods is subject to the hypothesis that one is willing
to test. The same data can be analysed in various ways, depending on what inferences
one wants to make out of them. In the studies presented in this thesis, different types
of experimental designs are used, which will be described below.
In general, two main approaches were used in this thesis. In the initial experi-
ments, mixed-effects models were designed, which were analysed using the Analysis
of Variance (ANOVA) parametric test (Fisher, 1936). In the second and most compli-
cated phase of the experiments, the models were designed and evaluated using Linear
Mixed Models (LMM) (McCulloch & Neuhaus, 2001; Bates et al., 2014b). Before
talking about their similarities and differences, it is worth clarifying what a mixed
model stands for.
Mixed models or better mixed-effects models refer to a variety of models that have
as main feature both fixed and random effects. However, the distinction between fixed
and random effects is not always clear. Fixed effects are those where the possible
values of the variable are fixed. On the other side, random effects refer to variables
in which the possible set of values can change (McLean et al., 1991). A clear way of
thinking about the distinction between fixed and random effects is at the observation
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level. Fixed effects assume independency of scores or observations, whereas random
effects assume some type of relationship between some scores or observations. For
instance, gender is a fixed effect variable because one knows all the values of that
variable, and at the same time they are mutually exclusive (independent). A good
example for a random effects variable is a group of patients with diabetes at a hospital
department; one can only sample some of the departments that exist. Besides, patients
can and many of them do move into and out of those departments from time to time
indeed, depending on the treatment and the disease.
There are many types of random effects; repeated measures of the same individuals
is one of them. This is the main random effect that the progression study of this thesis
includes. The scores at each time constitute samples from the same individual for ”in-
definite” number of times. Another example, which is also part of the models here, is a
nested design, e.g. for the previous example, the multiple retinal screenings of patients
that are nested within departments and these departments nested within hospitals. A
nested structure assumes a relationship among groups such that measurements that be-
long to a department (individuals) are considered to be similar to the other scores of
the same department, in such a way as to be able to distinguish them from measure-
ments of other departments (Bates et al., 2014a). Some of the candidate features that
are being investigated in this thesis include multiple vascular measurements, which
are nested within individuals. This is also a random effect, allowing to deal with the
non-independence. Individuals and measurements are the random effects factors; the
disease stages (e.g. three years pre-DR, two years pre-DR, one year pre-DR and onset
of DR), which is defined and cannot be changed, is the fixed effects factor. These fac-
tors represent the independent variables, since they stand alone and are not changing
by other variables. On the other hand, the different features under investigation are
the dependent variables, because their values depend on the other factors, such as the
stage of the disease or a specific individual. The general design can be seen in figure
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Figure 4.1: A mixed model design for the progression study. The same patients are used in all four
groups and the multiple measurements within each of them represent the nested factor. In this way
we account for the fact that the measurements within each individual are not independent, hence being
nested.
4.1.
4.2.1 Repeated Measures ANOVA
In the initial stage of the analysis, where the data were more limited and balanced,
a repeated measures ANOVA was preferred. ANOVA is a statistical method used to
test general rather than specific differences between two or more means. Although the
technique is called ”Analysis of Variance” rather than ”Analysis of Means, the name
is indeed appropriate because inferences about means are made by analysing variance.
In order to use the ANOVA parametric test, instead of a non-parametric one, one
has to make sure that the dependent variable is approximately normally distributed,
even though it is robust in slight violations of normality. Another important assumption
for the repeated measures is the sphericity, which refers to the fact that the variance
of the population difference scores for any two conditions should be the same as the
variance of the population difference scores for any other two conditions. A possible
violation causes the test to become unstable (i.e. leads to an increase in the Type I
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error; that is, the likelihood of detecting a statistically significant result when there is
not one) (Girden, 1992).
The Shapiro-Wilk tests were used for testing for the normality of each feature
(Shapiro & Francia, 1972). Regarding sphericity, Mauchly’s test was used to test for
this assumption (Mauchly, 1940).
4.2.2 Linear Mixed Models
Linear mixed effects models (LMM) model the fixed and random effects as having a
linear form. The outcome variable is contributed by additive fixed and random effects
and of course the error term. Using the hierarchical notation of (Laird & Ware, 1982),
one can express the LMM as
Yi = Xiβ︸︷︷︸
fixed
+ Zibi︸︷︷︸
random
+ ϵi︸︷︷︸
error
(4.1)
where
Y : (n×1) response vector
X : (n×p) design matrix for fixed effects
β : (p×1) regression coefficients for fixed effects
Z : (n×q) design matrix for random effects
b : (q×1) random effects
ϵ : (n×1) error vector
Assumptions for the distributions: bi and ϵi are independent, with prior distributions:
b ~ N (O,σ2D(θ))
ϵ ~ N (0, σ2 I)
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whereD is a symmetric, positive semi definite matrix, which can be parametrised
by a variance component vector θ, I is an n-by-n identity matrix and σ2 is the error
variance (Fox, 2002).
In the above described model, the parameters one needs to estimate are the fixed-
effects coefficients β and the variance components θ and σ2. In LMMs, the two main
methods to estimate the parameters are the maximum likelihood (ML) and restricted
maximum likelihood (REML) (Bates et al., 2014b). In the comparisons of models one
needs to fit the models with both methods, and the explanation for that follows.
Maximum Likelihood (ML) estimates both the regression coefficients and the
variance components, i.e. both fixed-effects and random-effects terms in the likelihood
function (Swaminathan & Rogers, 2008). For the previously defined linear mixed
model, the conditional response of the response variable y given β, b, θ and σ2 is
y|b, β, θ, σ2~N(Xβ + Zb, σ2In) (4.2)
So the likelihood of y given β, θ and σ2 is
P (y|β, θ, σ2) =
∫
P (y|b, β, θ, σ2)P (b|θ, σ2)db, (4.3)
The problem with ML is that it treats β as fixed, but unknown quantities, when it esti-
mates the variance components, but does not take into account the degrees of freedom
lost by estimating the fixed effects. This ends up with ML estimates to be biased with
smaller variances.
Restricted Maximum Likelihood Estimation (REML) includes only the vari-
ance components, i.e. those parameters that parametrise the random-effects terms in
the linear mixed-effects model. The parameter β is estimated in a second stage (Bates,
2014). Provided a uniform improper prior distribution for β and integrating the like-
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lihood (P (y|β, θ, σ2)) with respect to β, one ends up with the restricted likelihood:
P (y|θ, σ2) =
∫
P (y|β, θ, σ2)P (β)dβ =
∫
P (y|β, θ, σ2)dβ (4.4)
Following that, β is estimated with respect to the posterior distribution
P (β|y, θˆR, σˆ2R) (4.5)
The process starts by profiling out σˆ2R andmaximising the remaining objective function
with respect to θ, in order to find θˆR. The restricted likelihood is maximised with
respect to σ2 to find σˆ2R, and then find the expected value of β.
Given that REML accounts for the degrees of freedom lost for estimating the fixed
effects, makes a less biased estimation of random effects variances. Most importantly,
compared to the ML estimates, the estimates of θ and σ2 are invariant to the value of
β as well as less sensitive to possible outliers in the data (Cheung, 2013). Therefore
all the estimates in LMMs are made by fitting a REML. However, when it comes to
comparing two models with a likelihood ratio test, then one needs to refit them to
compare the fixed- and random-effects terms. Comparisons with REML can only be
made between models that are nested in their random-effects terms, thus having the
same fixed-effects term. In the results of the next chapters, whenever is needed to
compare the full model (the model with the fixed effect, i.e. the disease stage, and the
random-effects part) with the null (or restricted) model (the model without the fixed
effects term), then the models need to be refitted with the ML (Bates et al., 2014a).
When designing a LMM, there are two main design issues that one needs to re-
solve regarding the random effects. The first is the random effects intercept and the
second is whether one needs to include a random slope or not. Every individual is
different and so is his/her retina. The slightly different retinal vascular geometry and
functionality is going to be an idiosyncratic factor that affects all responses from the
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same individual, rendering these multiple responses inter-dependent rather than inde-
pendent. Random effects let us deal with this non-independence by assuming a dif-
ferent baseline response value for each individual (Bates et al., 2014a). For instance,
individual 1 in group 1 (e.g. DR group) may have a mean vessel angle of 85,4o across
measurements and individual 2 in group 1 may have a mean vessel angle of 88,3o.
These individual differences can be modelled by assuming different random in-
tercepts for each subject, i.e. each subject is assigned a different intercept value, and
the mixed model estimates these intercepts for us (Winter, 2013). In mixed models,
adding one or more random effects to our fixed effects, gives structure to the error
term ϵ. In the case of the studies here, the random effect for individuals characterises
idiosyncratic variation that is due to individual differences. The error term ϵ is nec-
essary because even if one accounts for the individual by-subject variations, there are
still going to be random differences between different utterances of the same subject.
Another example follows that does not apply to the studies of this thesis, but is men-
tioned in order to elaborate even further. If one has the stress levels of every individual
every time they had their retina screened, then this would be an additional random ef-
fect in the model, which could help explain some more variation and also account for
it, given that hypothetically higher levels of stress might possibly lead to the dilation of
the arteries, for instance. It is now clear why avoiding averaging the within-subjects’
values leads to a more robust and accurate model, offering more flexibility and also
allowing to take into account the full data (Locker et al., 2007; Baayen et al., 2008).
Going a step further, until now, all the described models account for the baseline
differences among individuals, but for that the assumption is that whatever the ef-
fect that the progression of diabetes has to the retina is going to approximately be the
same for all individuals (Winter, 2013). But this is an assumption one also needs to
check, because some individuals might be more or less affected by the progression of
diabetes than others. LMM can account for that by adding a random slope as well,
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where subjects are not only allowed to have different baselines, but are also allowed
to have different slopes for the effect of the progression of diabetes. As can be easily
understood, adding more parameters to be estimated by the LMM, increases the com-
plexity and interpretability of themodel, thus creating the need to think of the trade-off.
Luckily, there are metrics and comparisons one can make to decide whether a more
complicated model makes any difference or not. The next section will elaborate on
this part. All the LMM models implemented in this thesis were fitted by using the R
package lmer and its dependent functions (Bates et al., 2014a).
4.2.3 ANOVA versus Linear Mixed Models
The main reason to prefer LMMs over ANOVA is that the former are considerably
more general, e.g. they work well with both balanced and imbalanced designs and
can also be extended in multilevel modelling (Bates, 2007; Krueger & Tian, 2004).
In addition, linear mixed models deal very well with missing data, something that
ANOVA does not. If, for example, an individual is missing one time point, it needs
to be dropped off the entire analysis. On the contrary in LMMs, only this point will
be discarded, retaining all the remaining data (Little & Rubin, 2014; Krueger & Tian,
2004). Moreover, because of the way that the sums of squares are calculated in re-
peated measures nested ANOVA, post hoc tests are not appropriate (Howell, 2006)
or need some adjustments (Nolan & Heinzen, 2010); but they are using LMMs. It is
worth highlighting that the results from an ANOVA and a LMM are almost identical
when the design is balanced. In addition, an advantage of ANOVA is that it can be
communicated easier, reporting the F-statistics, degrees of freedom and p-values. In
LMMs especially in imbalanced designs, the p-values need to be approximated, due to
the not direct way of calculating the degrees of freedom (Schluchter & Elashoff, 1990;
Bates et al., 2014b). Therefore other metrics (which are supported by the purpose of
the development of the LMMs, (Bates et al., 2014a; Bates, 2014)), like the Akaike
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(Akaike, 1998) and Bayesian Information criterion (AIC and BIC) (Posada & Buck-
ley, 2004) and likelihood ratio test (Vuong, 1989) are more indicative metrics of the
performance of the model, or in simpler words, for making inferences out of our data.
These are the main differences that in the second phase of the experiments the LMMs
were preferred over ANOVA. Further details for each of the two approaches are given
in the next sections.
4.2.4 Evaluation Metrics
Traditionally, before conducting any statistical test, one has to form some kind of null
hypothesis to be tested. Hereafter, every single feature that is tested is forming its
own hypothesis. That is the fixed effect (disease) has a significant effect on the mea-
sured feature, which is tested against the null hypothesis. Null hypothesis asserts that
the samples being compared or contrasted are drawn from the same population with
regards to the outcome variable. This means that a) any observed differences in the
dependent variable (features) must be due to sampling error (chance) or b) the inde-
pendent (predictor) variable (disease) does not make a difference (Blackwelder, 1982).
In literature, to test the above, the most widely utilised metric is the p-value, or
more correctly, the calculated probability (Fisher, 1925). P-value refers to the proba-
bility of finding the observed result when the null hypothesis of the study in question
is true. This metric has undergone a great deal of controversy in literature about its
importance in communicating results (Anderson et al., 2000; Wagenmakers, 2007).
Other metrics are also useful in deciding whether a predictor has an effect on the
outcome variable. Therefore for each feature that is being investigated in this thesis,
a series of metrics will be reported in order to give an overall performance indica-
tion, hence avoiding to only follow a specific evaluation method. The p-values for
the LMMs cannot be directly extracted, because the estimation of the denominator de-
grees of freedom is not straightforward (Bates et al., 2016; Kuznetsova et al., 2015).
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Since the parameters are calculated by the REML, they are not based on observed and
expected mean squares or on error strata, thus being able to handle imbalanced de-
signs with multiple nested, fully or partially crossed grouping factors for the random
effects. Therefore, there are a few approximations for the degrees of freedom leading
to approximated p-values, which will be described next.
For each feature in chapter 6, the following metrics will be reported:
1. Likelihood ratio testX2 (chi-square) is a goodness of fit between two models,
one being the null model and the other being the full one (Vuong, 1989). Re-
moving variables from the model will most probably reduce the model fit, but
the purpose is to evaluate whether this possible reduction is statistically signifi-
cant. The likelihood ratio test (LRT) does this by comparing the log likelihoods
of the two models; supposing that this difference is statistically significant, then
the less restrictive model (the one with the most variables) is said to fit the data
significantly better than the null one. The formula for the LRT is:
LR = −2 ln L(nullmodel)
L(fullmodel)
(4.6)
where L(nullmodel) and L(fullmodel) are the likelihoods of the respective
models. The resulting probability distribution of the test statistic is approxi-
mately chi-squared distributed, with degrees of freedom equal to the number of
parameters that are constrained (i.e. the number of variables removed from the
full model).
2. Akaike Information criterion (AIC) is another penalised measure of the rela-
tive quality of a statistical model (Akaike, 1998). AIC is used to comparemodels
relative to each other, hence making a model selection. AIC is not a hypothe-
sis test, rather a relative estimate of the information lost, when a specific model
is used to represent the process that generates the data. In other words, it pro-
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vides us with a trade-off between the goodness of fit and the complexity of the
model. AIC can provide no information about the quality of the model in abso-
lute sense, meaning that if a model fits the data poorly, this cannot be monitored
by the value of AIC. The value of AIC is given by
AIC = 2κ− 2 ln(Lˆ) (4.7)
where Lˆ is the maximum value of the likelihood function for the model and κ is
the number of estimated parameters in the model.
3. Bayesian Information Criterion (BIC) is a similar to AIC penalised measure
for the comparison between two models. Its value is given by
BIC = −2 ln Lˆ+ κ ln(n) (4.8)
where Lˆ is the maximised value of the likelihood function of the model, n is the
number of data points and κ is the number of free parameters to be estimated.
BIC provides us with an estimate of a function of the posterior probability of
a model being true, and just like AIC, it is based on various assumptions and
asymptotic approximations, but it penalises model complexity more heavily.
Lower BIC denotes a better fit. Both BIC and AIC aim to avoid overfitting
(Posada & Buckley, 2004). Empirically, in both AIC and BIC, a difference be-
tween two models greater than or equal to 2 is considered positive evidence that
one model is better than the other.
4. Welch–Satterthwaite approximation is a method for obtaining approximated
p-values. In statistics, degrees of freedom is the number of values in the final cal-
culations that are free to vary. As aforementioned, for various reasons, in LMMs
calculating the effective degrees of freedom is not straightforward, hence the
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need for approximations. Based on uncertainty analysis, the aim is to combine
multiple variances characterised by various distributions. The linear combina-
tion of the sample variances gives a probability distribution, which cannot be
expressed analytically. However, it can be approximated by a chi-squared dis-
tribution, giving the pooled degrees of freedom, needed for the inference tests,
thus coming up with an approximated p-value (Satterthwaite, 1946).
5. Kenward-Roger’s approximation proposes a scaled Wald statistic, involving
an approximate covariance matrix, which accounts for the variability introduced
by the estimation of the variance components. The advantage of this method is
that it performs well under small sample conditions; they showed that its small
sample distribution can be approximated by an F-distribution, obtaining the de-
nominator degrees of freedom, using similar to Satterthwaite’s approximations
(Kenward & Roger, 1997).
6. Intraclass correlation is mainly used for two purposes. Firstly as a measure
of reliability or agreement between two or more raters, or for the evaluation of
methods on the same set of subjects. Secondly, it allows to assess whether the
random effect is present in a dataset or not. To do so, one first creates a null
model, which only includes the fixed- and random- effects intercepts and the
random effect for the highest level variable, in case of nested model (Snijders,
2011). After fitting the null model the ICC is calculated by dividing the random
effect’s variance by the total variance estimate (random effect’s variance and the
residual’s variance). The final value ranges from 0 to 1 and gives an indication
of how much of the variance in the response variable can be explained by the
random effect (West et al., 2014).
7. Explained variation refers to the variation that can be explained by the covari-
ates under the linear mixed model. In ordinary linear regression theR2 is a mea-
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sure of explained variation and is very popular in the applied fields of statistics
(O’Grady, 1982). When promptly defined,R2 consistently estimates the propor-
tion of explained variation in the population, since it is not affected by the sample
sizes, as happens with p-values. Another advantage of R2 is the assessment of
the importance of a covariate, overcoming the limitation of the regression co-
efficient, which depends on the scale; in multiple regression it summarises the
effects of all the covariates. For the LMMs, (Xu, 2003) proposed a generalised
measure similar to R2, the Ω20, which also provides information about the effect
size. It can be estimated by
Ω20 = 1−
σ2
σ20
(4.9)
where σ2 is the residual variance of the full model, i.e. the amount of variation
in the response Y that is not explained by the covariates, and σ20 is the residual
variance of an intercept-only null model (for fixed- and also possibly random-
effects; depends on one’s purpose). It is worth pointing out that goodness of fit
and/or coefficient of determination metrics are still an on-going field of research
in LMMs (Xu, 2003).
In case one wants to simply find the amount of variance of a specific grouping
random effect, another way is to divide the variation attributed to this effect by
the total variation of the full model and based on the outcome decide whether
this effect is meaningful or not. Another way to address this is to compare the
two created models, by including or excluding this effect; if the outcome is sig-
nificant then one can keep it, otherwise the simplest model is preferred (Stark-
weather, 2010).
8. Bootstrap confidence intervals for the estimates is a way of obtaining a range
of values (intervals) that act as good estimates of the unknown population pa-
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rameters and are calculated from a given set of sample data (DiCiccio & Efron,
1996). The level of a confidence interval gives the probability that the estimated
interval includes the true value of a parameter (e.g. variance estimates or area un-
der the curve (AUC)). The most common confidence level value is 0.95 (95%).
In non-Bootstrapped approaches the estimation begins with a sampling distribu-
tion of a statistic, e.g the sample mean. From the sampling distribution, based
on a 95% confidence level, one argues that 95% of the time the sample mean X¯
will fall between µ ± 1.96 SE, where SE is the standard error of X¯ as the esti-
mator of the population mean µ. Practically, the underlying distribution of the
data is most of the times unknown and all one has are the data. So the basic idea
of bootstrap is to take (re-)samples x∗1, ..., x∗n, taken with replacement from the
original sample x1, ...xn. To get the boostrapped confidence intervals, a variety
of different concepts have been proposed (Efron & Tibshirani, 1997; Davison &
Hinkley, 1997). However it is common in the LMMs to use either a parametric
or nonparametric approach. Without getting into much details, given the vast
information on that subject, one can say that the nonparametric bootstrap makes
no assumptions about the distribution of the data. The data are assumed to be
a vector yi of n independent observations and one is interested in a confidence
interval θˆ(yi). On the other side, a parametric bootstrap assumes that a paramet-
ric model for the data, FY (y; .), is known up to the unknown parameter vector,
θ. Then, the bootstrap data are sampled from FY (y; θˆ), where θ actually is the
maximum likelihood estimate of the original data (DiCiccio & Efron, 1996).
9. Post-hoc tests is an advantage that one has with the LMMs, even when the data
are imbalanced or have nested factors. As the term implies (latin phrase for
”after this”), one is looking at the data after the experiments have concluded,
looking for patterns not specified a priori (Jaccard et al., 1984). With these tests
one can reach to further conclusions about the data, usually focusing on the pos-
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sible pairwise comparisons. It is very important to clarify the difference between
”proper” post-hoc tests and multiple comparisons. Starting with the latter, it oc-
curs when one considers multiple statistical inferences simultaneously. Failure
to compensate for that by adjusting the p-values will most likely lead to TYPE
I errors, i.e. falsely rejecting the null hypothesis. The reason is simple: If one
performs a test at 5% level, there is only a 5% chance of incorrectly rejecting the
null hypothesis, if the hypothesis is true. On the other hand, the former accounts
for the above issue and in literature there are many methods. In this thesis the
Tukey post-hoc test (Tukey, 1949) and the Bonferroni correction post-hoc test
(Weisstein, 2004) are utilised. Both methods correct for family-wise error rate,
but following a different approach. In Bonferroni the adjustment is simple and
it can be used as a post-hoc test or with planned contrasts, being more suitable
when one has a small set of planned comparisons. If α = 0.05 is the level and
κ = 10 is the number of pairwise comparisons, the adjusted p-values will be
α/κ = 0.005. Tukey’s approach follows upon a significant main test and it can
tell us, which subgroups actually differ. Tukey’s formula is very similar to the
one of the t-test, except that it corrects for the family-wise error rate. At first,
the difference between the largest and the smallest of the two means is divided
by the standard error of the data. The obtained value qt is then compared to a q
value from the studentised range distribution. If qt is larger than the q, the two
means are said to be significantly different.
4.3 Classification & Feature Selection
In order to test the discriminative power of the proposed features, two different ap-
proaches were followed, given their popularity in literature. Firstly, a regularised ran-
dom forests classifier was used, which is an adjusted for the feature selection process
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random forests classifier, as proposed in (Deng & Runger, 2012, 2013). Secondly, an
elastic-net logistic regression process was also used, which includes a feature selection
step based on the Least Absolute Shrinkage and Selection Operator (Lasso) and Ridge
regression, creating a hybrid penalty for the coefficients of the features (L1- and L2-
norms) (Friedman et al., 2010; Zou & Hastie, 2005) .
4.3.1 Regularised Random Forests
Random forests is a well-established supervised classifier and very popular in machine
learning. It was proposed by Breiman as an improvement to the decision trees bagging
method (Breiman, 2001). It consists of multiple decision trees, each of which is grown
on a bootstrap sample, taken from the original training data. The Gini impurity index
(Gini(u)) at node u, is defined as
Gini(u) =
c∑
c=1
puc (1− puc ) (4.10)
where pcu,is the proportion of class-c observation at node u. Subsequently, the Gini
information gain of Xi for splitting node u, is the difference between the impurity at
node u and the weighted average of impurities at each child node of u. This can be
seen in equation 4.11 (Deng & Runger, 2013).
Gain(Xi, u) = Gini(Xi, u)− wLGini(Xi, uL)− wRGini(Xi, uR) (4.11)
where uL and uR are the left and right children nodes of u respectively. Similarly
wL and wR are the proportions of instances assigned to the left and right children
nodes. Gini index is used in random forests as a measure of variable importance.
An important part of random forests is the mtry parameter (i.e. the square root of
the number of predictor variables (rounded down)), which defines the random set of
95
4.3. CLASSIFICATION & FEATURE SELECTION
features out of P that is evaluated each time (Cutler et al., 2007). The feature with the
highest Gain(Xi, u) is used for splitting the node u. The importance score for variable
Xi is then calculated as,
Importancei =
1
ntree
∑
u∈SXi
Gain(Xi, u) (4.12)
where SXi refers to the set of nodes split by Xi in random forests with ntree number
of tree. In short, the regularised version of random forests (RRF) can select a compact
feature subset, by including an additional penalty coefficient, creating a regularized
information gain (equation 4.13) (Deng & Runger, 2013),
GainR(Xi, u) =
{
λ ·Gain(Xi, u) i ̸∈ F
Gain(Xi, u) i ∈ F
(4.13)
in which F refers to the set of indices of features used for splitting in the previous nodes.
The parameter λ ∈(0,1] is the penalty coefficient. When i̸∈ F the coefficient penalises
the ith feature for splitting node u. Smaller λ leads to a larger penalty. Regularised
random forests uses GainR(Xi, u) at each node, and adds the index of a new feature
to F. For instance a RRF with λ = 1, has the minimum regularisation, however a new
feature has to be more informative at a given node than the features that have already
been included to the feature subset. The feature subset selected by RRF(λ = 1) is
termed the least regularised subset, as it offers minimum regularisation. Apart from
the feature selection process, the rest of the algorithm is exactly the same as the initially
proposed random forests classifier (Deng & Runger, 2013).
For the evaluation of the performance of RRF, in addition to the other metrics,
the Out of Bag error (OOB) is also used, which is the internal way of validating the
performance of random forests classifier (Breiman, 2001).
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4.3.2 Logistic Regression with Elastic-Net
In all the instances of this study, in addition to the RRF, a regularised logistic regression
model is also used, as has been proposed in (Friedman et al., 2010; Zou & Hastie,
2005). The difference with the ordinary logistic regression has to do with the penalty
parameter applied to the coefficients. In the case of ridge regression, the coefficients of
correlated predictors are shrunk towards each other, letting all of them work together.
From a Bayesian perspective, the ridge regression performs better, if there are many
predictors and all have non-zero coefficients.
On the other side the least absolute shrinkage selector operator (Lasso) is to some
extent indifferent to very correlated predictors, tending to pick one and discard the rest
(Tibshirani, 1996). The Lasso penalty corresponds to a Laplace prior, which expects
many coefficients to be zero or close to zero and also a small subset of non-zero coef-
ficients. In the middle of this, elastic net with the mixing parameter (i.e. the balance
between Lasso and ridge regression) α = 1 - ϵ for small ϵ > 0 (parameter defines
the amount by which one moves away from Lasso-only penalty,i.e. α=1), performs
similar to Lasso, dealing with any extreme behaviour caused by highly correlated pre-
dictors. The general formula Pa of elastic net, as seen in equation 4.15, introduces a
trade-off between ridge and Lasso. As α increases from 0 to 1 for a specific value of
parameter λ, the sparsity of the solution in equation 4.17 (referring to the coefficients
equal to zero), increases monotonically from 0 to the sparsity of the Lasso solution.
More specifically, assuming that the response variable Y = {1, 2}, then the logistic re-
gression model represents the class-conditional probabilities, through a linear function
of the predictors, which in the logarithmic form is given by equation 4.14 (Friedman
et al., 2010).
log
Pr(Y = 1|x)
Pr(Y = 2|x) = β0 + x
Tβ (4.14)
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Where in this case the model is fit by regularised maximum binomial likelihood.
Pα(β) =
p∑
j=1
[1
2
(1− α)β2j + α|βj|
] (4.15)
Let p(xi) = P (Y = 1|xi) be the probability according to equation 4.16.
P (Y = 1|xi) = 1
1 + e−(β0+x
T
i β)]
(4.16)
For an observation i at specific values for the parameters (β0, β), the penalised log
likelihood is maximised.
max
(β0,β)∈R(p+1)
[
1
N
N∑
i=1
{
I(gi = 1)logp(xi) + I(gi = 2)log(1− p(xi))
}− λPα(β)
]
(4.17)
Replacing , the log-likelihood part of equation 4.17 takes the form,
v(β0, β) =
1
N
N∑
i=1
yi · (β0 + xTi β)− log(1 + e(β0+x
T
i β)) (4.18)
a concave function of the parameters. In this approach, for every value of λ, an
outer loop is created for the computation of the quadratic approximation vQ in equation
4.19 about the current parameters (β˜0, β˜).
vQ(β0,β) = − 1
2N
N∑
i=1
wi(zi − β0 − xTi β)2 + C(β˜0,β˜)2 (4.19)
where
zi = β˜0 + x
T
i β˜ +
yi − p˜(xi)
p˜(xi)(1− p˜(xi)) (4.20)
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wi = p˜(xi)(1− p˜(xi)), (weights) (4.21)
Finally, the penalised weighted least-squares problem can be solved by equation 4.22,
using the coordinate descent approach (Friedman et al., 2010).
min
(β0,β)∈R(p+1)
[
− vQ(β0, β) + λPα(β)
]
. (4.22)
A number of sequential nested loops are created :
• Outer loop: Decrement λ.
•Middle loop: New quadratic approximation vQ for the current parameters (β˜0, β˜).
• Inner loop: Execute the coordinate descent algorithm on the penalised
weighted least-squares problem (equation 4.22).
Further information of the above method is given by Friedman et al. (Friedman et al.,
2010; Zou & Hastie, 2005; Tibshirani, 1996).
4.3.3 All-Relevant Feature Selection (Boruta)
The minimal-optimal problem, which refers to the selection of a small feature set that
gives the best possible classification result has been intensively studied in literature
(Nilsson et al., 2007; Kursa et al., 2010). This is quite practical when one is mainly
interested in building a classifier with high performance. The all-relevant features
approach aims to accomplish something complementary to that, by identifying all at-
tributes that are somehow relevant for the classification. As the creators of this ap-
proach claim, finding all relevant attributes, instead of only the non-redundant ones, is
necessary when one is also interested in understanding the underlying mechanisms re-
lated to the topic of interest, instead of simply creating a black box with high predictive
power.
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This algorithm is a wrapper around random forests, because the important part is
to have an efficient and relatively quick classifier that can provide a numerical feature
ranking, just like random forests classifier does (Kursa et al., 2010). As importance
measure the authors use the Z-score, since it takes into account the fluctuations of the
mean accuracy loss among the trees in the random forests. However, the Z-score is
not directly related to statistical significance of the feature importance returned by the
random forests. So the algorithm proceeds by creating a corresponding ”shadow” at-
tribute, the values of which are obtained by shuffling the values of the original attribute
across objects.
After that, all the attributes, both the shadowed and the original ones, are used to
perform a classification and compute their importance (Z-scores). Then the maximum
score among the shadowed attributed (MSA) is found (in the corresponding figures
in chapters 4 and 6 this is referred as ”shadowmax”), which is compared with the
corresponding scores of the other attributes. The attributes that are found to score sta-
tistically significantly higher than the MSA ones are marked as important. If there
are attributes with undetermined importance, then a two-sided test of equality is per-
formed between the attribute under question and the MSA, to determine the outcome.
Similarly, the attributes that have importance significantly lower than the MSA are
marked as unimportant and are permanently removed from the system. Finally the
shadow attributes are removed and the process is repeated again until the importance
is assigned for all the attributes, or the algorithm has reached the maximum number of
runs or when it cannot converge (Kursa et al., 2010).
In the beginning this algorithm is preceded by three start-up rounds, which at this
stage they have less restrictive importance criteria. The purpose of the start-up rounds
is to deal with the high fluctuations of the Z scores, when the number of features is
large at the beginning of the process. All of the features are compared respectively
with the fifth, third and second best shadow attribute. The rejection test is performed
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at the end of each initial round, whereas the test for confirmation is not performed at
all (Kursa et al., 2010).
4.3.4 Validation & Metrics
In order to evaluate the performance and validate the classification models, a num-
ber of approaches were adopted. As was previously described, three feature selection
processes were utilised. In addition, the evaluation process was conducted by using a
repeated 10-fold cross validation (Devijver & Kittler, 1982) and 0.632 bootstrap (Ko-
havi et al., 1995). The different models were compared according to their performance
in terms of the average area under the receiving operators curve (AUROC or AUC),
but additionally, other metrics are also utilised and/or reported, such as kappa, speci-
ficity and sensitivity (both of these are only used for building the ROC curve) and out
of bag error (not for the model comparison, but as complementary to AUC metric;
only for the random forests).
Cross validation (Geisser, 1993) is possibly the most widely used model valida-
tion technique to assess the performance of a classifier. Initially, the original sample is
partitioned into k equally sized subsamples. Of these k subsamples, a single subsample
is kept out as the validation sample for testing the model, with the remaining k - 1 sub-
samples used as training data. This process is then repeated k times, but making sure
that each fold is used only once as the validation data. In our studies, given the relative
small amount of features and observations, the above process is repeated 1000 times,
getting 1000 AUC values and hence reporting the average AUC with the confidence
intervals. This approach was used for the final, post-feature selection classification
process.
0.632 Bootstrap has been proposed as a way of reducing the bias arising from
the ordinary bootstrap method (Kohavi et al., 1995). In general, bootstrapping refers
to the process of using the data of a sample as a surrogate population, in order to
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approximate the sampling distribution of a statistic, i.e. to resample with replacement
from the sample data, known as bootstrap samples. Finally, the sample summary is
estimated on each of the bootstrap samples. The 0.632 bootstap aims to reduce the
bias arising from the ordinary bootstrap, which is due to non-distinct observations in
the bootstrap samples that result from sampling with replacement. To resolve this they
proposed the 0.632 estimator,
ˆError0.632 = 0.368 ¯error + 0.632 ˆError
(1) (4.23)
in order to correct the upward bias in ˆError(1) (leave-one-out bootstrap error estimate)
, by averaging it with the downwardly biased estimate ˆError(0.632). ¯Error is the
apparent error rate, or resubstitution rate. The two coefficients 0.368 = e−1 and 0.632
were suggested based on the fact that the bootstrap samples are supported on roughly
0.632n of the original data points (Kohavi et al., 1995; Efron & Tibshirani, 1997).
Receiver Operating characteristic (ROC) curve (figure 4.2) is a graphical plot
that provides us with important information about the performance of a binary clas-
sifier, as its discrimination threshold is varied. The curve in its x axis includes the
false positive rate (FPR), also known as fall-out, and can be calculated as 1-specificity
(Hanley & McNeil, 1982). This term gives us the proportion of positive samples that
are erroneously identified as such. In its y axis it includes the true positive rate (TPR),
also known as sensitivity or recall. ROC analysis provides a useful tool to select op-
timal models irrespectively from the cost context or the class distribution. The TPR
(sensitivity) is a rate telling us the proportion of positive samples that are correctly
classified as such (e.g. the percentage of DR individuals who are correctly identified
as having the disease). A similar metric, specificity, also called the true negative rate
(TNR), measures the proportion of negative samples that are correctly identified as
such (e.g. diabetic subjects that are correctly identified as not having DR; convention-
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ally one of the two classes represents the negative outcome without implying anything
further). Therefore sensitivity, additionally quantifies the avoiding of false negatives
in the same way that specificity does for false positives. Lastly the false negative rate
(FNR) refers to the proportion of negative samples that are mistakenly classified as
being negative. From a statistical point of view, false positives and false negatives
can be thought of as concepts analogous to Type I and Type II errors, where a positive
outcome corresponds to rejecting the null hypothesis, whereas a negative outcome cor-
responds to not rejecting the null hypothesis. From these four metrics one can create a
2-by-2 contingency table or else confusion matrix, to additionally visualise the results
(Bradley, 1997).
An important additional metric that we get out of the ROC curve is the Area under
the ROC curve (AUROC, or from now on AUC), or c − statistic, which together
with the ROC curve gives an overall estimate of the performance of a binary classifier
(Hanley &McNeil, 1982). AUC is equal to the probability that the classifier will rank
a randomly chosen positive sample higher than a randomly chosen negative sample,
i.e. P (sample(x+) > sample(x−)). When the classifier cannot distinguish between
the two classes, i.e. there is no difference between the two distributions, the AUC
will be equal to 0.5. In the case of perfect separation of the classes the value of AUC
will be equal to 1. One important characteristic of the AUC, which depends on integral
calculus, is that it makes no assumptions about the form of the x+ and x− distributions.
The statistical properties of this important metric have also been stressed in literature,
as the AUC is intimately connected with the Wilcoxon or Mann-Whitney statistical
tests (Bamber, 1975; Hanley & McNeil, 1982).
Out-of-Bag error (OOB), or else out-of-bag estimate is a method of estimating the
prediction error in random forests classifier, in decision trees but also in other machine
learning models (Breiman, 2001). It utilises bootstrap aggregating to sub-sample the
training data. This estimate is reliable and efficient in that it can be computed during
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Figure 4.2: An example of the ROC curve that is going to be part of the results. On the x and y axes
the false positive rate and the true positive rate can be found respectively. As can be seen the more we
move towards the left upper corner the performance of the classifier improves. This plot is the averaged
ROC curve over all the cross-validation runs, including the variation and the spread estimates around
the average curve, by using box plots. The spread estimated are shown at 11 equally spaced positions
along the curve.
the same run that constructs the bagged predictor. OOB is a random number, since it
is based on random resamples of the data. Given a training set P with an output vector
y and an input x, a predictor f(x, P ) is constructed and a given loss functionM(y, f)
measures the error in predicting y by f. Next the bootstrap training sets P(κ,B) and
the predictors f(x, T(κ,B)) are formed, aggregating them in a way to form the bagged
predictor fB(x). For each y, x in the training set, the predictors are only aggregated
over those κ for which P(κ,B) does not contain y, x. If we denote these OOB predic-
tors by fOOB , then the OOB estimate for the generalisation error is the average of
M(y, fOOB(x)) over all the samples in the training set.
Accuracy is another common metric given by
ACC =
TruePositive+ TrueNegative
Positive+Negative
(4.24)
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Table 4.1: Summary of the classifiers, feature selection process and evaluation metrics
Techniques Overview Process
Logistic regression Linear classifier Classification
Random forests Non-linear classifier Classification
Elastic-net Regularisation parameter & mixing parameter for
LASSO and Ridge regression
Feature Selection
Regularised random
forests
Regularised information gain using penalty parameter Feature selection
AUC Represents a probability, the closer to 1 the better Evaluation metric
ROC Graphical plot for the performance of the classifiers Evaluation metric
kappa Adjusted accuracy based on the balance of the classes Evaluation metric
OOB Prediction error using bootstrap aggregating Evaluation metric
and it merely refers to the corrected classified instances of the classifier in a specific
cut-off point (denominator refers to the total sample size). Accuracy itself is an unreli-
able and misleading metric if used alone, especially when comparing the performance
of different classifiers (Provost et al., 1998). Therefore, it has to be accompanied by the
”no information rate”, which is the largest class percentage. That is because a 75% of
accuracy in a balanced design (50-50) is not the same to an imbalanced design, where
for instance the largest class represents the 70% of the whole sample. Therefore, there
is another metric known as ”kappa”, which compares the observed accuracy with the
expected accuracy, yielding a metric that can be used for evaluating both the perfor-
mance of a single classifier and also many classifiers among themselves (Ben-David,
2008).
kappa =
ObservedAccuracy − ExpectedAccuracy
1− ExpectedAccuracy (4.25)
where expected accuracy is defined as the accuracy that any random classifier would
be expected to achieve based on the confusion matrix. A summary of the processes
can be seen in Table 4.1
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4.3.5 Classification Models
The classification process was conducted for the following combinations:
1. Year three versus onset of DR (progressors’ group)
2. Year two versus onset of DR (progressors’ group)
3. Year one versus onset of DR (progressors’ group)
4. Mean diabetics versus Onset of DR (progressors’ group)
5. Mean diabetics (non-progressors’ group) versus onset of DR
6. Mean diabetics (non-progressors’ group) versus mean diabetics (progressors’
group)
7. Year 3 minus year 2 versus onset of DR minus year 1 (progressors’ group)
8. Mean diabetics (non-progressors’ group) versus mean diabetics (progressors’
group) versus onset of DR (One versus All method)
The primary objective of this work is to evaluate the discriminative power of the entire
feature set (candidate biomarkers), as an additional, complementary to the statistical
analysis step. The secondary objective is to find the optimum model for each of the
above combinations, in order to assess the appropriateness of these classifiers in having
a possible clinical interest. To accommodate these purposes, the above combinations
include balanced classes. The number of features are 112 in total and the relevant list
is provided in Tables 3.3 and 6.15.
The purpose of the various evaluated combinations is to find out whether different
periods of time and different cohorts can actually be efficiently classified, using ex-
clusively geometric and haemodynamic features. This will give us a very important
indication of how the feature sets perform in practise, and also whether they change
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according to the combination. Combinations 1, 2 and 3 will show how extensive the
alterations are as we move towards the onset of DR, always in reference to the onset of
DR. Combination 4 includes the average of the three year period before the onset of
DR, which offers a more realistic and representative sample for a wider period of time.
Combination 5 is similar to combination 4, but during this time, the group contains a
non-progressors’ diabetic cohort, for which the last four consecutive years of diabetes
are combined and averaged, in order to form this group that will be tested against the
DR group. Combination 6 aims to actually find out, whether two diabetic groups that
on first sight belong to the same category, in reality they come from predefined peri-
ods, for which the prior information that one of them will progress to DR shortly, is
available. However in a prospective study this information will not be available and
therefore subjects from both categories are mixed up, adding much unnecessary vari-
ation in the sample. The purpose is therefore to find out if indeed two such diabetic
cohorts are starting early to be affected by DR to a level that defines the progression.
Combination 7 intends to show whether the vascular changes from the three years-
to two years- pre-DR are more or less extensive or even non-existent at all, compared
to the changes when progressing from one year pre-DR to the onset of DR. Finally,
combination 8, which is an extension of combination 5, 6 and 7, will provide us with
an overview of whether the three main groups, non-progressors diabetics, progressors
diabetics and DR subjects, can actually be efficiently differentiated among each other,
but this time altogether. As it will be stressed more in details in chapter 6, if this com-
bination yields a good performance, it can possibly have a direct clinical application,
since the first two categories, i.e. non-progressors diabetics and progressors diabetics,
can denote the progression towards DR, which can be an indication for the clinicians
to run more tests or try to adjust the patient’s treatment plan.
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4.3.5.1 Feature Selection Process
The feature selection process includes various steps. For the combinations 1-7 the
steps are exactly the same, but for the combination 8 the process is slightly different.
Everything was fulfilled using Rstudio and a number of packages (RStudio Team,
2015; Kuhn, 2016; Kursa & Rudnicki, 2010; Friedman et al., 2010; Deng & Runger,
2013; Sing et al., 2005).
As was previously described , each of the feature selection algorithms follows a
specific process for coming up with a feature subset. Given the randomness behind all
the processes involved, the feature subsets slightly change every time the algorithms
are executed. Initially the data are randomly partitioned into 10 balanced folds. Leav-
ing one fold aside at a time, the feature selection process is executed 10 times in total,
ending up with 30 different models (10 from each selection process). Each of these
models will inevitably probably include a slightly different feature subset. In order to
arrive at this point, the whole feature set is penalised by the algorithms, trying to find
the optimum subset. Given the complexity of the feature selection processes, in order
to select the optimum regularisation parameter for each fold that gives the final subset,
a 0.632 bootstrap process is run, for 1000 iterations in total.
Regarding the elastic-net, the parameters of α and λ were bootstrapped within the
range of 0 and 1, with a step of 0.02. Similarly, the regularised random forests process
was bootstrapped for the parameters mtry (4 and 5; 6 and onwards were giving inferior
results), i.e. the square root of the number of predictors sampled for splitting at each
node rounded down , the penalty λ and the importance coefficient κ within the range
of 0 and 1, with a step of 0.02. At the end of this process the optimum parameters that
give the best classification result (based on AUC) is estimated, which in turn gives the
final feature subset for the respective fold. Figures 4.3, 4.4 and 4.5 show an example of
the bootstrap process for each of the three feature selection techniques. As previously
described, this process defines the final regularisation parameters, and consequently a
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Figure 4.3: The plot shows the bootstrap process for ending up with the optimum regularisation param-
eters. The x axis shows the mixing parameter, alpha, which is the trade-off between Lasso and Ridge
regression. The y axis includes the 0.632 Bootstrapped AUC. Each line inside the plot represents the
penalty parameter λ.
feature subset, that yield the best performance for a given fold (each of the 10 folds).
Figure 4.3 is presented here for purely visualisation purposes, in order to show how the
combinations of the different values of the regularisation (λ) and themixing parameters
(α) in the elastic net yield varying performances. The combination of values that scores
higher in the y axis (ROC) is selected, providing us with the corresponding feature
subset.
4.3.5.2 Validation Process
Having created the 30 models in total from the elastic-net, the regularised random
forests and the all-relevant features selection process (boruta) for each combination
(apart from the combination 8), it is now time to find out, which feature subset performs
best in the whole dataset. A 1000 repeated 10-fold cross validation process is followed,
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Figure 4.4: This plot is split into two parts, one for each of the two mtry values. It includes the im-
portance coefficient on x axis and the 0.632 bootstrapped AUC on y axis. The dots are the different
regularisation values, which in turn define the corresponding feature subsets.
which gives an averaged ROC curve with box plots in different points on the curve,
and also the average AUC with bootstrapped confidence intervals. And all that for
each of the 60 classifications (30 with the random forests and 30 with the logistic
regression classifiers). A plot with a bootstrapped AUC will also be reported for every
combination, mostly for visualising how each bootstrap sample performs.
The five best models out of this process for each of the seven combinations will
be presented in chapter 6. The final models provide a solid representation and a final
verdict of which features are effective predictors and good biomarkers for the respec-
tive combination that is under investigation each time. A ranking of the twenty best
features, based on the times that they were selected in all of the 420 models will also
be shown.
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Figure 4.5: Example of the selection process with the all-relevant features algorithm. On x axis the
group of features with the relevant box plots can be seen, starting from the less important (left) to
the more important (right). Red coloured features represent the non-selected ones, whereas the green
coloured are the important ones. The blue coloured boxes show the minimum, mean and maximum
importance of the shadow attributes, in order to have an idea where the candidate features stand in
comparisonwith them. Values that are statistically significantly higher than the shadowmax are declared
as confirmed features.
4.3.5.3 One Versus All Approach
In contrast to the other combinations, in combination 8 the aim is to figure out whether
a classification model that combines the three main scenarios that are of our interest,
when building a classification system for diagnosing the disease and the progression,
is plausible. These scenarios refer a) to the non-progressors’s group, b) to the progres-
sors’ group (years of diabetes but no DR) and c) to the group of patients with DR. This
combination is of high clinical importance because the progressors’ group state is the
pre-DR situation, which we would ideally like to know. Given that DR is just around
the corner, possible treatment interventions to slow down the proliferation might be
feasible. Therefore, this classification model, which includes these three scenarios,
could be used to identify not only the transition between the diabetic state and the
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pre-DR one (or alternatively progressors’s state), but also DR.
The one versus all method (Rifkin & Klautau, 2004) reduces the problem from
multi-class to multiple binary classification problems, and was preferred due to the
complexity and the few available observations that are not enough for building a mean-
ingful multi-class classifier.
The process starts by training a single classifier per class, with the samples of this
class as positive and the rest as negatives. To achieve that, for each combination of
classifiers (in this case three), the probabilitiesmust be returned instead of the predicted
class labels. The final prediction is then performed by executing these binary classi-
fiers and finally choosing the prediction instance with the highest confidence score
(probability). Similarly to the other combinations, the evaluation of this ensemble of
individual models is decided by a 1000 repeated 10 fold cross-validation, getting one
ROC curve for each of the three cases. Three feature subsets were used to test this
ensemble, which are the best feature subsets of the combinations 4, 5 and 6. Given
that the best performance in these combinations was achieved by the random forests,
this classifier was used for the ensemble, without any regularisation.
4.4 Conclusion
This chapter gives some important information regarding the different ways that the
biomarkers are going to be evaluated and tested in practise. Themethods of the statisti-
cal analysis together with the metrics that are adopted for the evaluation and validation
processes were described, focusing on the linear mixed models, which are the basis of
the whole statistical analysis. Furthermore, the feature selection and classification
processes were also elaborated, giving detailed information about the different com-
binations, based on which the multiple classification models are going to be built and
evaluated. In chapter 6, the results and findings of the all the studies will be presented,
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after applying the methods and techniques described in the present chapter as well as
in chapter 3.
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Chapter 5
Summarising the Retinal Vascular
Calibres
5.1 Introduction
5.1.1 Background
As previously described, the human retina is an important and non-invasive window
for monitoring the blood vessels, being part of the brain’s vascular system (Dowling,
1987). In numerous studies in literature, alterations of the retinal vessels have been
associated with diseases, like diabetic retinopathy (DR) (Leontidis et al., 2015a), hy-
pertension (Wigdahl et al., 2015) and glaucoma (Arend et al., 2002). In diabetes and
DR especially, changes have been identified both in the blood flow and the vessel wall
structure, leading to geometric alterations, which can be measured in fundus images
(Bursell et al., 1996; Gardner et al., 2002; Kohner et al., 1995; Barber et al., 2011).
DR, at the advanced stages, has already caused serious damages and can lead to blind-
ness. Early detection of these alterations, before the onset of DR, could possibly assist
the clinicians to decide a better series of treatment interventions.
The retinal vascular geometry offers a unique opportunity to study a number of
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different diseases. However, to do so, reliable and robust methods are needed in order
to extract all of the relevant information for running the statistical analysis. Accurately
measuring and summarising the calibre (width) of the parent vessel trunks in the most
efficient way, no matter how subtle the improvement will be, can contribute towards
defining biomarkers of the progression of a disease. Additionally, taking into account
that during the proliferation of retinal diseases, as defined by the anatomical structure
of the retinal vessels, any alterations are very fine, any possible improvement, regard-
less of how negligible it might be, is undoubtedly important.
The main purpose of this chapter’s study is to provide an alternative method for
quantifying the retinal vessel calibres. Even the slightest improvement of this quan-
tification can have a direct effect on studies of retinal pathologies, especially if we take
into account that in different diseases, like diabetes and DR, the vascular changes are
quite subtle (even less than 5%), especially during the consecutive years of the pro-
gression of the disease (Leontidis et al., 2015a). In addition, these changes are difficult
to quantify in digitised images, which thus may warrant and justify the innovation of
methods to quantify those small changes of the vessel calibres. The proposed method
aims to improve and for the first time to specify the quantification for healthy, diabetic
and DR eyes.
5.1.2 Related Work
As it was briefly described in chapter 2, the central retinal artery (CRA) and vein
(CRV) are the two main vessels of the retina. The CRV leaves the optic nerve head,
draining the blood from the capillaries directly into either the superior ophthalmic vein
or to the cavernous sinus. Meanwhile, the CRA branches off the ophthalmic artery,
passing under the optic nerve head within its dural sheath to the eyeball (Rodieck,
1973). Initially Parr et al. (Parr & Spears, 1974a,b) and then Hubbard et al. (Hub-
bard et al., 1999) completed some important work in the quantification of the retinal
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vessel calibres, which was then extended and improved by Knudtson et al. (Knudtson
et al., 2003). In their methods, the central retinal vein and artery equivalents (CRVE
and CRAE) were proposed. In both cases, the calibre measurements around the optic
nerve head were combined into one index, giving us the CRVE and CRAE. All of the
measurements are collected around the optic nerve head, in an area of interest that lies
within 0.5 to 1.0 optic disc diameters from the optic disc margin. To improve the es-
timation, Knudtson et al. revised the formulas used in the previous studies, in order
to be independent of the units of measurement (e.g. pixels or microns) and without
constant terms. The derived formulas for arteries and veins can be seen in equations
5.1 and 5.2 respectively, which are based on branching coefficient values of 1.28 for
arteries and 1.11 for veins.
Arterioles : wˆ = 0.88 ∗
√
(w21 + w
2
2) (5.1)
V eins : wˆ = 0.95 ∗
√
(w21 + w
2
2) (5.2)
where wˆ is the estimate of the parent trunk arteriole or venule and w1, w2 are the two
branches (children).
It is worth mentioning that the data used to derive these formulas included only
normotensive subjects. However, as has been shown in previous studies (Leontidis
et al., 2015a, 2016a), applying these formulas to diabetic and DR subjects give us
different estimates of the BC. This could lead to errors in the measurements, in the
event that they are about to be used in summarising the vessel calibres in diabetic
and/or DR patients.
Following a similar logic, Patton et al. attempted to improve the above formulas
for calculating the BC, recruiting healthy subjects to measure the retinal vessels cali-
bres (Patton et al., 2006a). Following that, they tested the performance on a different
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group of people that they also recruited. Their main method included the design of a
least-squares linear regression model for the arteries only, since the main independent
variable, the asymmetry index, was found to be related only to the arteries and not the
veins. Their developed model can be seen in equation 5.3.
BC_arteries_model = 0.78 + 0.63 ∗ Asymmetry index (5.3)
5.1.3 Proposed Approach
The relationship between parent and daughter vessels at vascular junctions has been
expressed by using the junction exponent (x) (Murray, 1926b). It has been shown that
deviations from the optimal value, as predicted byMurray’s cubic law (x=3), can be an
indication of a vascular disease. Witt et al. (Witt et al., 2010) proposed an alternative
parameter, which they called the optimality ratio, that is simpler to calculate and more
robust in the presence of noise than Murray’s junction exponent.
In addition, in another study (Takahashi et al., 2009), they assessed the arteriove-
nous distribution of haemodynamic parameters throughout a microvascular network
inside the human retina. They suggested an alternative value for the exponent, based
on the fractal dimension and a branch exponent, with the latter derived from data on
cerebral vessels, mainly because they share similar structural and functional charac-
teristics as the retina (Kamiya & Takahashi, 2007). The reasoning behind this is that
Murray’s theoretical value of 3, actually ranges between 2.7 and 3.0 in various vascular
beds (Sherman, 1981; Suwa & Takahashi, 1971). Fractal dimension has been vastly
studied in literature and is primarily used to quantify complex vascular networks like
the retina (Mandelbrot, 1983). The branch exponent, which is also consistent with a
fractal recursive rule, can also define the relation between the length and radius of a
branch segment as L(r) = 7.4ra (Suwa & Takahashi, 1971). In the study of Takahashi
et al. they assume a value of 1.7 for fractal dimension and 1.15 for the branch exponent
117
5.2. METHODS AND TOOLS
(Takahashi et al., 2009).
In the proposed method, the mean diameter ratio is combined with a revised expo-
nent, which has been derived from data of healthy, diabetic and DR subjects. There-
fore, the final exponent, although part of it utilises the standard branch exponent of
1.15, as suggested in (Takahashi et al., 2009; Kamiya & Takahashi, 2007), it is com-
binedwith the fractal dimension, aswas experimentally calculated in these three groups.
The newly derived formulas were compared to the BC of Knudtson et al. and the lin-
ear regression model of Patton et al. for all the above cases, using the mean absolute
percentage error (MAPE).
The following study is organised into four main sections. In Section 1, a thorough
description of the methods and techniques is given, alongside the tools and the data that
were used. In Section 2, more details will be given about the study of the evaluation
of the AVR and the arteries and veins individually, as biomarkers of progression to
DR. Section 3 will be devoted to presenting the results in two parts. The first part
will present the comparisons between the three techniques for summarising the retinal
vessel calibres. The second part will present the results and the statistical analysis for
the study of progression to DR, in the four different groups, using a repeated measures
mixed model design. In the last section, the implications and importance of this study
will be stressed, followed by the conclusion.
5.2 Methods and Tools
5.2.1 Data Collection
As previously mentioned , numerous studies have shown that the retinal vasculature
changes during the progression of diabetes and DR (Barber et al., 2011; Wong et al.,
2006; Antonetti et al., 2006; Klein et al., 1998; Yang et al., 2016).Therefore, in order
to improve the accuracy of the calibre’s estimation of the parent vessel trunk for both
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arteries and veins, different data for healthy, diabetics with no-DR and DR subjects
were utilised. All of the individuals in the diabetic and DR groups had no history of
hypertension or any other cardiovascular disease. The healthy group included 25 im-
ages, coming from a previous unpublished study, conducted at the School of Computer
Science at the University of Lincoln, UK (3888X2592 pixels). The diabetic group in-
cluded data from 25 diabetic subjects taken annually, over a three-year period, before
the onset of DR (3 years pre-DR, 2 years pre-DR and 1 year pre-DR). The same exact
junctions were used in all three cases, which were then averaged and used to derive
the formulas, constituting one group (age range 35-60 years, mean 47.5 (±7.48)). The
rationale behind this is that in order for the formulas to be useful in estimating the
vessel trunk in diabetic subjects, who can be at different stages of diabetes, more than
one year is needed to have a more accurate representation of the junctions.
Regarding the DR group, 25 DR patients (first year that the first lesions appeared).
The data of both these groups come from a diabetic/DR screening database in the UK
(3216X2316 pixels) (age range 37-70, mean 53.2 (±9.63)). The image resolution in
the above groups does not affect the implementation of the method, because the final
estimated value comes from the ratio between the calibres of the two children vessels
(nominator) and the calibre of the parent vessel. Moreover, in all of the above cases,
either the left or the right eye was used, chosen at random before the beginning of the
study.
5.2.2 Tools
The junctions were labelled and measured using a semi-automated tool described in
(Al-Diri et al., 2010) and in chapter 3. In brief, using this tool, each junction is firstly
manually labelled as being a vein or an artery and then in a second stage the calibre is
determined by fitting a rectangle between the wall edges of each vessel (in pixels). The
entire process is conducted in a semi-automated manner, going through each junction.
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The rectangle is adjusted by the user until she/he is confident that the measurement
is correct. In that way, if a junction cannot be accurately measured, then the user
can discard and select another one, making sure that the included measurements are
accurate. The process was repeated twice for every junction, taking the average of the
two measurements, after calculating the intra-rater reliability (95.6% (95%CI=94.3,
96.8) of agreement). The performance of the expert user of the tool (myself) has been
validated against a fully automated tool as proposed in (Al-Diri et al., 2009), with the
average agreement being 96.1% (95%CI=95.1, 97.9).
The fractal dimension estimation was calculated using the well-established box-
counting algorithm, which was described in chapter 3 (Mandelbrot, 1983; Li et al.,
2009). Initially, the fundus images are segmented using a tram-line algorithm (chapter
3) as proposed in (Hunter et al., 2005) (figure 5.1). In the second stage, the box-
countingmethod is applied in the binary segmented trees, getting the fractal dimension.
5.2.3 Γ Ratio
It is well known that the relationship between the diameters of the parent and daughter
vessels at a junction is described by the junction exponent(x) defined by equation 5.4.
dx0 = d
x
1 + d
x
2 , (5.4)
where d0 is the diameter of the parent vessel and d1, d2 are the daughter vessels’ di-
ameters (Murray, 1926b). Murray’s law predicts that this exponent is equal to 3 under
conditions of optimum power loss in the bifurcation. A few studies have shown that
healthy veins and arteries followMurray’s law with the exception of very large vessels
(Sherman, 1981; Chapman et al., 2002).
Witt et al. suggested an alternative parameter to characterise the optimality of
the relationship between the vessel’s diameter at a bifurcation, which they called the
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optimality ratio, aiming to reduce the bias and variability in the presence of noise in
the measurements of individual vascular diameters, from which the junction exponent
calculation suffers. This optimality ratio is based on the non-dimensional variants ζ1,
ζ2 of the daughter diameters at a bifurcation (equation 5.5).
ζ1 =
d1
d0
, ζ2 =
d2
d0
(5.5)
After a few transformations, the mean diameter ratio Γ is calculated by the equation
5.6.
Γ =
d1 + d2
2d0
=
ζ1 + ζ2
2
(5.6)
Finally, after some algebraic manipulations of the mean diameter ratio and the asym-
metry factor, they define the optimality ratio for a bifurcation obeying Murray’s cubic
law as
Γratio =
(
d31 + d
3
2
2d30
) 1
3 (5.7)
More information for the above derivation of the formula is given inWitt et al. (2010).
5.2.4 Experimental Exponent
As previously mentioned , Murray’s cubic law of x=3 has actually been found to range
between 2.7 and 3.0 for various vessels. Following the mathematical proofs in (Taka-
hashi et al., 2009), who showed that this exponent can be more accurately approx-
imated, by combining the fractal dimension (estimated in this study) and a branch
exponent ( taken by (Kamiya & Takahashi, 2007; Takahashi et al., 2009), various ex-
ponents were derived for this study, from data of healthy, diabetic and DR eyes.
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Figure 5.1: Two segmented images, as used in this study.
5.2.5 Estimation of Fractal Dimension
All of the 125 images used for this specific study (25 for healthy, 75 for diabetic and
25 for DR eyes) were segmented and the binary trees were used to calculate the fractal
dimension (figure 5.1). In the diabetic group, the fractal dimensions of the same retinas
were averaged over the three-year period, in order to get a more accurate representation
of the multiple and versatile changes that occur during the progression of diabetes. The
final 25 measurements for each of the three groups (healthy, diabetic and DR) were
summarised using both the mean and median values. Therefore, all of the experiments
were run using both the mean and median fractal dimension to derive the exponent.
5.2.6 Adjusted Γ Ratio
The general form of the adjusted Γ ratio, using the experimentally measured fractal
dimension, combined with the branch exponent of 1.15 is summarised in equation 5.8,
Adj.Γratio =
(dm1 + dm2
2dm0
) 1
m , (5.8)
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wherem is taking six different values, for the three groups and for themean andmedian
fractal dimensions. By solving equation 5.8 with respect to the parent vessel d0, the
generalised equation 5.9 is obtained, which, after adjusting for the different exponents,
will be used in all of the following experiments and will be compared with the other
two methods in the literature (Knudtson et al., 2003; Patton et al., 2006a).
trunkvessel_d0 = m
√
dm1 + d
m
2
2 ∗ 1m√adjΓratio
= m
√
dm1 + d
m
2
2 ∗ (adjΓratio)m (5.9)
5.2.6.1 Group Specific Γ Ratio
In Table 5.1, the experimental results for the three groups can be found. Depending on
the value of the exponent, the adjusted Γratio has been calculated based on equation
5.8. For each exponent, the corresponding equation was derived, in order to calculate
the performance within the different groups, for both veins and arteries, using the mean
andmedian FD. In total, twelve equations were obtained, to be used and comparedwith
the other two methods (Knudtson et al., 2003; Patton et al., 2006a).
V ein : Healthy_d0_mean = 2.8
√
d2.81 + d
2.8
2
0.8894
(5.10)
V ein : Healthy_d0_median = 2.78
√
d2.781 + d
2.78
2
0.8936
(5.11)
V ein : Diabetic_d0_mean = 2.76
√
d2.761 + d
2.76
2
0.9377
(5.12)
V ein : Diabetic_d0_median = 2.79
√
d2.791 + d
2.79
2
0.9317
(5.13)
V ein : DR_d0_mean = 2.74
√
d2.741 + d
2.74
2
0.9314
(5.14)
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V ein : DR_d0_median = 2.77
√
d2.771 + d
2.77
2
0.9253
(5.15)
Arteries : Healthy_d0_mean = 2.8
√
d2.81 + d
2.8
2
1.079
(5.16)
Arteries : Healthy_d0_median = 2.78
√
d2.781 + d
2.78
2
1.0826
(5.17)
Arteries : Diabetic_d0_mean = 2.76
√
d2.761 + d
2.76
2
1.118
(5.18)
Arteries : Diabetic_d0_median = 2.79
√
d2.791 + d
2.79
2
1.1129
(5.19)
Arteries : DR_d0_mean = 2.74
√
d2.741 + d
2.74
2
1.152
(5.20)
Arteries : DR_d0_median = 2.77
√
d2.771 + d
2.77
2
1.1465
(5.21)
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Table 5.1: Group specific measurements
Group Number of
Junctions
(Images)
Mean/Median
FD (SD)
Adjusted
Γmedian
(CI 95%)
Adjusted
Γmean
(CI 95%)
Exponent
m
(mean/median)
Healthy
Veins
150(25) 1.646/1.633
(0.03)
0.7484
(0.736,0.7564)
0.7487
(0.7363,0.7568)
2.8/2.78
Diabetic
Veins
450(75) 1.613/1.638
(0.035)
0.7605
(0.7514,0.77)
0.76
(0.751,0.7696)
2.76/2.79
DR
Veins
150(25) 1.591/1.621
(0.028)
0.7571
(0.7519,0.7714)
0.7566
(0.7418,0.771)
2.74/2.77
Healthy
Arteries
150(25) 1.646/1.633
(0.03)
0.8019
(0.7886,0.8084)
0.8022
(0.7888,0.8086)
2.8/2.78
Diabetic
Arteries
450(25) 1.613/1.638
(0.035)
0.8105
(0.789,0.8185)
0.81
(0.787,0.862)
2.76/2.79
DR
Arteries
150(25) 1.591/1.621
(0.028)
0.818
(0.801,0.837)
0.8176
(0.799,0.833)
2.74/2.77
As can be seen in Table 5.1, the final values for the exponent range between 2.74
and 2.8. These values are within the previous suggestions found in (Sherman, 1981;
Suwa & Takahashi, 1971), and also different from the rough estimation of 2.85 in
(Takahashi et al., 2009).
5.2.7 Methodology of the Estimation of the AVR
Knudtson et al. suggested using a region around the optic nerve head in order to es-
timate the CRVE, the CRAE and the AVR. They also observed that the number of
included vessels does not significantly affect the final estimation (Knudtson et al.,
2003). This methodology was adopted here to make the AVR estimation. Therefore
the area used can be seen in figure 5.2.
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However, although the number of vessels might not significantly affect the final
estimation, the branching order might play an important role. In an example that will
be presented later on (cases 1, 2 and 4 versus case 3), the final estimation is affected
when vessels of different branching order are combined. Nevertheless, just looking at
the fundus images, one cannot be certain about the branching order of the vessel that is
measuring, since the vessels might have branched before they exit the optic disc. This
also makes it practically impossible to identify in which subtree a specific segment
originally belongs to .
Having said this, in many retinas, the excluded area, which is 0.0-0.5 optic disc
diameters from the optic nerve head margin, might include the branching of some
segments. Therefore zone B (figure 5.2) might include vessels of different branching
order. The same problem however exists with the area inside the optic disc, where the
branchings cannot be identified as well.
Taking into consideration the above reasons and that the branching order cannot be
accurately defined, despite the limitations of this methodology, the established zone B
is adopted here, where the vessels are larger and more accurately measured, with their
status already attained.
Figure 5.2: Schematic representation of the region used for calculating the CRVE, CRAE and AVR
(Knudtson et al., 2003).
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Another issue is that in (Knudtson et al., 2003), the six vessels are summarised
using an iterative process, where the largest vessel is paired with the smallest one and
then the second largest with the second smallest and so on. However, experimentally
testing that, by summarising the calibres of four different parent trunk vessels (4 cases),
using the six subsequent vessels (children) of the same tree, showed that both this
method and simply taking the vessels in an ascending order, leads to mixed results (two
versus two), when compared with the actual measured trunks (Table 5.3). Therefore,
according to these estimations, there is no evidence that one method is consistently
more accurate than the other. This suggests that either can be used to obtain the AVR,
as long as it remains consistent.
5.2.8 Comparison of the Proposed Method with the State of the
Art
In contrast to themethod in (Knudtson et al., 2003), themethod in (Patton et al., 2006a)
includes only the arteries, hence the comparison with this one will be limited to the
arteries. For the other method a full comparison will be made. In addition, despite
the fact that in previous studies (Leontidis et al., 2015a, 2016a), updated branching
coefficients for both diabetic and DR groups have been reported, the purpose of this
study is not to revise the established methods rather to propose a new one. Therefore
these methods are utilised exactly as they have been described in literature and used
by other researchers.
5.2.8.1 Statistical Analysis
In order to compare the performance and accuracy of the estimations of the proposed
method against the other two, the mean absolute percentage error (MAPE) is used,
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which is defined as:
MAPE =
1
n
n∑
i=1
∣∣∣∣Ai − PiAi
∣∣∣∣ ∗ 100%, (5.22)
where Ai is the actual measurement and Pi is the predicted one.
The whole sample of junctions is initially partitioned into 10 equal parts, in order to
run a repeated 10-fold cross validation. For instance, for the healthy group, each time
the formulas are derived using 135 junctions and tested with the other 15; this process
is repeated for every combinations, for a total 1000 times. This means that all of the
above equations, as well as the reported errors, are the average of all the iterations. In
this way it is avoided the bias that arises from using the same data for training and test
purposes.
In addition, in order to justify taking multiple junction measurements from the
same image, the within each image variation was compared with the between images
variation, using the intraclass correlation coefficient (Snijders, 2011; Fisher, 1925).
For the progression study, using the individually measured matched vessels of each
image, a mixed-effects model was used, analysed by a repeated measures analysis of
variance (ANOVA) (Fisher, 1936), as described in (Leontidis et al., 2015a), as well
as a linear mixed model (Bates, 2007; McCulloch & Neuhaus, 2001) with a random
intercept for every subject. Both model types account for the multiple measurements
taken within the same fundus images, and in balanced designs, they produce similar
results. Adding random effects in a model allows us to make inferences about a pop-
ulation, which is the desired situation in this study. Dealing with a non-repeatable
covariate, one aims to characterise the variation induced in the response by the differ-
ent levels of this covariate, thus adding it as a random effects term. As described in
details in chapter 4, the random intercept lets us model the fact that each individuals’
baseline can be different, hence each subject is assigned a different intercept value
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(differences can be seen in two examples in figure 5.3). An even more complicated
model could include a random slope as well, which can model varying correlations
within a subject. However, in this case, comparisons between the more complicated
random intercept/random slope models and the random intercept only models, yielded
no significant difference for any case, therefore the simplest model approach (only
random intercept) is preferred.
Taking the opportunity of measuring the vessels around the OD, these will also be
evaluated, in order to test whether they follow the same trend like the junctions of the
main study (category 1 of chapter 6). However they are going to be elaborated in this
chapter, because they are not part of the main studies (no junctions).
Normality, using the Shapiro-Wilk test (Shapiro & Wilk, 1965), and sphericity,
using the Mauchlys test (Mauchly, 1940), were run prior to the analysis, to make sure
that the data can be analysed using the ANOVA. Similarly, the residuals in each model
were also evaluated in order to make sure that they are normally distributed (figure
5.4). Accordingly, the same assumption stands for the random effects of each model.
Post-hoc comparisons were also made for the significant results, adjusted accord-
ing to the Bonferroni correction (Bland &Altman, 1995), for retaining the family-wise
error rate, in order to specify which group means actually differ. All of the analyses
were fulfilled using a balanced design. It is worth pointing out, that the dependent
variables are the veins, arteries, CRVE, CRAE and AVR, and the independent vari-
ables are the different stages of the disease (fixed effect) and the factor ”subjects” with
random intercept (random effect). In the case of the analysis of the multiple vessel
measurements, the ones used to calculate the CRVE and CRAE, an additional random
effects factor is used (the within each subject’s vessel measurements), which is a nested
within the subjects factor .
In the case of the linear mixed model, the (AIC) (Akaike, 1998) is used to evaluate
each model, together with the corresponding p-value of the ANOVA (the smaller the
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AIC the better; the relative value does not imply anything). To do so, the full model
(the one with the fixed effect) is compared with the restricted model (without the fixed
effect), in order to see whether this effect leads to a better model, i.e. having a signif-
icant effect to the dependent variable. As was described in a previous chapter, due to
the bias of maximum likelihood (ML) for the estimation of variance components, it is
suggested that linear mixed models are fitted using the restricted maximum likelihood
(REML) (Corbeil & Searle, 1976). However, in order to compare the two models (full
and restricted), we need to refit them using the maximum likelihood (ML) method.
The reason is that ML estimates the variances as if the fixed parameters are known,
so it does not account for the degrees of freedom lost during the estimation. On the
other hand, the REML adjusts for the uncertainty of the fixed parameters. Therefore,
we generally cannot use REML to compare models, because whatever difference in
the fixed effects part invalidates the comparison.
Finally, Table 5.5 is complementary to Table 5.4, showing for each feature, the
corresponding variance and standard deviation values of the random effects (intercept
and residuals), accompanied by the parametric bootstrapped confidence intervals (after
1000 simulations) (DiCiccio & Efron, 1996). In addition, the ICC is also reported
(derived by the restricted model), which gives us the proportion of the total variance
that is explained by the respective blocking/grouping factor (random effect), telling us
if it is worth fitting a mixed model instead of a fixed effects only (West et al., 2014).
The ICC (Starkweather, 2010) values in Table 5.5 definitely suggest that the proper
and more meaningful way to fit the model is using a mixed effects model.
5.2.8.2 Summary of the Trunk Vessel
In figure 5.5 two example images out of the four can be seen that were used to estimate
the trunk veins. In each of these cases, the trunk vein is estimated from the subsequent
daughter veins of different orders. The number 1 is the trunk vein, and 2, 3, 4, 5, 6, 7
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Figure 5.3: AVR (Left plot) and CRAE (Right plot) according to the proposed method. Both plots
show how different the random intercepts for each level of the random factor ”subjects” are, including
also the prediction intervals. The x axis refer to the intercept value whereas y axis to the different levels
of the factor.
Figure 5.4: Both of the above plots are used to check the normality assumption for the errors. Up:
Pearson residuals versus the fitted values for the linearmixedmodel of the AVR (the estimated according
to the proposed method). Down: a Q-Q plot of the standardised residuals versus the standard normal
quantiles. Both plots suggest normally distributed residuals.
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are the six veins that are used to estimate the trunk. The same four images were used
to compare the ascending order iteration with the largest-smallest.
Figure 5.5: Two example images that were used for quantifying the vein trunk and also compare the two
methods against each other, using both the established methodology and an ascending iteration process.
On the left the branching order is equal, whereas on the right it is uneven. Such case is common when
estimating the CRVE/CRAE, where some daughter segments might belong to a lower order.
5.2.9 Evaluation of the Estimated Features
All of the candidate biomarkers are going to be evaluated in chapter 6. However the
purpose of this chapter is primarily to assess the proposed method of quantifying the
calibres of the vessel trunks and subsequently apply them in a short diabetic/DR pro-
gression study, in order to figure out whether the results of the analysis change accord-
ing to the utilised method. Therefore, it has to become clear and avoid any confusions
that in this chapter, some of the results that are needed in order to elaborate and validate
the proposed method will be presented, with the full details of them (CRVE, CRAE
and AVR) to be presented in the next chapter with all the other studies.
Supplementary to this, since the six veins and six arteries are measured to estimate
the CRVE, the CRAE and the AVR, the same ones are used for evaluating them over
the four consecutive years of progression (last three years of diabetic eye and the first
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year of DR), but they will only be included in this chapter. In both these studies, 200
fundus images from 50 diabetic patients who progressed to DR were used, extracting
and measuring 2,400 vessels in total (1,200 veins and 1,200 arteries).
5.3 Results of the Evaluation and the Comparisons
Firstly, the intraclass correlation coefficient was 0.12 (95%CI=0.11-0.15) for the ar-
teries and 0.14 for the veins (95%CI=0.12-0.17). In this way, we are confident that
each fundus image has no more variation than the variation between the images. Addi-
tionally, the proposed method and the method in Knudtson et al. (2003), are positively
correlated, with the correlation coefficients ranging from 0.975 to 0.989.
5.3.1 Analysis and Evaluation of the Methods
In Table 5.2 the estimates of the mean absolute percentage errors for all the methods
are included. The proposed method indeed improves the quantification of the vessel
calibres for every group under consideration. In addition, in Table 5.3 the results of the
quantification of four different vein trunks from four retinas of different subjects can
be found. In absence of data of the actual measurements of the central retinal arteries
and veins, this is the closest alternative one can do to simulate a real case scenario,
and present the performance and comparison of both methods as well. Therefore, as
can be seen in Table 5.3, the column ”Measured values” refers to the reference ground
truth, against which the methods are compared. This is an intuitive way of simulating
and hence evaluating the performance of the methods, and it is as close to the real
scenario of estimating the CRV as possible. That means that the trunk vessels, in the
simulations of this study, ”represent” (play the role of) the CRVE (or CRV/CRA, when
referring to the actual central vessels).
The first two cases refer to the trunk veins of two healthy eyes, whereas the third
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Table 5.2: Comparison between the methods for the vessel calibre quantification (MAPE)
Group Proposed method
(Mean/Median)(CI95%)
Knudtson et al.
(CI95%)
Pratton et al.
(CI95%)
Healthy
arteries
7.83%(0.0705,0.086)/
7.81%(0.0707,0.0858)
8.05%
(0.0727,0.883)
8.01%
(0.0730,0.0881)
Diabetic
arteries
9.21%(0.0819,0.1023)/
9.21%(0.0825,0.1012)
9.45%
(0.084,0.1087)
9.41%
(0.087,0.1101)
DR
arteries
7.1%(0.0575,0.0845)
7.09%(0.0583,0.0853)
7.58%
(0.0623,0.0887)
7.56%
(0.0634,0.0895)
Healthy
veins
6.8%(0.0611,0.0774)/
6.83%(0.0615,0.0777)
7.22%
(0.0642,0.0803)
-
Diabetic
veins
6.79%(0.0609,0.0750)/
6.81%(0.0611,0.0752)
7.11%
(0.0637,0.0780)
-
DR
veins
6.74%(0.0577,0.0741)/
6.75%(0.0579,0.0744)
7.15%
(0.06,0.0794)
-
and fourth refer to the trunk veins of two diabetic eyes. The results of the estimation
of the trunk veins for these cases can be seen in Table 5.3.
1. 10.30, 6.7, 5.9, 7.9, 9.4, 8.9
2. 10.60, 6.9, 6.4, 7.6, 8.9, 8.2
3. 13.1, 9.1, 8.5, 10.2, 9.7, 5.8
4. 6.3, 10.8, 10.7, 13.1, 9, 5
As it was anticipated, the results are quite close, however a notable difference does
exist indeed. The more accurate the estimation of the calibre of a vessel trunk is,
the more constructive the statistical analysis will be as well (reference to chapter 6 as
well). And despite the close mean absolute percentage errors between the methods,
when used in real case examples (Table 5.3), the differences are more extensive and
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Table 5.3: Quantification of the Calibres of the Vein Trunks
Veins Proposed
method
Knudtson et al. Ascending
grouping
(Knudtson/Proposed)
Measured value
case1 17.88 17.8 17.91/17.74 19.54
case2 17.66 17.55 17.69/17.49 19.2
case3 20.03 20.60 20.79/19.91 19.65
case4 20.02 20.46 20.64/19.91 18.33
can make an actual difference, especially when studying the progression of a disease
(clearer in chapter 6).
5.3.2 Classification
In order to illustrate the proposed improvement in an additional manner, the elastic-net
logistic regression classifier was utilised. Although there is no actual feature selection
process intended, the elastic-net was preferred over the ordinary logistic regression,
in order to find out whether all three features are actually needed. The purpose be-
hind this classification process is not to build an optimum classification system at this
stage (objective of chapter 6), but rather show an example of how this newly proposed
method of quantifying the retinal trunk vessels could improve the performance of such
a system, in conjunction with other features. To do so, an elastic-net regularised logis-
tic regression classifier was trained, according to the method proposed in (Friedman
et al., 2010). As described in details in chapter 4, this algorithm linearly combines the
L1 (least absolute shrinkage and selection operator) and L2 (ridge regression) penal-
ties, using a cyclic coordinate descent, computed along a regularisation path, in order
to improve prediction accuracy. After running a 1000 bootstrap , for both parameters α
and λ, the optimum result with the highest AUC andminimummean squared error was
achieved with α=0.07 and λ=0.108 for both cases (proposed and method in (Knudtson
et al., 2003)), penalising but keeping at the same time all three features (reminder: α
= balance between L1 and L2, and λ = magnitude of regularisation/penalty).
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AVR, CRVE and CRAE were the three features used inside the binary classifica-
tion system. Given the amount of data and the use of only three features, this system
was trained and applied between two groups: the group of subjects with diabetes and
the DR group. The ROC curves of the two methods under comparison, the proposed
one (Leontidis et al., 2016b) and the one in (Knudtson et al., 2003), can be seen in fig-
ure 5.6, which reflect the performance of the logistic regression classifier, after being
trained using the three features under investigation. Both of them show the average
classification performance and the values of the AUC, after following a 10-fold cross
validation process for both methods.
The average AUC (maximum possible value equals to 1) is 0.594 for the proposed
method and 0.581 for the method of Knudtson et al. The improvement in this example
case by 0.013 (or 1.3%) in terms of the AUC is particularly important. First, because
it clearly shows that the proposed method can provide better estimates of these three
features, leading to biomarkers with greater discrimination potential in real world ap-
plications than the similar ones in (Knudtson et al., 2003) (Table 6.23 clearly depicts
that).
As initially indicated by the decrease of the MAPE using the proposed method,
the outcomes of the classifications also suggest that getting more accurate estimates of
the CRVE, CRAE and AVR can in turn lead to a better performance of a multi-feature
classification system.
5.3.3 Inferences about the AVR
Firstly, no violation of normality and sphericity was observed in either of the investi-
gated cases (p-values ranging from 0.27 to 0.46 and from 0.18 to 0.26 respectively). In
Tables 5.4 and 5.5 the results of the analysis for the AVR data can be seen, as well as
for the CRVE and CRAE separately, using both the proposed method and the method
in (Knudtson et al., 2003), since the method in (Patton et al., 2006a) refers only to the
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Figure 5.6: ROC curves showing the performance of the two methods. The blue line shows the pro-
posed method (Leontidis et al., 2016b), whereas the red line represents the method in (Knudtson et al.,
2003).
arteries.
In this experiment, the semi-automated tool described in (Al-Diri et al., 2010) was
used to manually label the arteries and veins. The methodology in (Knudtson et al.,
2003) was followed, using the six largest veins and six largest arteries to estimate the
CRVE and CRAE.
In figure 5.7 the within subjects confidence intervals for both methods can also be
seen. Adjusting the p-values according to the Bonferroni correction, pairwise com-
parisons using the method in (Knudtson et al., 2003) gave significant results for both
the CRVE and CRAE for the combinations three years pre-DR/onset of DR, two years
pre-DR/onset of DR and one year pre-DR/onset of DR, but not for any other com-
bination (p-values ranged from 0.0001 to 0.007 for CRVE and from 0.0006 to 0.008
for CRAE). No significant result was observed for the AVR whatsoever. Similarly,
using the proposed method, significant results were found for the same combinations
as above, apart from the group two years pre-DR/onset of DR of the CRAE (p-values
ranged from 0.0009 to 0.005 and from 0.003 to 0.008 for CRVE and CRAE respec-
tively). Likewise, no significant results were observed for any combination of the
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Figure 5.7: On the left: Error bars for the within subjects confidence intervals of the AVR, using the
proposed method; on the right a similar plot using the method in (Knudtson et al., 2003).
AVR.
Table 5.4: Results of the Progression study
Scenario p-value
(a=0.05)
F-value
(dfn,dfe)a
AIC (p-value)
(full/restricted)b
Group means (SD)
(3y, 2y, 1y, DR)
CRVE(Knud.) 0.002 5.49
(3,147)
744.3/753.4
(<0.00)
29.56(4.93),27.50(4.45),
28.19(5.03),27.14(4.89)
CRAE(Knud.) 0.009 4.11
(3,147)
589.7/595.8
(<0.00)
20.1(2.99),19.33(2.86),
19.56(3.07),19.87(2.82)
AVR(Knud.) 0.10 2.04
(3,147)
302.1/301.01
(0.19)
0.688(0.082),0.704(0.082),
0.702(0.094),0.723(0.093)
CRVE(Leon.) 0.003 5.16
(3,147)
736.3/745.4
(<0.00)
28,88(4.77),26.88(4.40),
27.28(5.03),27.04(4.73)
CRAE(Leon.) 0.02 3.02
(3,147)
608.3/611.8
(0.01)
20.12(3.04),19.37(2.93),
19.52(3.03),19.28(2.75)
AVR(Leon.) 0.31 1.33
(3,147)
294.3/289.8
(0.45)
0.691(0.081),0.712(0.084),
0.718(0.091),0.723(0.092)
Veins <0.00 9.1
(3,897)
250.3/261.4
(<0.00)
13.32(4.36),12.38(4.03)
12.72(4.2),12.51(4.21)
Arteries <0.00 6.01
(3,897)
311.1/320.5
(<0.00)
11.25(2.99),10.89(2.83)
10.95(2.9),11.01(2.96)
a: F-Value for the ANOVA, b: AIC for the Linear Mixed Model
5.3.4 Analysis of the Calibres of the Vessels
Similarly, no violation of either normality or sphericity was observed for the individual
analysis of the calibres of the vessels (p-values = 0.28 and 0.35 for veins and arteries
for normality and p-values = 0.3 and 0.37 for veins and arteries for sphericity, respec-
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Table 5.5: Random effects summary of each model
Scenario Subjects
Variance
(CI95%)
Residuals
Variance
(CI95%)
Subjects
Std. Dev.
(CI95%)
Residuals
Std. Dev.
(CI95%)
ICC
CRVE(Knud.) 18.65
(10.93, 30.84)
5.84
(4.12, 7.72)
4.31
(3.32, 5.54)
2.41
(2.32, 2.93)
0.737
CRAE(Knud.) 7.12
(4.33, 11.71)
1.87
(1.46, 2.49)
2.66
(2.15, 3.44)
1.44
(1.13, 1.57)
0.776
AVR(Knud.) 0.0034
(0.0018,0.0057)
(0.0039)
(0.0027,0.0059)
0.062
(0.043,0.081)
0.073
(0.057,0.075)
0.442
CRVE(Leon.) 18.09
(10.89, 30.09)
5.48
(4.11, 7.06)
4.25
(3.30, 5.48)
2.34
(2.02, 2.65)
0.745
CRAE(Leon.) 7.03
(4.23, 11.72)
2.22
(1.66, 2.87)
2.65
(2.05, 3.42)
1.49
(1.29, 1.69)
0.748
AVR(Leon.) 0.0038
(0.0019,0.0070)
(0.0048)
(0.0036,0.0063)
0.062
(0.044,0.083)
0.069
(0.06,0.079)
0.445
Veins 0.41
(0.24,0.62)
nested:0.23
(0.16,0.34)
0.19
(0.17,0.22)
0.63
(0.49,0.78)
nested:0.48
(0.40,0.58)
0.44
(0.42,0.47)
0.624
Arteries 0.22
(0.11,0.35)
nested:0.043
(0.016,0.103)
0.047
(0.038,0.054)
0.46
(0.34,0.59)
nested:0.19
(0.11,0.32)
0.22
(0.19,0.24)
0.813
tively). Tables 5.4 and 5.5 present the analysis of the progression study in details. As
can be seen, the differences are significant for both veins and arteries. Studying the
progression in a repeated measures way, at the exact same segments over a period of
few years, yields more accurate results, and as has been suggested, increases the power
of the study at the same time (Guo et al., 2013).
Finally, significant results were also observed for all of the combinations of arterial
and venular calibres, apart from the group three year pre-DR/two years pre-DR, when
analysed in a two-group design (p-values ranged from 0.0003-0.002 and 0.0009-0.006
for the veins and the arteries accordingly). These findings are also in line with the
respective results presented in Table 6.1 of chapter 6 that follows.
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5.4 Discussion
As has been shown in previous studies (Grunwald et al., 1996; Sasongko et al., 2010;
Leontidis et al., 2015a) and in the other chapters of this thesis, both geometric and
haemodynamic features can be studied for different diseases of the human retina.
However, due to factors such as the different modalities used, the low image qual-
ity of real-life data and the difficulty of implementing tools that will account for all
these properties consistently and accurately, the study of diseases is a difficult process,
leading to ambiguous and contradicting results. For this reason, this study focuses on
trying to bridge this gap and introduce some new and more specific formulas for the
vessel quantification for healthy, diabetic and DR subjects.
A crucial point when calculating the CRVE and CRAE around the optic disc, is
that the exact branching order remains uncertain, and it is also unclear whether the
vessels have branched before they come out of the optic disc or not. As can be seen in
figure 5.5, this exact scenario was simulated, by quantifying the vessel trunk in uneven
branching order daughter vessels. Even in this case, the quantification proved to be
more accurate (cases 1, 2 and 4 in Table 5.3), which covers this important possible
situation. The more accurate the quantification is, the more robust and meaningful the
statistical inferences will be as well, because the opposite scenario implies approximate
estimates that it is uncertain whether they actually reflect the calibre of the vessel trunk
that one wants to estimate. In this study, an alternative, more generalised and improved
method was presented in comparison to the state of the art in the literature (Knudtson
et al., 2003), for quantifying the retinal vessel calibres, adding up to the previous works
found in (Parr & Spears, 1974b; Hubbard et al., 1999; Knudtson et al., 2003; Patton
et al., 2006a).
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5.5 Conclusion
A new approach for summarising the calibre of the retinal vessel trunk has been pro-
posed. The improvement in terms of the mean absolute percentage error, ranged from
0.24% to 0.49%, whereas the improvement in the classification capability of the pro-
posed method against the method in (Knudtson et al., 2003) between the diabetic and
DR group was 0.013 of the AUC. Using the newly derived formulas one can estimate
and summarise more accurately the retinal vessel trunks and use them in studies of any
retinal disease. In addition, if we take into account that during the iteration process, six
vessel calibres are summarised before the final vessel trunk value is estimated, then the
actual improvement is more extensive than what the mean absolute percentage error
suggests, since the errors are accumulated during the process (Table 5.3). In addi-
tion, many studies rely only on estimating the CRVE, CRAE and AVR as biomarkers
that can be standardised across different cohorts, the improvement in their estimation
becomes even more important.
The progression study that was presented shows a difference between the two com-
pared methods, both in the results of the estimation of the CRVE, CRAE and AVR and
in the statistical analyses. Therefore it is apparent from the results of the statistical
analysis and the values of the AUC that the improved estimations lead to even more
accurate analysis of the data.
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Chapter 6
Evaluation of the Candidate
Biomarkers
6.1 Introduction
This chapter is focusing on presenting the results of the evaluation of all the geomet-
ric and haemodynamic features that were described in the previous chapters. It also
examines the main hypothesis of this thesis that the retinal vascular geometry and
haemodynamics can give us important biomarkers, that not only significantly differ
among the different periods of the progression of the disease, but can also have a cer-
tain predictive and discriminative power. The results that follow shed some light on
some not previously investigated situations, like the progression of DR within a pro-
gressors’ group across a period of time, and the simultaneous examination of a vast
collection of geometric and haemodynamic features that provide an important base for
future studies.
The Tables that will be presented in this chapter, include all the necessary infor-
mation, in order this study to become a reference point for future studies and clearly
convey the results. For that purpose, the results of every significant feature will be
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documented, allowing one to make additional inferences, even beyond the scope of
this thesis. Each Table contains different features, starting with the general ones (ves-
sel widths and angles, fractal dimension, etc.), followed by the individual areas, the
tortuosity metrics and the haemodynamic features. Before the presentation of the re-
sults, a short description of the data that were used for each study will be presented. In
addition, at the end of each category, another Table is also reported, which is the post-
hoc analysis, wherever applicable. All of the non-significant results are documented
in appendix A.
The first section of this chapter includes the introduction of the chapter, followed
by sections 2 and 3 that present the results of the statistical analysis and the classi-
fication, respectively. Finally, section 4 will include the conclusion and discussion,
providing a summary of the results and highlighting the importance of the findings.
6.1.1 List of Candidate Biomarkers
This chapter contains several plots and Tables, in which all the investigated features
appear. The main goal is every feature to be self-explainable, including information
that will help others make comparisons and/or additional inferences. In order to make
the visualisation possible, the features will appear in a short form, details of which can
be found in Table 3.3.
6.2 Statistical Inferences
Following the methodology and approaches that were described in the previous chap-
ters, the results of each of the six categories that will follow, include the following
distinct analyses:
1. Progressors’ group - four year period of progression with matched segments
(four groups).
143
6.2. STATISTICAL INFERENCES
2. Progressors’ group - four year period of progression with non-matched segments
(four groups).
3. Non-progressors’ group - four year period of progressionwithmatched segments
without DR (four groups).
4. Non-progressors’ group - four year period of progression with non-matched seg-
ments without DR (four groups).
5. Averaged non-progressors’ group (one group) versus averaged progressors’ group
(one group) versus DR-only group (one group). The averaging is made on the
matched segments.
6. Progressors’ group - four year period of progression with independent groups
(different individuals in each group)
6.2.1 Data Included in Each Category
The data that were extracted for conducting the above six studies can be found as
follows:
Category 1: Out of the 127 subjects and 508 temporal images, 852 venular
junctions were successfully matched for the main features across the four year
period , giving us 2556 venular width measurements. For the arteries, the total
amount was 388 junctions, hence successfully measuring 1164 arterial widths.
Tortuosity, fractal dimension and lacunarity were estimated for the whole set
of images. Regarding the individual areas, for each of the three ellipses, 240
junctions (same number for the local tortuosity measurements as well) for each
vessel type were measured in total (720 venular and 720 arterial widths). CRVE,
CRAE and AVR features were extracted out of 200 nasal images. Finally, the
haemodynamic features were estimated out of each of the 240 vascular trees
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(120 arterial and 120 venular), based on the boundary conditions that were de-
fined in chapter 3. For categories 1, 3, 5 and 6, the two different conditions of
pressure are applied to the whole tree (therefore, only one pressure per tree and
per boundary condition exists) - also the inlet blood flow rate through the parent
vessel is always the same, hence changing only after the bifurcation point (no
statistical evaluation for the blood flow rate of the parent vessels then).
Category 2: 904 arterial and 2534 venular junctions (same number for vessel
angles) were included in this non-matched progressors study (2712 and 7602
arterial and venular vessel widths, respectively).
Category 3: The non-progressors’ group contains 27 subjects across a four year
period, including 108 temporal images. 136 arterial junctions were successfully
matched, measuring 408 widths in total. Accordingly, 220 venular junctions
were also matched, giving a total number of 660 width measurements. Tortuos-
ity, fractal dimension and lacunarity were estimated for the whole set of images.
CRVE, CRAE and AVR were extracted out of 80 nasal images. Regarding the
individual areas, for each of the three ellipses, 108 junctions (same number for
the local tortuosity measurements as well) for each vessel type were measured in
total (324 venular and 324 arterial widths). Finally, the haemodynamic features
were estimated out of 160 vascular trees (80 arterial and 80 venular).
Category 4: 379 arterial and 594 venular junctions were included in the non-
matched non-progressors’ study (1137 arterial and 1782 venular widths, respec-
tively).
Category 5: For the arteries, 228 junctions were included, and similarly 471
venular junctions. Tortuosity, fractal dimension and lacunarity were estimated
on a total 282 temporal images. CRVE, CRAE and AVR features were extracted
out of 100 nasal images. As far as the areas are concerned, each of the three
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ellipses included 147 junctions (same number of segments for the local tortu-
osity). 70 venular and 70 arterial trees were used for all the haemodynamic
features’ estimation.
Category 6: This final category included only the main features. The 127 sub-
jects were randomly assigned to one of the four groups, discarding at the same
time three of the subjects, in order to have equal number of subjects in each
group. Therefore, each group contained 31 subjects, which contributed with
their non-matched measurements for the analysis. The total number of junc-
tions were 219 for arteries (657 vessel widths) and 456 for veins (1368 vessel
widths). Accordingly, for the FD and lacunarity a total number of 124 images
were used (31 for each of the four groups).
All of the investigated features and categories conform with the necessary assump-
tions of the LMMs. An example of the residual plots of the arterial widths and random
intercepts of category 1 can be seen in figure 6.1. The blue-coloured features (main
analyses; post-hoc analyses appear in black) reported in this chapter are considered to
be significantly changing throughout the investigated periods, with the non-significant
ones appearing in appendix A. This is decided by the p-value, with values lower than
or equal to 0.05 to be considered significant. Regarding the other reported metrics
(their importance already described in details in chapter 4), AIC and BIC provide an
additional way of quantifying how better one model is compared to the other, with a
higher difference denoting a much better model. ICC and Ω2 give us an overview of
how extensive is the random effect in our model (restricted one) and also the effect
size of it, respectively. As far as Fc is concerned, it refers to the ratio of the variances
(random effects and nested factor of the full model, wherever applicable) to the vari-
ance of the residuals. In addition to all these, the values of the variances of each model
are reported, alongside the group mean values and standard deviations.
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Figure 6.1: Up: Both plots are used to check the normality assumption for the errors. Down: The plot
shows how different the random intercepts for each level of the random factor ”subjects” are, including
also the prediction intervals for each level.
6.2.2 Four Year Matched Study of the Progressors
This group represents the main study of this thesis, around which all the other cate-
gories and analyses will be compared against. The main hypothesis suggests that the
alterations in the retinal vascular geometry and haemodynamics during the last stages
of the diabetic eye are distinct; but given the diversity of the retina, a proper design
is needed, accompanied by a suitable analysis, in order to make robust and solid in-
ferences. In this category, the same subjects are used in all four groups, and the exact
same segments are included in all of the four year period. Therefore the whole study is
absolutely balanced. The purpose is to show how different the results can be depend-
ing on the design of an experiment that aims to study the effects of the disease in the
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retinal vasculature - and also make the statistical inferences about the progression to
DR.
Table 6.1 shows the results of themain features, followed by Tables 6.2, 6.3 and 6.4,
which include the results of the different areas, the tortuosity metrics and the haemo-
dynamic features, respectively. Finally Table 6.5 includes the post-hoc results.
Table 6.1: Analysis of the main features for category 1
Feature
name
AICa BICa (p-(χ2)/
p-(s))b
ICC Ω2 Fc (VR/VE)d Group Means(SD)
(Y3, Y2, Y1, DR)
AlphaA 306.5/
308.8
283.9/
292.4
0.039/
0.042
0.46 0.605 0.378
nested:0.126
0.0089/
0.0116
0.77(0.16),0.82(0.15)
0.81(0.12),0.79(0.16)
LambdaA 600.1/
603.5
578.6/
585.9
0.023/
0.025
0.484 0.622 0.416
nested:0.108
0.0032/
0.0036
0.87(0.1),0.90(0.09)
0.901(0.07),0.885(0.095)
Lambda2A 595.9/
600.1
575.1/
581.7
0.017/
0.019
0.554 0.726 0.389
nested:0.259
0.0024/
0.0033
0.807(0.062),0.837(0.061)
0.826(0.068),0.827(0.072)
Width_parentA276.3/
280.7
294.9/
301.2
0.015/
0.017
0.786 0.882 0.592
nested:0.254
0.294/
0.076
3.93(0.71),3.81(0.69)
3.86(0.73),3.79(0.65)
Width_child1A 208.3/
210.9
226.2/
228.2
0.05/
0.05
0.81 0.863 0.762
nested:0.064
0.287/
0.065
3.65(0.61),3.57(0.62)
3.56(0.6),3.57(0.6)
Width_allA 144.5/
146.2
157.9/
159.8
0.043/
0.038
0.645 0.875 0.722
nested:0.121
0.21/
0.047
3.585(0.528),3.524(0.559)
3.544(0.565), 3.493(0.51)
AlphaV 427.4/
436.6
404.7/
409.2
0.001/
0.002
0.33 0.577 0.177
nested:0.298
0.007/
0.021
0.68(0.19),0.71(0.19)
0.737(0.21),0.725(0.19)
BetaV 203.5/
206.7
174.8/
185.5
0.026/
0.027
0.344 0.62 0.168
nested:0.356
0.01/
0.028
1.11(0.18),1.15(0.19)
1.14(0.19),1.16(0.21)
LambdaV 1123/
1133
1100/
1105
0.002/
0.002
0.338 0.593 0.181
nested:0.313
0.002/
0.007
0.815(0.12),0.832(0.12)
0.85(0.13),0.843(0.12)
Lambda2V 1371/
1381
1349/
1352
<0.00/
<0.00
0.362 0.636 0.178
nested:0.363
0.002/
0.005
0.733(0.087),0.754(0.082)
0.759(0.081),0.761(0.091)
Width_parentV1282/
1285
1312/
1316
0.045/
0.047
0.624 0.812 0.483
nested:0.28
0.41/
0.199
4.38(0.9),4.29(0.91)
4.33(0.92),4.21(0.89)
Width_child1V 1078/
1080
1117/
1119
0.046/
0.049
0.62 0.805 0.502
nested:0.25
0.311/
0.153
4(0.83),3.935(0.75)
3.931(0.792),3.84(0.746)
Width_allV 840.5/
843.6
856.8/
858.9
0.047/
0.048
0.333 0.823 0.518
nested:0.258
0.244/
0.105
3.861(0.694),3.815(0.667)
3.848(0.698),3.792(0.653)
Angle.BC_V 6494/
6498
6510/
6515
0.05/
0.048
0.501 0.611 0.26
nested:0.263
229.3/
420.4
124.53(38.32),121.61(38.37)
122.96(42.74),119.91(38.15)
Fractal 531.1/
533.6
515.5/
521.3
0.047/
0.048
0.796 0.844 0.802 0.0031/
0.0007
1.662(0.06),1.648(0.05)
1.647(0.05),1.632(0.06)
a: Full versus Restricted (null) model, b: chi-squared p-value and p-value based on Satterthwaite’s approximation, c: Ran-
dom effect variance (for subjects and, when applicable, the nested factor), divided by the total variance under the full model, d:
Variance of Subjects/Variance of Residuals
Table 6.2: Analysis of the features of the different areas for category 1
Feature
name
AICa BICa (p-(χ2)/
p-(s))b
ICC Ω2 Fc (VR/VE)d Group Means(SD)
(Y3, Y2, Y1, DR)
ellipse1parV 234.8/
240.3
247.4/
249.1
0.007/
0.011
0.56 0.705 0.601 0.924/
0.613
6.1(1.2),5.32(1.03)
5.98(1.16),5.93(1.5)
ellipse2ch1V 250.2/
256
263.1/
264.5
0.008/
0.01
0.36 0.558 0.407 0.599/
0.87
6.14(1.22),5.4(0.99)
6.08(1.4),5.37(1.19)
ellipse2ch2A 279.1/
284.8
291.3/
294.1
0.016/
0.013
0.431 0.602 0.469 1.065/
1.201
5.87(1.88),4.91(1.22)
5.87(1.5),5.37(1.32)
CRAE_LEON 608.3/
611.8
626.5/
629.3
0.01/
0.02
0.75 0.818 0.759 7.038/
2.228
20.12(3.04),19.37(2.93)
19.52(3.03),19.28(2.75)
CRVE_LEON 736.3/
745.4
753.5/
756.8
0.001/
<0.000
0.745 0.826 0.767 18.09/
5.48
28.88(4.77),26.88(4.4)
27.28(5.03),27.04(4.73)
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CRAE_KNUD 589.7/
595.8
604.5/
607.4
0.007/
0.009
0.776 0.843 0.791 7.059/
1.857
20.10(2.99),19.33(2.86)
19.56(3.07),19.87(2.82)
CRVE_KNUD 744.3/
753.4
761.1/
763.1
0.001/
0.002
0.737 0.821 0.761 18.63/
5.84
29.56(4.93),27.50(4.45)
28.19(5.03),27.14(4.89)
a: Full versus Restricted (null) model, b: chi-squared p-value and p-value based on Satterthwaite’s approximation, c: Ran-
dom effect variance (for subjects and, when applicable, the nested factor), divided by the total variance under the full model, d:
Variance of Subjects/Variance of Residuals
Table 6.3: Analysis of tortuosity features for category 1
Feature
name
AICa BICa (p-(χ2)/
p-(s))b
ICC Ω2 Fc (VR/VE)d Group Means(SD)
(Y3, Y2, Y1, DR)
sd_tau 2452/
2455
2422/
2425
0.05/
0.051
0.295 0.406 0.296 1.7x10−4/
4.1x10−4
(7.99(2.4),8.3(2.3)
8.1(2.5),8.4(2.3))x10−2
Tort_ellipse3 271.8/
275.1
345.2/
348.3
0.026/
0.024
0.242 0.419 0.269 0.001/
0.0027
0.037(0.069),0.039(0.086)
0.037(0.046),0.047(0.026)
a: Full versus Restricted (null) model, b: chi-squared p-value and p-value based on Satterthwaite’s approximation, c: Ran-
dom effect variance (for subjects and, when applicable, the nested factor), divided by the total variance under the full model, d:
Variance of Subjects/Variance of Residuals
Table 6.4: Analysis of the haemodynamic features for category 1
Feature
name
AICa BICa (p-(χ2)/
p-(s))b
ICC Ω2 Fc (VR/VE)d Group Means(SD)
(Y3, Y2, Y1, DR)
qchild1A 1349/
1354
1339/
1342
0.008/
0.01
0.398 0.586 0.438 8.4x10−9/
1.1x10−8
(8.4(1.1),7.8(1.3)
7.4(1.7),8(1.2))x(10−4)
qchild2A 1348/
1355
1337/
1340
0.011/
0.008
0.399 0.587 0.439 8.5x10−9/
1.1x10−8
(5.3(1.1),6(1.3)
6.4(1.7),5.8(1.3))x(10−4)
Rechild2A 800/
804
812/
815
0.015/
0.017
0.622 0.752 0.653 421.9/
223.7
119.5(26.3),131.1(26.6)
132(26.57),125.4(23.6)
wssparentV 550.5/
554.2
561.3/
564.7
0.021/
0.024
0.942 0.936 0.951 355.48/
18.22
24.01(15.16),25.62(11.59)
22.46(11.87),25.43(17.23)
vparentaV 335.4/
339.2
346.3/
349.6
0.021/
0.024
0.932 0.933 0.942 4.468/
1.102
9.29(3.75),9.82(3.1)
8.96(3.12),9.59(4.19)
ReparentV 693.4/
696.8
703.9/
707.5
0.024/
0.027
0.922 0.931 0.933 41.85/
11.19
187.8(37),194.1(32.2)
185.1(32.4),190.2(40.6)
wsschild1V 472.1/
484.8
486.3/
491.9
<0.000/
<0.000
0.917 0.952 0.939 110.64/
7.11
19.52(10.52),21.59(10.14)
19.59(9.27),22.7(10.82)
qchild1V 1279/
1281
1267/
1272
0.034/
0.031
0.955 0.973 0.959 2.5x10−8/
1.1x10−9
(6.21(1.72),6.3(1.63)
6.4(1.7),6.1(1.6))x(10−4)
vchild1V 231.8/
247.2
246/
254.3
<0.000/
<0.000
0.896 0.941 0.927 4.43/ 0.34 6.25(2.03),6.85(2)
6.39(1.94),7(2.14)
Rechild1V 593.9/
610.3
608/
617.4
<0.000/
<0.000
0.892 0.946 0.925 449.92/
36.12
107.14(20.13),114.57(21.7)
109.98(22.59),113.8(22.53)
wsschild2V 490.6/
501.2
504.8/
508.3
<0.000/
<0.000
0.901 0.927 0.924 117.7/
9.68
18.77(7.87),21.8(9.67)
21.04(10.19),22.25(10.48)
qchild2V 1269/
1271
642.8/
646.8
0.035/
0.031
0.955 0.973 0.959 2.56x10−8/
1.1x10−9
(6.23(1.81),6.11(1.62)
6.14(1.72),6.3(1.6))x(10−4)
vchild2V 247.5/
256
261.6/
263.9
0.002/
0.003
0.915 0.973 0.932 5.71/ 0.41 6.35(1.97),6.88(2.06)
6.73(2.27),6.73(2.25)
Rechild2V 608.2/
610.9
618.1/
622.4
0.034/
0.04
0.944 0.96 0.95 734.35/
38.41
110.7(27.1),113.3(24.4)
112.4(27.4),116.5(25.6)
PinQoutV 444/
448.2
455.2/
458.1
0.017/
0.02
0.833 0.894 0.854 38.35/
6.54
31.63(5.62),29.34(8.31)
32.12(4.85),30.5(7.1)
a: Full versus Restricted (null) model, b: chi-squared p-value and p-value based on Satterthwaite’s approximation, c: Ran-
dom effect variance (for subjects and, when applicable, the nested factor), divided by the total variance under the full model, d:
Variance of Subjects/Variance of Residuals
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Table 6.5: Post-Hoc analysis for category 1
Significant LMM
features
Significant Linear
Hypotheses
P-values
AlphaA y3-y2 0.045
Lambda y3-y2 0.04
Lambda2A y3-y2 <0.000
Width_allA y3-DR
y2-DR
0.032
0.043
Width_parentA y3-DR
y3-y2
0.032
0.045
Width_child1A y3-DR 0.048
AlphaV y3-DR
y3-y1
0.019
0.001
BetaV y3-DR 0.035
Lambda y3-DR
y3-y1
0.017
0.002
Lambda2 y3-DR
y3-y1
y3-y2
0.001
0.003
0.03
Width_allV y3-DR
y2-DR
y3-y1
0.012
0.048
0.029
Width_parentV y3-DR 0.049
Width_child1V y3-DR 0.048
Angle.BC_V y3-DR 0.032
Fractal y3-DR 0.026
ellipse1parV y2-y1
y3-y2
0.036
0.008
ellipse2ch1V y3-DR 0.042
ellipse2ch2A y3-DR 0.024
qchild1A y3-y1 0.0058
qchild2A y3-y1 0.0052
Rechild2A y3-y2
y3-y1
0.035
0.024
wssparentV y3-y2 0.015
vparentaV y3-y2 0.0147
ReparentV y3-y2 0.0178
wsschild1V y3-DR
y3-y2
y3-y1
<0.000
0.002
0.019
qchild1V y2-DR
y3-y2
0.048
0.049
vchild1V y3-DR
y3-y2
y3-y1
0.001
0.001
0.008
Rechild1V y3-DR
y3-y2
y3-y1
<0.000
<0.000
0.009
wsschild2V y3-DR
y3-y2
y3-y1
0.003
<0.000
0.009
qchild2V y3-DR
y3-y2
0.049
0.049
Rechild2V y3-DR 0.017
vchild2V y3-DR
y3-y2
y3-y1
0.002
0.02
0.005
PinQoutV y3-DR
y2-y1
0.024
0.013
sd_tau y3-DR 0.035
Tort_ellipse3 y2-DR 0.032
CRAE_LEON y3-DR
y1-DR
0.017
0.049
CRVE_LEON y3-DR
y2-DR
y1-DR
0.034
0.05
0.012
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CRAE_KNUD y3-DR
y2-DR
y1-DR
0.023
0.026
0.039
CRVE_KNUD y3-DR
y2-DR
y1-DR
0.036
0.021
0.029
Additionally, multivariate comparisons combining arteries, veins and angles alto-
gether yielded no significant results. On the contrary, combining all the haemody-
namic features for veins and arteries, gave significant results only for the children of
veins (p-value= 0.006).
6.2.2.1 Comparison with the Studies of the Initial Phase
All of the above results are coming from the final stage of all the experiments, where
all the features were calculated and/or estimated on the extended amount of data. It
is worth pointing out that these results actually confirm most of the initial results. In
(Leontidis et al., 2015a), the studies followed a similar logic to the above ones, where
the analysis was conducted over the same four year period. In this study, the angles
and widths of the vessels, fractal dimension, lacunarity and some derivative features
were measured concluding to the same results as above.
In some other early experiments, we focused on the paired comparisons between
the three year pre-DR and first year of DR periods, as well as the one year pre-DR
and first year of DR periods. For the former, the investigated features were the fractal
dimension, lacunarity, tortuosity, AVR, CRVE, CRAE and vessels’ widths and angles.
Significant results were observed for the tortuosity (p-value=0.021), arteries widths
(p-value=0.01) and angles (p-value=0.022), fractal dimension (p-value=0.024) and
widths of the veins (p-value=<0.000) (Leontidis et al., 2015a,b, 2016a). Regarding
the latter combination, the investigations were limited to the widths and angles of the
vessels, where the only significant result was observed for the angles of the veins (p-
value=0.034). It is important to take into account that planning a pairwise experiment
151
6.2. STATISTICAL INFERENCES
between two groups is a totally separate hypothesis and shall not be confused with the
results of an ANOVA or of a LMM. In addition, as was mentioned earlier, the post-hoc
results refer to follow-up examinations after running the main tests, so any compar-
isons between a planned pairwise experiment and post-hoc outcome shall be carefully
made. Besides, the interest here is on the progression as this can be identified in an
extended period that includes a period before DR and the onset of DR; so investigat-
ing these stages altogether, minimises the chances of committing Type I error, with the
opposite being the case, if multiple paired comparisons without any adjustments were
conducted instead.
6.2.3 Four year Non-Matched Study of the Progressors
This part includes the same data as category 1 does, but the main features are not
matched, so all the measurements are used without any selection. The purpose is to
find out whether there will be any differences in the results in comparison to the similar
category 1, to justify or not the use of matched segments. Table 6.6 shows the results
of the main features, followed by the post-hoc analysis in Table 6.7.
Table 6.6: Analysis of the main features for category 2
Feature
name
AICa BICa (p-(χ2)/
p-(s))b
ICC Ω2 Fc (VR/VE)dGroup Means(SD)
(Y3, Y2, Y1, DR)
Width_child2A 1049/
1052
1072/
1082
0.02/
0.021
0.234 0.504 0.323
nested:0.097
0.079/
0.142
3.049(0.475),3.178(0.504)
3.137(0.501),3.112(0.481)
Width_child2V 2981/
3003
3022/
3027
<0.000/
<0.000
0.123 0.407 0.34
nested:0.048
0.091/
0.159
3.031(0.494),3.108(0.475)
3.149(0.521),3.108(0.466)
Angle.BC_V 24684/
24687
24705/
24711
0.045/
0.046
0.3 0.154 0.074
nested:0.031
76.42/
927.47
117.49(37.93),117.38(36.67)
115.74(36.81),114.17(35.21)
a: Full versus Restricted (null) model, b: chi-squared p-value and p-value based on Satterthwaite’s approximation, c: Ran-
dom effect variance (for subjects and, when applicable, the nested factor), divided by the total variance under the full model, d:
Variance of Subjects/Variance of Residuals
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Table 6.7: Post-Hoc analysis for category 2
Significant LMM
features
Significant Linear
Hypotheses
P-values
Width_child2A y3-y1
y3-y2
0.042
0.033
Width_child2V y3-DR
y3-y1
y3-y2
0.003
<0.000
0.004
Angle.BC_V y3-DR 0.039
6.2.3.1 Short Discussion for Categories 1 and 2
Comparing the Tables 6.1 ans 6.6, is apparent why not matching the segments can
lead to controversial results. A series of important biomarkers that define the vascular
changes, e.g. arterial and venular widths, branching coefficient etc., were missed out
in the non-matched design. The same exact segments compared over a period of time
can provide more accurate representation of the underlying changes, regardless of the
direction of the effect. A non significant result can be turned into a significant with the
presence of a few outliers in the sample and similarly a significant result can be missed
inside noisy data. Unless the data are of adequate magnitude to averagely compensate
for these noisy data, by more and more converging to a true random error, then studies
with small and different cohorts will be prone to leading to contradicting results.
6.2.4 Four Year Period Matched Study of the Non-Progressors
This category investigates a group of non-progressors, i.e. diabetic subjects that at the
moment of the data collection had not progressed to DR. They are followed over a four
consecutive year period of time, and the aim is to figure out whether in this period, any
significant alterations due to diabetes occur. Table 6.8 shows the results of the main
features, followed by Table 6.9, which includes the post-hoc results.
153
6.2. STATISTICAL INFERENCES
Table 6.8: Analysis of the tortuosity features for category 3
Feature
name
AICa BICa (p-(χ2)/
p-(s))b
ICC Ω2 Fc (VR/VE)d Group Means(SD)
(Y3, Y2, Y1, Y0)
median_psi 748.19/
750.84
735.7/
740.6
0.034/
0.039
0.44 0.592 0.466 (9.21/
10.53)x10−6
0.0158(0.0034),0.0152(0.0038),
0.0178(0.0053),0.0168(0.0048)
a: Full versus Restricted (null) model, b: chi-squared p-value and p-value based on Satterthwaite’s approximation, c: Ran-
dom effect variance (for subjects and, when applicable, the nested factor), divided by the total variance under the full model, d:
Variance of Subjects/Variance of Residuals
Table 6.9: Post-Hoc analysis for category 3
Significant LMM
features
Significant Linear
Hypotheses
P-values
median_psi y2-y1 0.0325
6.2.5 Non-Progressors Four Year Period Non-Matched Study
Similar to category 2, this particular study is the non-matched study of category 3,
using the same data but without any matching of the bifurcations whatsoever. Accord-
ingly, the purpose is to figure out whether any of the differences of category 3, are also
observed here and vice versa. However no significant results were found, suggesting,
just like with category 2, that using the same bifurcations and comparing them over a
period of time, can identify vascular alterations that could be missed otherwise. A list
of the analysis for all those non-significant features can be found in appendix A.
6.2.6 Progressors Versus Non-Progressors Versus DR
This particular analysis is very important, because it combines all the years within
the progressors’ and non-progressors’ groups, creating one category for each of them.
Since thematched segments are used in both of them, the final values are the average of
the same segments across thewhole period of time. For instance, in progressors’ group,
the three years of measurements are averaged segment-wise. Finally, in the two groups
that are created, a third also independent group is added, which represents a DR group.
Therefore, the analysis is run including three independent groups in total. The results
154
6.2. STATISTICAL INFERENCES
of this novel study will show us two things. Firstly, whether either of the progressors’
or non-progressors’ groups differ compared to the DR group, and secondly whether
they also differ between each other. Given that when selecting a cohort with current
data is unlikely to have any information about the future progression, it is likely that
many of the selected subjects will soon progress to DR, i.e. belonging to a progressors’
group. Therefore with this study the aim is to find out if a random non-progressors’
diabetic group, also differs from a carefully selected progressors’ diabetic group, and
therefore intonate the importance of more carefully selecting the cohorts.
Table 6.10 shows the results of the main features, followed by Tables 6.11, 6.12
and 6.13, which include the results of the different areas, the tortuosity measurements
and the haemodynamic features, respectively. Finally Table 6.14 includes the post-hoc
analysis.
Table 6.10: Analysis of the main features for category 5
Feature
name
AICa BICa (p-(χ2)/
p-(s))b
ICC Ω2 Fc (VR/VE)d Group Means(SD)
(Prog, Non-Prog, DR)
Width_parentA 1471/
1479
1501/
1504
0.002/
0.003
0.341 0.957 0.294
nested:<0.525
0.225/
0.138
4.413(1.071),4.062(0.671)
3.937(0.856)
Width_child1A 1357/
1362
1376/
1379
0.008/
0.009
0.373 0.409 0.338
nested:<0.000
0.221/
0.433
3.932(0.914),3.663(0.648)
3.675(0.795)
Width_child2A 908.11/
915.12
928.39/
930.24
0.004/
0.005
0.271 0.778 0.234
nested:<0.331
0.067/
0.124
3.461(0.641),3.167(0.453)
3.181(0.51)
Width_allA 1155/
1162
1171/
1174
0.003/
0.004
0.373 0.402 0.326
nested:<0.031
0.154/
0.3139
4.002(0.839),3.564(0.524)
3.597(0.669)
Width_parentV 2031/
2034
2047/
2053
0.03/
0.029
0.344 0.943 0.295
nested:<0.521
0.223/
0.139
4.83(1.215),4.423(0.896)
4.476(1.154)
Width_child1V 1925/
1928
1941/
1948
0.035/
0.043
0.276 0.3 0.257
nested:<0.000
0.2862/
0.8262
4.458(1.099),4.116(0.893)
4.147(1.061)
Width_child2V 1171/
1175
1188/
1194
0.021/
0.028
0.276 0.778 0.237
nested:<0.333
0.063/
0.12
3.482(0.691),3.173(0.431)
3.294(0.585)
Width_allV 1618/
1622
1636/
1641
0.021/
0.027
0.346 0.345 0.315
nested:<0.021
0.244/
0.519
4.256(0.925),3.904(0.652)
3.972(0.861)
Angle.BC_V 7845/
7865
7912/
7918
0.001/
<0.000
0.321 0.506 0.126
nested:<0.000
660.3/
4575
119.56(37.87),121.45(38.56)
117.62(36.08)
a: Full versus Restricted (null) model, b: chi-squared p-value and p-value based on Satterthwaite’s approximation, c: Ran-
dom effect variance (for subjects and, when applicable, the nested factor), divided by the total variance under the full model, d:
Variance of Subjects/Variance of Residuals
Table 6.11: Analysis of the features of the different areas for category 5
Feature
name
AICa BICa (p-(χ2)/
p-(s))b
ICC Ω2 Fc (VR/VE)dGroup Means(SD)
(Prog, Non-Prog, DR)
CRAE_LEON 1025/
1036
1042/
1046
<0.000/
<0.000
0.506 0.593 0.412 4.793/
6.828
19.57(3.13),16.29(4.08)
19.51(2.75)
CRVE_LEON 1163/
1165
1175/
1177
0.05/
0.053
0.515 0.607 0.483 12.07/
12.87
27.71(4.92),24.78(5.14)
27.69(4.74)
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CRAE_KNUD 955.9/
964.2
972.3/
974.8
0.002/
0.001
0.595 0.677 0.535 5.041/
4.374
19.58(3.03),17.01(3.18)
19.98(2.82)
CRVE_KNUD 1245/
1248
1255/
1257
0.016/
0.017
0.413 0.511 0.365 11.95/
20.76
28.38(5.03),24.61(7.09)
27.99(4.78)
a: Full versus Restricted (null) model, b: chi-squared p-value and p-value based on Satterthwaite’s approximation, c: Ran-
dom effect variance (for subjects and, when applicable, the nested factor), divided by the total variance under the full model, d:
Variance of Subjects/Variance of Residuals
Table 6.12: Analysis of the tortuosity features for category 5
Feature
name
AICa BICa (p-(χ2)/
p-(s))b
ICC Ω2 Fc (VR/VE)d Group Means(SD)
(Prog, Non-Prog, DR)
sd_phi 1062/
1065
1048/
1052
0.035/
0.029
0.144 0.198 0.096 (2.87/
27.26)x10−5
0.246(0.017),0.237(0.016)
0.249(0.018)
a: Full versus Restricted (null) model, b: chi-squared p-value and p-value based on Satterthwaite’s approximation, c: Ran-
dom effect variance (for subjects and, when applicable, the nested factor), divided by the total variance under the full model, d:
Variance of Subjects/Variance of Residuals
Table 6.13: Analysis of the haemodynamic features for category 5
Feature
name
AICa BICa (p-(χ2)/
p-(s))b
ICC Ω2 Fc (VR/VE)d Group Means(SD)
(Prog, Non-Prog, DR)
qchild1A 1521/
1528
1513/
1517
0.012/
0.018
0.354 0.515 0.375 (7.11/
11.86)x10−9
(7.19(1.48),7.94(1.87),
8.04(1.25))x10−4
qchild2A 1516/
1523
1523/
1529
0.015/
0.018
0.356 0.516 0.377 (7.12/
11.89)x10−9
(5.93(1.49),5.94(1.87),
5.81(1.26))x10−4
qchild1V 1407/
1413
1409/
1412
0.03/
0.034
0.952 0.888 0.975 (2.91/
0.14)x10−8
(6.28(1.7),6.49(2.17),
6.15(1.66))x10−4
vchild1V 320.98/
324.72
340.48/
342.22
0.018/
0.017
0.848 0.906 0.853 3.663/
0.63
6.49(1.98),6.32(1.45),
6.99(2.14)
qchild2V 1410/
1414
1400/
1403
0.012/
0.023
0.952 0.975 0.954 (2.9/
0.133)x10−8
(6.18(1.71),5.97(2.18),
6.31(1.68))x10−4
vchild2V 322.71/
326.1
342.21/
346.6
0.024/
0.035
0.876 0.923 0.881 4.27/
0.57
6.66(2.09),6.45(1.99),
7.06(2.25)
a: Full versus Restricted (null) model, b: chi-squared p-value and p-value based on Satterthwaite’s approximation, c: Ran-
dom effect variance (for subjects and, when applicable, the nested factor), divided by the total variance under the full model, d:
Variance of Subjects/Variance of Residuals
Table 6.14: Post-Hoc analysis for category 5
Significant LMM
features
Significant Linear
Hypotheses
P-values
Width_parentA prog-nonprog
prog-DR
0.001
0.014
Width_child1A prog-nonprog
prog-DR
0.011
0.021
Width_child2A prog-nonprog
prog-DR
0.006
0.013
Width_allA prog-nonprog
prog-DR
0.003
0.011
Width_parentV prog-DR 0.042
Width_child1V prog-DR 0.046
Width_child2V prog-DR 0.043
Width_allV prog-DR 0.03
Angle.BC_V prog-nonprog
nonprog-DR
<0.000
<0.000
CRAE_LEON prog-nonprog
nonprog-DR
<0.000
<0.000
CRVE_LEON prog-nonprog 0.04
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CRAE_KNUD prog-nonprog
nonprog-DR
<0.002
<0.001
CRVE_KNUD prog-nonprog 0.01
sd_phi prog-nonprog 0.021
qchild1A prog-DR
prog-nonprog
0.012
0.023
qchild2A prog-DR
prog-nonprog
0.015
0.028
qchild1V prog-DR
prog-nonprog
0.042
0.039
vchild1V prog-DR 0.011
qchild2V prog-DR
prog-nonprog
0.022
0.019
vchild2V prog-DR 0.033
6.2.6.1 Short Discussion for Category 5
It comes as no surprise that the vascular geometry both in a junction- and in image-
level and the haemodynamic features present differences across this three group cat-
egory. It also confirms the initial hypothesis, that the functional impairment and the
vascular adjustments, do not only occur when approaching DR, but also within the di-
abetic eye period. It is clear that the changes start much earlier, concluding with some
strong and solid indications that DR starts affecting the retinal vessels quite some time
before the first lesions appear.
6.2.7 Progressors Four Year Study - Independent Groups
This section is focusing on presenting the results in a similar to category 1 way, with
just a difference on the design. The subjects in each group are not the same across
all groups, but different ones. Nonetheless, it is known that they are coming from the
same cohort as in category 1, so they can be directly compared with each other and
make inferences about how the results are affected when the subjects are different and
when the sample is not as large as well. Having to include different subjects in each
group, the available data in each of them are by three quarters less, but still empiri-
cally adequate to define the trends. Due to the limited amount of data, the analysis
is only made for the main features, where, due to the grouping factor, multiple mea-
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surements are included within each subject. In case that the matching of the segments
and the follow-up design of category 1 does not make any difference, then we should
be able to observe the same or quite similar results with this type of design. How-
ever, as can be seen in Table A.15 in appendix, this is not the case. No wonder, why
in the above analysis no statistically significant results were observed. However, this
category shows something that should be stressed further. It is easy to conclude and
make decisions based on misleading results. The same features, with the same dataset
but slightly differently analysed, change the whole interpretation and direction of the
results. In our case, which is also a general issue with random effects, the variability
among our cohort, does not let us identify the subtle vascular changes, suggesting that
an alternative way (category 1) is needed.
Given the higher variability that can also be seen across the features, in comparison
to the results in category 1, it is much more difficult to identify a difference. To do
so, the sample has to be a lot larger and the outliers have to be quite limited. Taking
into account that the above groups are coming from the same cohort as the subjects
in category one, albeit not the same ones across all four groups, then it is even more
convincing that committing Type I and Type II is easier. Needless to mention again that
the retina by definition can drive us to more easily committing these errors, bringing
again to the surface the importance of carefully selecting representative amount of
large and fine vessels, if matching the same segments is not an option.
6.2.8 Discussion About the Results of the Statistical Analysis
The above results come from the most comprehensive and complete study yet to ap-
pear in literature. Seeing the problem from multiple different angles can give us a
more thorough representation of what is happening in the retina during the progres-
sion of a disease, either inside a longitudinal follow-up design, or an independent one,
or even a non-matched one etc. It was made clear at the previous chapters that the
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exact mechanisms that affect the retina during the proliferation of diabetes are not ac-
curately defined, although the general concepts have been clarified, i.e. pericyte loss,
capillary occlusion, vascular permeability etc (Hammes et al., 2002; Joussen et al.,
2004). Besides, there are factors that inevitably cannot be taken into account or in-
cluded in the model when studying a disease. In addition it needs to be clear, which
exact periods one is investigating and not try to vaguely generalise. A healthy group, a
diabetic group and a DR group have already enough variability themselves to be able to
come up with accurate conclusions about them. Besides, a diabetic group can include
subjects in their early stages or at a stage which is near to progressing to a different
one, e.g. to the early stages of DR. To account for this variability one either needs to
include a really large representative sample, or instead target a specific period of time,
just like it was done in this retrospective study, given that obtaining a large dataset is
rather difficult.
In addition, as can be seen in category 5, these results indicate something extremely
important. Two groups, that both include diabetic patients, and representative mea-
surements averaged over a consecutive three- and four- year period accordingly, are
statistically significantly different across many features (CRVE, CRAE, venular and
arterial widths, blood flow etc.). That tells us something that has to be taken into
account in future studies. The selection of a diabetic cohort has to have stricter re-
quirements, since the alterations in the retinal vasculature are shown to change even
during the progression of diabetes, before the onset of DR. Although it is also observed
that between the late stages of the diabetic eye and the onset of DR quite pronounced
alterations exist, they still remain less distinct than when compared with a diabetic
group, in which one does not know the exact period that the images were taken from.
Regarding the above results, it is important to point out that, although the non-
significant ones are also documented, the exact numbers of the variances andΩ2 should
not be used to make sound inferences, but rather for reference purposes and indica-
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tions. The reason is that one cannot be confident at the defined significance level ,
that the observed results can be generalised beyond the random results that have been
observed. Therefore, fluctuations in the variances and/or explained variances can be
considered as random and more like point estimates of the specific sample, which can
actually take any value. On the other hand, for the significant results, these metrics
can provide us with important information. Intraclass correlation shows whether the
random effect is actually present in our data justifying the use of LMMs. In all of the
above results, wherever applicable, the use of both the nested effect and the random ef-
fects is justified, hence making sense conducting this type of analysis, producing more
accurate estimates, explaining more variance, and finally reducing the residual vari-
ance. Moreover, the Ω2 can give us an additional magnitude of the explained variance
and the effect of the random covariate and the additional grouping. The interpretation
of Ω2 in LMMs is not that straightforward, however larger values generally indicate
more important and higher effect of the covariates, with lower values indicating the
opposite. Most of the significantly different biomarkers in the above categories are
observed to have fair values of Ω2, which indicates that the effect is high and not just
significant.
In addition, no significant influence was observed when the factor age was added
to the models of category 1 and 2, meaning that the comparison between a model with
the fixed effect of age and a model with just the fixed effect of the disease gave no
significant difference, which can be attributed either to the fact that the age groups
of our data were relatively close, with many subjects around the same age, or that
the number of subjects is not so great to offer enough information about this factor.
An example of the non-existent correlation between the age and the differences in
veins and arteries between the three year period pre-DR and the onset of DR can be
seen in figure 6.2, which comes from the early phase’s results. However, it needs
to be highlighted, that for accurate conclusions about such factors, like age or other
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Figure 6.2: Up:Plot shows the difference between the three years pre-DR and the onset of DR for the
arteries in relation to the age. Down: Similar plot but for the veins.
demographic information, a large sample is required, with enough representation of
different levels of those factors. In addition, this study does not focus on demographic
data, rather to the geometry and haemodynamics of the retina, so this information is
only offered for reference purposes.
Another interesting fact to point out is that in all the combinations above, a ran-
dom slope model was not justified over a simpler random intercept-only one. All the
comparisons between them yielded no significant differences, strongly suggesting that
the simpler model is adequate to model the changes. In terms of the studies presented
here, this implies that it makes sense to assume that different subjects start from a dif-
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ferent base, hence including a random intercept model. However, making a random
slope no difference, suggests that the rate that the disease affects each subject is not
significantly different among subjects.
To sum up, the statistical analyses of this novel study, gave us some very important
findings.
1. Two different diabetic cohorts (analysis of category 5) can give totally different
results, which can lead to contradicting findings, by committing either TYPE I
or TYPE II errors. This enhances the importance of studying the same subjects
over a period of time, and as far as possible, the same exact segments/junctions
over a period of time. Planning such an experiment, and recruiting diabetic sub-
jects, one cannot know at the moment of recruitment whether some of these
subjects will progress to DR very soon after. This suggests that the variability
within the cohort might be high enough to be possible to identify subtle vascu-
lar changes, when compared to a DR group. This difference could also suggest
one additional thing. The diabetic cohort that is about to progress to DR in the
near future, presents some noticeable differences compared to another diabetic
group, which actually supports the hypothesis, that the retinal vasculature is af-
fected and adapts to the underlying functional alterations that occur right before
the onset of DR. Examples of that can be seen in Table 6.14, where many of
these features, such as CRAE, arteries widths, tortuosity, blood flow, etc., differ
significantly between the two diabetic cohorts.
2. In the investigated areas, apart from the widths of the parent veins in ellipse 1,
the width of the large arterial child in ellipse 2 and the tortuosity in ellipse 3,
no other significant result was observed, at least from a statistical point of view.
Given that the same features, among others, were also found to significantly
differ in the retina as a whole, shows no actual meaningful importance in specif-
ically focusing on these areas, instead of studying the retina as a whole. This
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observation also includes the local arteriovenous ratio, which does not seem to
be changing during the progression of the disease, just like occurs with the AVR.
3. The haemodynamic features definitely add to the inferences, and makes sense to
include them in any analysis of the disease’s progression, especially the haemo-
dynamics of the venular network, which as it was observed, it seems to be af-
fected more than the arterial network.
It needs to be kept in mind that micro-aneurysms are formed due to the loss
of pericytes, whereas vascular occlusion is a consequence of basement mem-
brane thickening and endothelial cell proliferation (King et al., 1994). These
processes, which are initially subtle, affect the retinal haemodynamics. In the
normal retina, blood flow remains constant by the autoregulated vascular re-
sponses over a range of systemic blood pressures and intra-ocular pressures
(Riva et al., 1981). Local factors, which target smooth muscle cells in arteri-
oles and capillary pericytes in patients with diabetes are controlling the vessels
(De La Rubia et al., 1992). In addition, there are changes occurring in the lo-
cal vasoactive factors and in the response of pericytes due to these local factors
(Burgansky-Eliash et al., 2010).
4. In the progressors’ group, prior to the onset of DR, all of the significantly al-
tered features (CRVE, CRAE, fractal dimension, venular and arterial widths)
are following a trend of decrease. On the other hand, the generalised tortuosity
is increased, suggesting that the progression of diabetes to DR is linked to more
tortuous vessels.
6.2.9 Conclusion
Undoubtedly, the retinal vascular geometry and haemodynamic functionality is shown
to be changing during the progression of diabetes, which can be possibly attributed to
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processes that include, among others, the neurodegeneration, the subclinical inflam-
mation, the oxidative stress and the dysfunction of the endothelial cells that hyper-
glycaemia also causes (Leontidis et al., 2014). In addition, the dysfunction of the en-
dothelial cells affects the production of nitric oxide in response to shear stress, which
can lead to the development of atherosclerosis, i.e. the hardening and thickening of
the arterial wall, thus the observed arterial alterations.
As it was hypothesised, matching the vessel junctions and studying them over a
period of time, one can identify changes that otherwise might not be identified or even
misidentified. All of the above results strongly suggest that it is very easy to be misled
and come up with conclusions that are not representative of what is being studied.
Nonetheless, our studies showed that the geometry and the underlying haemodynamics
are indeed affected during the progression of diabetes, which are more or less in line
with our early results (Leontidis et al., 2015a, 2016a, 2015b). The vessel widths, FD,
venular angle to BC ratio, CRVE, CRAE, the blood flow rate of both arteries and veins,
the pressure and velocity in the veins, etc. (Tables 6.5 and 6.14), are all biomarkers
of progression to DR. CRVE and CRAE observations are in line with the findings
of Klein and , when looking at Table 6.14, and partly with (Yang et al., 2016; Tsai
et al., 2011; Islam et al., 2009; Kifley et al., 2007). These observations are linked
possibly to the endothelial dysfunction, inflammatory changes, and hyperglycemia, all
of which are factors involved in the pathogenesis of DR (Schmidt et al., 1999; Klein
et al., 2000, 2012, 2004). However, on the exact same table, it can be seen that not
only there is an increase to both these biomarkers (CRVE and CRAE) between non-
progressors’ diabetics and DRs, but also more importantly, the same occurs between
the non-progressors and progressors. This extends the observations of Klein et al.,
suggesting that the changes are not necessarily occurring during or because of DR,
but rather during the last few years just before the onset of DR, when the retina is
adjusting to the upcoming vascular and functional alterations. Fractal dimension is
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also an important biomarker, with significant differences between diabetics and DR,
which comes in contrast to the findings in (Kunicki et al., 2009).
Finally, the most important and rigorous observation is that by not following a
matched and repeated measures design, it is more likely to not observe an otherwise
significant difference than the opposite, i.e. observe a significant one when there is
not one. As a final remark, regarding the non-significant features (Appendix A), it is
clear that the alterations attributed to the progression of the disease cannot be illus-
trated, as expected, in every single investigated feature. This is totally in line with the
purpose of this thesis, which aims to identify important features, given the lack of sim-
ilar pre-existing studies. This exploratory process yielded some important biomarkers,
as mentioned previously in details, and this is something that was made possible by
including all these candidate biomarkers in the analyses.
6.3 Classification Results
Following the statistical evaluation of the features in each category, which gives us a
specific type of information, this section aims to check these features in practice and
also decide whether a subset of them can be useful in discriminating between groups
that correspond to different type of cohorts. The novelty of this approach includes two
parts. The first is that the proposed approaches and experiments have never been at-
tempted in the past, and also include different combinations that come from different
periods of time. The second one is that this is done exclusively by using informa-
tion directly from the vascular geometry and haemodynamics, with no information or
features extracted from the images per se, whatsoever.
In this section, for each of the eight combinations that were described in chapter
4, the results of the feature selection process and the classification models will be
presented. For each combination and each feature selection process, the final five best
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models and feature subsets will be presented. Additionally, one plot for each feature
selection method will be included, which will correspond to the best model and to two
other models that were selected by a different selection process.
All the features were standardised before any of the processes is executed, by sub-
tracting, feature-wise, each value from the corresponding feature’s group mean value
and diving by the standard deviation. All of the combinations contain balanced classes,
112 features with thirty observations per class for those that come from the progres-
sors’ data, and twenty obervations for those that come from the non-progressors’ data.
The combinations that include classes between non-progressors and progressors are
also balanced, selecting randomly twenty out of the thirty observations that are avail-
able from the progressors’ group. An exemption is the one vs all process, in which the
three classes are still balanced, but the binary combinations merge two classes each
time, creating a new one with forty observations, and therefore performing the classi-
fication versus the third class. Nevertheless, the folds of the cross validation process
were kept balanced, in order not to have overpopulated from one class folds.
In comparison to the features in Table 3.3, which were used for the statistical analy-
sis, for the classification the majority of them is the same, except for some differences
that exist, which are summarised in Table 6.15. The differences mostly refer to the
widths and angles of the vessels of the main features, which are summarised based on
their descriptive statistics, in order to have equal observations for each feature in the
classification, and also one observation per image.
6.3.1 Year Three Versus Onset of DR (Progressors’ Group)
Starting with the classification of the three year period pre-DR versus the onset of
DR, the aim is to actually visualise and evaluate how well the features can discrimi-
nate between these two different periods, which are still apart by three years. All the
classification and feature selection processes previously described are applied in this
166
6.3. CLASSIFICATION RESULTS
Table 6.15: Additional features for the classification
Features (Short form)
1.Arterial parent’s width of haemodynamics (parenta) 12.Arterial average length of junctions (lengthArt)
2.Arterial small child’s width of haemodynamics (smallchild2a) 13.Arterial average branching coefficient(BC_Mean_Art)
3.Arterial large child’s width of haemodynamics (largechild1a) 14.Standard deviation of arterial widths (arterySD)
4.Venular parent’s width of haemodynamics (parentv) 15.Venular average length of junctions (lengthVein)
5.Venular small child’s width of haemodynamics (smallchild2v) 16.Average Branching coefficient of veins (VeinBc)
6.Venular large child’s width of haemodynamics (largechild1v) 17.Standard deviation of venular widths (Vein_SD)
7.Average arterial widths (MeanArt) 18.Average venular widths (MeanVein)
8.Median arterial widths (MedArt) 19.Median venular widths (MedVein)
9.Standard deviation of arterial angles (ArtAngleSD) 20.Standard deviation of venular angles (VeinAnglSD)
10.Average arterial angles (MeanAngArt) 21.Average venular angles (MeanAngVein)
11.Median arterial angles (MedAngArt) 22.Median venular angles (MedAngVein)
combination and also to all the subsequent ones, apart from combination 8.
In Table 6.16 the summary of the results of the whole process can be seen. In
this combination the best classification performance and feature subset selection was
achieved by the regularised random forests classifier, yielding an averageAUC= 0.878
(Table 6.16), which outperforms the previous reported results (Leontidis et al., 2015a,
2016a).
Table 6.16: Summary of the classification performance for Year three versus Onset of DR
(Combination 1)
Summary Best model Model 2 Model 3 Model 4 Model 5
Random Forests
AUC (CI95%)
0.878
(0.732-0.921)
0.842
(0.694-0.935)
0.835
(0.671-0.936)
0.813
(0.659-0.924)
0.74
(0.582-0.852)
Logistic Regression
AUC (CI95%)
0.754
(0.643-0.842)
0.76
(0.648-0.856)
0.73
(0.629-0.816)
0.793
(0.703-0.89)
0.811
(0.694-0.902)
Random Forests
kappa
0.632 0.614 0.609 0.602 0.498
Logistic Regression
kappa
0.483 0.492 0.476 0.534 0.619
Random forests
OOB
0.191 0.213 0.228 0.253 0.298
Feature selection
process
RF RF BO EN EN
As described in chapter 4, for each of the seven combinations of the classifications,
sixty different models are created, based on the feature selection process (according
to the penalisation parameters as provided by the bootstrapping process), classifier
(logistic regression or random forests) and the different folds of the cross validation.
However, instead of only presenting the one with the best performance, the five best
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of them that yielded the highest performance are described, alongside their results and
their feature subsets. The features for the above models, ordered according to their
importance, are the following:
Bestmodel: ArtAngleSD, lengthVein, BC_Mean_Art, Angle.BC_Art, MeanArtAng, pressureA,
MedAngArt, Tort_ellipse3.
Model 2: LengthVein, Angle.BC_Art, BC_Mean_Art, Angle.BC_Vein, ArtAngleSD, Tort_ellipse3.
Model 3: ArtAnglesSD, BC_Mean_Art, Angle.BC_Art, MedAngArt, lengthVein.
Model 4: Qchild1v, Angle.BC_Art, Vein_SD, Tort, Tort_ellipse3, lengthVein.
Model 5: Angle.BC_Art, Vein_SD, BC_Mean_Art, Tort, Tort_ellipse3, lengthVein.
In the following figures 6.3, 6.4, 6.5 and 6.6 the examples of the feature selection
process of the three techniques can be seen, including the ROC curves of the two best
models. Figure 6.7 also shows the bootstrapped AUC.
Figure 6.3: On the left: ROC curve and AUC of the best model with the confidence intervals for
combination 1; on the right similar information is given for the second best model.
The above plots give a proper visualisation of the whole process of both feature
selection and classification performance. The bootstrapped AUC and the ROC plots
suggest that the classifier has a good performance in differentiating between the ob-
servations that come from the three year period pre-DR and those that come from the
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Figure 6.4: Feature ranking of the regularised random forests classifier for the best model of combina-
tion 1, according to the mean decrease accuracy, which shows how the performance of the classifier is
affected if one of these features is removed.
Figure 6.5: This plot refers to the elastic-net feature selection process of the model 4 of the combination
1. On the left: The regularisation path of the elastic-net can been seen, with the x axis including the
penalty parameter λ in a logarithmic scale, the y axis being the performance according to the AUC and
on top of the plot the number of features. In addition the upper and lower standard deviation curves
along the red cross-validation curve are included; on the right the coefficients and the final selected
features can be seen, where x axis is the index of the number of features, with the y axis including the
values of the coefficients of the predictors.
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Figure6.6:Featureselectionprocessaccordingtoborutamethodformodel3ofcombination1;yaxisshowstherelativeimportanceofeachfeature,
whereasxaxisincludesthefeatures.Greencolouredfeaturesarethefinallyselectedones,whereastheredaretherejectedones.
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Figure 6.7: Bootstrapped AUC for the best model of the combination 1. It shows all the 1000 iterations
of the bootstrap, including the box plot, and the lines of the apparent and null error models, i.e. the
model tested using the same training set and the random model, respectively.
onset of DR, which follows the same trend as the statistical analysis. The final model
includes a combination of the derivatives of arterial angles, the lengths of the veins,
the tortuosity of ellipse 3, the arterial pressure and the ratio of the arterial to the the
branching coefficient.
6.3.2 Year Two Versus Onset of DR (Progressor’s Group))
Just like the previous section’s process, the best performance according to the AUC
as achieved by the best model equals to 0.745 (Table 6.17). This performance was
achieved by the logistic regression classifier, using a feature subset that was selected
by the elastic-net (α = 0.13 and λ = 0.23). All the details of the performance of the
five best models can be seen in Table 6.17.
The features for the above models, ordered according to their importance, are the
following:
Bestmodel: PressureV,Angle.BC_vein, Angle.BC_Art, ellipse1vpar, ellipse1Vch1, ellipse2Ach2,
ellipse3Vtheta, Tort_ellipse3.
Model 2: Angle.BC_Vein, Angle.BC_Art, Lambda1V,MedAngArt, ellipse1Vpar, ellipse3Vtheta,
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Table 6.17: Summary of the classification performance for Year two versus Onset of DR
(Combination 2)
Summary Best model Model 2 Model 3 Model 4 Model 5
Random Forests
AUC (CI95%)
0.668
(0.541-0.752)
0.643
(0.512-0.732)
0.658
(0.529-0.754)
0.698
(0.514-0.813)
0.710
(0.523-0.802)
Logistic Regression
AUC (CI95%)
0.745
(0.576-0.843)
0.724
(0.587-0.845)
0.714
(0.554-0.848)
0.713
(0.532-0.822)
0.619
(0.483-0.723)
Random Forests
kappa
0.293 0.282 0.274 0.307 0.312
Logistic Regression
kappa
0.478 0.483 0.466 0.473 0.244
Random forests
OOB
0.391 0.403 0.382 0.343 0.324
Feature selection
process
EN EN BO BO RF
Figure 6.8: On the left: ROC curve and AUC of the best model with the confidence intervals for
combination 2; on the right similar information is given for the second best model.
Tort_ellipse2.
Model 3: Median_tau, Angle.BC_Vein, ellipse3thera, Fractal.
Model 4: CRAE_LEON, Tort_ellipse3, ellipse1Vpar, smallchild2a, CRVE_LEON,CRVE_KNUD,
mean_psi.
Model 5: Tort_ellipse3, veingamma, Fractal, CRVE_LEON, Tort_ellipse1, ellipse3ch2, arterySD,
ellipse3VTheta, Lambda2A, ellipse1Vch1.
In the figures that follow, i.e. figures 6.8, 6.9, 6.10, 6.11, 6.12, all three feature selec-
tion processes can be seen, the ROC curves of the two best models and the bootstrapped
AUC as well.
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Figure 6.9: Feature ranking of the regularised random forests classifier for the model 5 of combination
2, according to the mean decrease accuracy, which shows how the performance of the classifier is
affected if one of these features is removed.
Figure 6.10: This plot refers to the elastic-net feature selection of the best model of the combination 2.
On the left: The regularisation path of the elastic-net can been seen, with the x axis including the penalty
parameter λ in a logarithmic scale, the y axis being the performance according to the AUC and on top
of the plot the number of features. In addition the upper and lower standard deviation curves along the
red cross-validation curve are included; on the right the coefficients and the final selected features can
be seen, where x axis is the index of the number of features, with the y axis including the values of the
coefficients of the predictors.
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Figure6.11:Featureselectionprocessaccordingtoborutaformodel3ofcombination2,withtheyaxisshowingtherelativeimportanceofeachfeature.
Thexaxisincludesthefeatures.Greencolouredfeaturesarethefinallyselectedones,whereastheredaretherejectedones.
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Figure 6.12: Bootstrapped AUC of the best model of the combination 2. It shows all the 1000 iterations
of the bootstrap, including the box plot, and the lines of the apparent and null error models, i.e. themodel
tested using the same training set and the random model, respectively.
In contrast to the results of the combination 1, passing into the two year period
pre-DR, makes the changes less distinct. Therefore predicting the two classes is more
difficult and the performance is fair but not enough to provide a reliable way of doing
so. Nevertheless, the performance was achieved by a combination of venular pressure,
venular angle to BC ratio, arterial angle to BC ratio, and venular widths and angles
coming from the areas.
6.3.3 Year One Versus Onset of DR (Progressors’ Group)
This combination includes two groups that are very close in time. The changes at this
level between the two groups are possibly more intense, since the retinal vasculature
undergoes a series of functional alterations that precede DR. The best performance
based on the AUC equals to 0.776 (Table 6.18), achieved by the random forest’s clas-
sifier, using a feature subset as selected by the boruta feature selection process.
The features for the above models, ordered according to their importance, are the
following:
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Table 6.18: Summary of the classification performance for Year one versus Onset of DR
(Combination 3)
Summary Best model Model 2 Model 3 Model 4 Model 5
Random Forests
AUC (CI95%)
0.776
(0.633-0.836)
0.728
(0.587-0.843)
0.637
(0.483-0.758)
0.678
(0.512-0.792)
0.725
(0.546-0.836)
Logistic Regression
AUC (CI95%)
0.653
(0.521-0.744)
0.765
(0.598-0.873)
0.745
(0.568-0.854)
0.732
(0.567-0.765)
0.689
(0.538-0.853)
Random Forests
Kappa
0.508 0.489 0.243 0.278 0.458
Logistic Regression
kappa
0.311 0.512 0.498 0.475 0.378
Random forests
OOB
0.273 0.324 0.415 0.397 0.314
Feature selection
process
BO EN EN RF RF
Best model:Ellipse1Vch2, PinQoutV, X75th_psi, pressureV.
Model 2:Qchild1a, qchild2a, pressureV, wsschild1V, ellipse3Vch1.
Model 3: Qchild1a, pressure, wsschild1V, PinQoutV, Lambda1A,AlphaV,MeanArtAng,MedAn-
gart, ellipse2Ach2, ellipse3Vch1, ellipse3Vch2.
Model 4: Lambda1A, pressureV, wsschild1v, qchild2a, PinQoutV, Angle.BC_art, median_phi,
ellipse3Atheta, x75th_psi, CRVE_LEON, ellipse3Ach1, Lambda1V, MeanArt.
Model 5: Ellipse2Ah2, pressureV, Lambda1A, Rechild2A,median_phi, ellipse1Vch2, ellipse2Ach1,
largechild1V, ellipse3Ach2, Tort_ellipse1, AvmidAvbeg, Tort_ellipse2.
Figures 6.13-6.17 present a series of plots that visualise the performance of the selec-
tion processes and classifications for combination 3.
This combination achieved the best performance by using geometric and haemo-
dynamic features from the venular network. The performance also suggests that there
are still underlying changes occurring at this transitional year, despite the closeness to
progressing to DR. This can be better justified by the fact that the changes on the exact
same segments are evaluated. A combination of the venular pressures, tortuosity and
venular widths in ellipse 1 provided the best classification performance.
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Figure 6.13: On the left: ROC curve and AUC of the best model with the confidence intervals for
combination 3; on the right similar information is given for the second best model.
Figure 6.14: Feature ranking of the regularised random forests classifier for model 4 of combination
3, according to the mean decrease accuracy, which shows the effect that removing a feature has to the
performance of the classifier.
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Figure 6.15: This plot refers to the elastic-net feature selection of model 2 of the combination 3. On
the left: The regularisation path of the elastic-net can been seen, with the x axis including the penalty
parameter λ in a logarithmic scale, the y axis being the performance according to the AUC and on top
of the plot the number of features. In addition the upper and lower standard deviation curves along the
red cross-validation curve are included; on the right the coefficients and the final selected features can
be seen, where x axis is the index of the number of features, with the y axis including the values of the
coefficients of the predictors.
Figure 6.16: BootstrappedAUC for the best model of the combination 3. It shows all the 1000 iterations
of the bootstrap, including the box plot, and the lines of the apparent and null error models, i.e. themodel
tested using the same training set and the random model, respectively.
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Figure6.17:Featuresubsetaccordingtoborutaselectionprocess.Theplotreferstothebestmodelofcombination3;yaxisshowstherelativeimportance
ofeachfeature,whereasxaxisincludesthefeatures.Greencolouredfeaturesarethefinallyselectedones,whereastheredaretherejectedones.
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6.3.4 Mean Diabetics (Progressor’s Group) Versus Onset of DR
This combination includes two classes; one being the DR group, just like in the previ-
ous combinations, and the other one being the average of the entire three year period
pre-DR, i.e the average of the diabetic classes of combinations 1, 2 and 3. The previous
combinations aim to give us an indication of the discriminative power of the features
as the disease progresses, whereas combination 4 is a more realistic situation where a
group that takes information from a few year period is included, in order to create a
more representative group of the progessors of the subjects with diabetes. Still the pur-
pose of this combination remains to evaluate the definite changes that have occurred
to the retinal vasculature between the last stages of the diabetic eye and the onset of
DR. The best performance in this combination was achieved by the feature subset and
classification of the regularised random forest’s classifier, yielding an AUC of 0.841
(Table 6.19).
Table 6.19: Summary of the classification performance for meandiab vs DR (Combination 4)
Summary Best model Model 2 Model 3 Model 4 Model 5
Random Forests
AUC (CI95%)
0.841
(0.698-0.932)
0.819
(0.645-0.912)
0.813
(0.654-0.921)
0.647
(0.489-0.777)
0.672
(0.543-0.798)
Logistic Regression
AUC (CI95%)
0.735
(0.534-0.853)
0.675
(0.521-0.765)
0.754
(0.567-0.843)
0.763
(0.574-0.853)
0.724
(0.531-0.834)
Random Forests
kappa
0.542 0.514 0.511 0.245 0.269
Logistic Regression
kappa
0.468 0.343 0.503 0.509 0.462
Random forests
OOB
0.223 0.254 0.245 0.367 0.389
Feature selection
process
RF BO RF EN EN
The features for the above models, ordered according to their importance, are the
following:
Best model Ellipse1Vch2, Tort_ellipse1, Angle.BC_Art, Tort_ellipse3, Fractal.
Model 2: Tort_ellipse1, ellipse1Vch2, ellipse3Vtheta, pressureV, pressureA.
Model 3: Ellipse1Vch2, Tort_ellipse1, Fractal, Tort_ellipse3, pressureV.
Model 4: Fractal, Angle.BC_Vein, Angle.BC_Art, ellipse3theta, Tort_ellipse3.
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Model 5: PressureV, Fractal, Angle.BC_Vein, Angle.BC_Art, Artgamma, MedAngArt, ArtAn-
gleSD, ellipse1Vch2, ellipse2Vch1, ellipse3Vtheta, Tort_ellipse3.
Just like previously, the figures in this section show the performance of the feature
selection processes and the classification.
Figure 6.18: On the left: ROC curve and AUC of the best model with the confidence intervals for
combination 4; on the right similar information is given for the second best model.
The features that yielded that performance include the ones coming from the dif-
ferent areas, the ratio of the arterial angles and BC, and also the fractal dimension. The
performance suggests that still distinct changes are occurring that could differentiate
between diabetic and DR cohorts. Such classifier could have an application in auto-
matic diagnosis of DR, where instead of looking only at the lesions, information from
the vascular geometry can also be included for an initial sorting of the pre- to post-DR
cases. In addition, the good performance of the classifier implies that it can be directly
used for classifying a progressors’ cohort versus a DR one, since the three year period
of available information is possibly enough to create a representative sample.
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Figure 6.19: This plot refers to the elastic-net feature selection of model 4 of the combination 4. On
the left: The regularisation path of the elastic-net can been seen, with the x axis including the penalty
parameter λ in a logarithmic scale, the y axis being the performance according to the AUC and on top
of the plot the number of features. In addition the upper and lower standard deviation curves along the
red cross-validation curve are included; on the right the coefficients and the final selected features can
be seen, where x axis is the index of the number of features, with the y axis including the values of the
coefficients of the predictors.
Figure 6.20: Feature ranking of the regularised random forests classifier for the best model of combi-
nation 4, according to the mean decrease accuracy, showing the effect that removing a feature has to
the classifier’s performance
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Figure6.21:Featuresubsetaccordingtoborutaselectionprocess.Theplotreferstomodel2ofcombination4;yaxisshowstherelativeimportanceof
eachfeature,whereasxaxisincludesthefeatures.Greencolouredfeaturesarethefinallyselectedones,whereastheredaretherejectedones.
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Figure 6.22: BootstrappedAUC for the best model of the combination 4. It shows all the 1000 iterations
of the bootstrap, including the box plot, and the lines of the apparent and null error models, i.e. themodel
tested using the same training set and the random model, respectively.
6.3.5 Mean Diabetics (Non-Progressor’s Group) Versus Onset of
DR)
In contrast to the purpose of the previous four combinations, where the objective is to
evaluate the extent of the vascular changes in an alternative to the statistical analysis
manner, and also how these can be used inside a classification system, in this combi-
nation the focus is to try to see how a classifier can possibly perform in a pragmatic
and realistic situation. If in the future, a high performance and reliable classification
model is to be proposed that could classify diabetic and DR subjects, it needs to include
independent information, given that the future instances that will need to be classified
will come from independent subjects. To test this scenario, the classifier was trained
by including information from the non-progressors’ group and the DR group.
The maximum achieved performance was made possible by the logistic regres-
sion’s classifier from a feature subset coming from the elastic-net process (α = 0.08
and λ = 0.17), giving an AUC of 0.968 (Table 6.20).
The features for the above models, ordered according to their importance, are the
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Table 6.20: Summary of the classification performance for non progressors vs DR (Combination 5)
Summary Best model Model 2 Model 3 Model 4 Model 5
Random Forests
AUC (CI95%)
0.945
(0.817-0.991)
0.961
(0.869-0.992)
0.943
(0.835-0.987)
0.942
(0.844-0.975)
0.931
(0.812-0.972)
Logistic Regression
AUC (CI95%)
0.968
(0.923-0.999)
0.823
(0.656-0.912)
0.786
(0.643-0.889)
0.794
(0.587-0.887)
0.903
(0.789-0.981)
Random Forests
kappa
0.887 0.907 0.875 0.867 0.854
Logistic Regression
kappa
0.891 0.654 0.567 0.587 0.803
Random forests
OOB
0.113 0.124 0.133 0.122 0.127
Feature selection
process
EN BO BO RF EN
following:
Best model: Vparenta, wsschild1v, PinQoutV, Vein_SD, lengthVein, MedArt, MedVein, Mean-
VeinAng, VeinAnglSD, CRAE_KNUD, CRAE_LEON, sd_phi, mean_tau, Tort_ellipse3.
Model 2: CRAE_LEON, CRAE_KNUD, CRVE_KNUD, arterySD, Artgamma, VeinAnglSD,
CRVE_KNUD, lengthVein, wsschild2a, Rechild2v,Medart, wsschild1v, Rechild1a, VeinBc, Re-
parenta, vparenta, ArtAnglSD, BC_Mean_Art.
Model 3: CRAE_LEON, CRAE_KNUD, CRVE_LEON, Artgamma, arterySD, wsschild2a,
sd_phi, BC_Mean_Art, MedAnglVein, ArtAngleSD, Medvein, MedArt, wsschild1v, Rechild1a,
CRVE_KNUD, Rechild2v, largechild1v, veingamma.
Model 4: CRAE_LEON,MedAngVein, lengthart, lengthvein, Rechild2v, wsschild1v, arterySD,
wssparenta, Rechild1a.
Model 5: Vparenta, Reparenta, PinQoutA, lengthVein, MedVein, VeinAngSd, CRAE_KNUD,
CRAE_LEON, CRVE_KNUD, CRVE_LEON, sd_phi, Tort, Tort_ellipse3.
The following figures 6.23-6.27, show the examples of the feature selection process
of the three processes, the ROC curves of the two best models and the bootstrapped
AUC.
The features that gave this performance includemostly venular haemodynamic and
geometric features but also a few arterial geometric ones. The interesting part is that
these features are different from the ones in combination 4. This suggests that there are
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Figure 6.23: On the left: ROC curve and AUC of the best model with the confidence intervals for
combination 5; on the right similar information is given for the second best model.
Figure 6.24: Feature ranking of the regularised random forests classifier for model 4 of combination
5 based on the mean decrease accuracy, which shows the effect that removing a feature has to the
performance of the classifier.
different attributes that differentiate the two different diabetic cohorts from DR, impli-
cating that the vascular changes are not the same across all the periods of time that the
disease proliferates. This is something that is also supported by the statistical analy-
sis. Therefore it is worth investing on collecting representative data from both diabetic
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Figure 6.25: This plot refers to the elastic-net feature selection of the best model of the combination 5.
On the left: The regularisation path of the elastic-net can been seen, with the x axis including the penalty
parameter λ in a logarithmic scale, the y axis being the performance according to the AUC and on top
of the plot the number of features. In addition the upper and lower standard deviation curves along the
red cross-validation curve are included; on the right the coefficients and the final selected features can
be seen, where x axis is the index of the number of features, with the y axis including the values of the
coefficients of the predictors.
Figure 6.26: BootstrappedAUC for the best model of the combination 5. It shows all the 1000 iterations
of the bootstrap, including the box plot, and the lines of the apparent and null error models, i.e. themodel
tested using the same training set and the random model, respectively.
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Figure6.27:FeatureselectionprocessaccordingtoBorutaforthesecondbestmodelofcombination5.Greenlabeledfeaturesarethefinallyselected
ones,whereastheredaretherejectedones.Theyellowrepresentthetentativefeatures,whichcaneitherberejectedoraccepted,subjecttorepeatingsome
ofthestepsofthealgorithm.
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cohorts and also make all the efforts to be considered separately in the future studies.
The remarkable performance of this classification model, with the tight confidence
intervals as well, gives evidence that such a model could be used for differentiating
between subjects with diabetes and subjects with DR.
6.3.6 Mean Diabetics (Non-Progressor’s Group) Versus Mean Di-
abetics (Progressor’s Group))
Similar to the objective of category’s 5 statistical analysis, this combination aims to
actually try to differentiate between a group of subjects with diabetes that are not pro-
gressors and a group that they are about to progress to DR soon. This combination
has high clinical importance, given that being able to accurately differentiate between
these two groups, can give precious indications that one is about to progress to DR in
the near future. The random forests classifier gave the best performance of 0.963 (Ta-
ble 6.21) according to the AUC, using a feature subset that was selected by the boruta
feature selection process.
Table 6.21: Summary of the classification performance for groups Meandiab vs meanNonProg
(Combination 6)
Summary Best model Model 2 Model 3 Model 4 Model 5
Random Forests
AUC (CI95%)
0.963
(0.898-0.998)
0.957
(0.887-0.991)
0.957
(0.893-0.997)
0.949
(0.896-0.987)
0.937
(0.867-0.977)
Logistic Regression
AUC (CI95%)
0.923
(0.854-0.995)
0.865
(0.667-0.934)
0.902
(0.756-0.983)
0.845
(0.673-0.921)
0.856
(0.667-0.946)
Random Forests
kappa
0.903 0.896 0.856 0.843 0.823
Logistic Regression
kappa
0.834 0.723 0.805 0.709 0.715
Random forests
OOB
0.092 0.098 0.107 0.111 0.126
Feature selection
process
BO RF RF RF RF
The features for the above models, ordered according to their importance, are the
following:
Bestmodel: CRAE_LEON,CRVE_LEON,ArtAngSD, CRVE_Knud, CRAE_KNUD, Tort_ellipse2,
arterySD, pressureV, BC_Mean_Art, artgamma, vparenta, Reparenta, MeanArt, wsspareanta,
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Figure 6.28: On the left: ROC curve and AUC of the best model with the confidence intervals for
combination 6; on the right similar information is given for the second best model.
lengthart, MedArt, wsschild1v, Angle.BC_Art, wsschild1a, Rechild2v, MedAngVein, vchild1a.
Model 2: CRVE_LEON, CRVE_KNUD, CRAE_LEON, ArtAngSD, Veingamma, Medvein,
Rechild2, wssparenta.
Model 3: CRVE_LEON, ArtAngSD, MeanVeinAng, mean_tau.
Model 4: CRVE_LEON,BC_Mean_Art, CRAE_LEON,ArtAngleSD, Reparenta, VeinAnglSD,
MeanArtAng, sd_phi, ellipse3theta.
Model 5: CRAE_LEON, artAngSD, CRVE_LEON,Angle.BC_Art, CRVE_KNUD,wsschild1v,
PinQoutv, wsschild2v.
The figures that follow include the feature selection process according to boruta and
regularised random forests, the ROC curves and the bootstrapped AUC.
Just as was indicated by the statistical analysis, it comes as no surprise that features
like CRAE, CRVE, tortuosity, arterial and venular widths and angles, as well as a
series of haemodynamics ones, can provide a very good predictive performance of
the disease’s progression. The performance is decent enough to suggest that such a
classifier could be used in the near future for identifying and predicting the progression
of a not yet progressed subject with diabetes. This is a very strong observation, which
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Figure6.29:FeatureselectionprocessaccordingtoBoruta,whichalsogavethebestperformance.Greenlabelledfeaturesarethefinallyselectedones,
whereastheredaretherejectedones.Theplotreferstothecombination6.
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Figure 6.30: Feature ranking of the regularised random forests classifier for model 2 of combination 6.
Figure 6.31: Bootstrapped area under the curve of the best model for combination 6. It shows all the
1000 iterations of the bootstrap, including the box plot, and the lines of the apparent and null error
models, i.e. the model tested with the same training set and the random model, respectively.
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can be catalytic for managing to have in the future a clinical system that can assist with
the assessment of the disease’s progression, prior to arriving in an irreversible stage.
It goes without saying that the amount of data needed to do so are much more than
the ones that were available for these studies, but the results are promising enough to
suggest the possibility of introducing such a classifier with definite clinical importance.
6.3.7 Year 3 Minus Year 2 Versus Onset of DRMinus Year 1 (Pro-
gressors’ Group)
This specific combination is adopted mostly for reference purposes in order to figure
out whether there is any difference to the extent of the vascular alterations between the
transitional phase from diabetic eye to DR and the transition from three years pre-DR
to two years pre-DR. The best performance was achieved with the the feature subset
selected by the boruta selection process and the random forests classifier. The final
AUC is 0.842 (Table 6.22).
Table 6.22: Summary of the classification performance for the differences Y3-Y2 vs DR-Y1
(Combination 7)
Summary Best model Model 2 Model 3 Model 4 Model 5
Random Forests
AUC (CI95%)
0.842
(0.698-0.931)
0.834
(0.678-0.921)
0.831
(0.667-0.921)
0.828
(0.687-0.931)
0.821
(0.658-0.921)
Logistic Regression
AUC (CI95%)
0.798
(0.612-0.904)
0.789
(0.598-0.887)
0.783
(0.586-0.889)
0.718
(0.545-0.853)
0.743
(0.578-0.868)
Random Forests
kappa
0.688 0.675 0.665 0.671 0.658
Logistic Regression
kappa
0.589 0.592 0.579 0.423 0.465
Random forests
OOB
0.231 0.256 0.248 0.267 0.272
Feature selection
process
BO BO RF RF RF
The features for the above models, ordered according to their importance, are the
following:
Best model: Wsschild2v, arterySd, artAngleSD.
Model 2: ArtAngSd, wsschild2V, arterySD, lacunarity.
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Figure 6.32: On the left: ROC curve and AUC of the best model with the confidence intervals for
combination 7; on the right similar information is given for the second best model.
Model 3: Wsschild2v, arterySD, artAngleSD, lacunarity, veinAnglSD, smallchild2a, vein_SD,
pressureV, ellipse2Vch1.
Model 4: ArterySD,wsschild2v, VeinBc, VeinAngSD, ellipse2Vch1, ArtAngleSD, ellipse1Vpar,
Vein_SD.
Model 5: Wsschild2v, arterySD, ArtAngleSD, pressureA, lacunarity, VeinAnglSD, VeinBc,
Tort_ellipse1.
The figures that come next include the feature selection process of boruta (best model)
and regularised random forests (third model) and also the ROC curves and the boot-
strapped AUC.
The performance of this combination suggests something that was presumed; the
direction of the changes based on the values of the two classes show that the alterations
during the transitional year, i.e. from the last year of diabetic eye to DR, are more pro-
nounced than the three years- to two years- pre-DR. The fact that all five models of
this combination are close in performance suggests that actually a series of haemody-
namic and geometric features of both the venular and arterial network are supporting
the above statement.
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Figure 6.33: Feature ranking of the regularised random forests classifier for the model 3 of combination
7. The importance of each feature is expressed in terms of the mean decrease accuracy, that is how the
classifier is affected by removing a specific feature.
Figure 6.34: Bootstrapped area under the curve of the best model for combination 7.It shows all the
1000 iterations of the bootstrap, including the box plot, and the lines of the apparent and null error
models, i.e. the model tested with the same training set and the random model, respectively.
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Figure6.35:FeatureselectionprocessaccordingtoBorutaofthebestmodelforcombination7.Greenlabelledfeaturesarethefinallyselectedones,
whereastheredaretherejectedones.Theplotreferstothecombination7.
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6.3.8 Mean Diabetics (Non-Progressors’ Group) Versus Mean Di-
abetics (Progressors’ Group) Versus Onset of DR (One Ver-
sus All Method))
This final combination presents a pilot classification model, in order to figure out
whether a complete classifier that can differentiate the whole progression of the dis-
ease and the stages could be feasible. Such a model can have a direct application in
identifying the stage that a subject is and/or the probability that it belongs to a specific
stage. Just like in combination 5 and 6, it is paramount to be able to predict the stage of
the disease and assist the clinicians with adopting a treatment plan and/or conducting
further tests.
As mentioned in the previous chapter, in this specific comparison, the best feature
subsets from the combinations 4, 5, 6 were used to train the random forests classifier.
The best result was obtained by the feature subset of combination 6 (AUC = 0.821).
In figure 6.36 the ROC curves of all the combinations can be seen, as well as the
individual ROC curves for each binary classifier.
The performance is decent enough to suggest that it is possible to identify these
important stages of the disease. It is also promising that such a performance was
achieved with limited observations and only with information of the retinal geometry
and haemodynamics. The application and use of such a classifier in a clinical study
could be possible and definitely useful.
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Figure 6.36: ROC curves for each of the three combinations used in building the one vs all classification
models. For each feature subset, the plot includes three ROC curves that correspond to the three different
possible classifications: progressors versus the rest, non-progressors versus the rest and DR versus the
rest. The upper left plot, coming from combination 6, presents the best results, followed by the one
on the upper right, which belongs to combination 4, and finishing with the one down, coming from
combination 5.
6.3.9 Feature Ranking
The top 22 features as they appeared in all of the feature selection processes (210 in
total) across all the different combinations can be seen in Table 6.23. This table pro-
vides us with very important information, showing that the retinal vascular geometry,
and mainly the vessel widths, vessel angles and tortuosity are strong biomarkers, with
extensive discrimination potential, across all the combinations that were investigated.
This is even further highlighted by the fact that they appear in the models of all the
seven combinations. The 20 out of the 22 features are coming directly from the retinal
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Table 6.23: Ranking of the 22 most selected features
Features Appearances
ArtAngleSD 78
CRAE_LEON 72
CRVE_LEON 70
Angle.BC_art 64
PressureV 62
CRVE_KNUD 62
Tort_ellipse3 62
ArterySD 58
CRAE_KNUD 54
VeinAnglSD 54
lengthVein 54
BC_Mean_Art 48
Artgamma 40
Ellipse1Vch2 40
Fractal 40
Reparenta 40
wsschild1v 38
Angle.BC_Vein 38
Tort_ellipse1 34
MedVein 34
Ellipse3Vtheta 34
Sd_phi 34
vascular geometry, with the remaining two representing the haemodynamic features.
Pressure of the veins appears as the fifth best feature, contributing to the higher perfor-
mance of the classificationmodels. Aswas observed bothwithin the statistical analysis
and the classifications, the features of Table 6.23 shall be taken very seriously into ac-
count when building a diagnostic system, because they are among the first ones to be
affected from the proliferation of the disease (e.g. oxidative stress, local metabolic
stimuli and pericyte loss).
6.3.10 Summary
For the first time in literature, multiple classification models were trained and tested,
in order to investigate and achieve two things. Firstly to evaluate the discriminative
power of the investigated biomarkers and secondly to figure out whether a classifica-
tion system based exclusively on information of the retinal geometry and haemody-
namics can have a performance that could warrant a possible clinical application. It
is shown in an explicit way, based on robust feature selection processes and by using
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repeated cross validation and bootstraping to validate the performance of every model,
that many candidate biomarkers (Table 6.23) can discriminate between different stages
of the progression of the disease, tested in various combinations. The achieved per-
formance in all eight combinations ranged from 0.745 to 0.968 in terms of the AUC.
Finally the results suggest that a model built solely with information of the retinal
geometry and heamodynamics can possibly provide reliable classifiers that could be
tested and incorporated in a real clinical application. These features accommodate the
purpose of this thesis, which is the early detection and diagnosis of DR. Therefore
these novel findings have a clear clinical importance, which is originally reported in
this thesis.
6.4 General Conclusion and Discussion
This chapter presents the main results of the evaluation of all the candidate biomarkers.
The first part is devoted to the complete statistical analysis for every category that is
of our interest. Taking into account that the main goal of this thesis is to identify and
early detect the progression to DR, many different categories were evaluated that cover
every possible analysis, accomplishing this goal. A large enough progressors’ diabetic
group was included alongside a non-progressors’ diabetic one, in order to emphasise
and show that in order to make proper inferences, a carefully designed experiment
is required. Significant results were observed for a number of biomarkers, both ge-
ometric and haemodynamic, including venular and arterial widths, tortuosity, fractal
dimension, CRVE, CRAE, blood flow, venular wall shear stress, venular velocity and
others (Tables 6.5 and 6.14). Changing the novel design to a more conventional one,
masked all these differences, affecting massively the analysis. This strongly suggests
that in order to quantify the vascular changes, a deep investigation and a follow-up of
the same segments is needed.
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Another important observation is that there are extensive changes between the non-
progressors’ diabetic group and the progressors’ one, e.g. in the CRVE, CRAE, the
venular widths and tortuosity, the arterial and venular blood flow, among others. This
is one of the key finding, suggesting that the changes start earlier, much before the
DR, and continue until the years before the onset of DR, adopting at this stage the
characteristics of a progressors’ group. Following that, more differences are under
way, until the first lesions finally appear in the retina. The findings for the CRAE and
CRVE confirm the ones in (Klein et al., 2004) and also (Islam et al., 2009).
The second part of this chapter took the analysis a step further, evaluating all those
biomarkers in practise. Many different models were created, which included 8 dif-
ferent combinations, and evaluating 210 different features subsets, as came out of the
feature selection processes. 420 different classification models were created and com-
pared in total, in order to find the optimum one for the 7 combinations. The key and
rigorous finding out of this process is that it was unequivocally shown that a reliable
and high performance classifier can indeed be used to differentiate between different
stages of the disease’s progression, trained only with geometric and haemodynamic
features.
Therefore, three major and robust contributions were made. The first one is the
evaluation and estimation of haemodynamic features for studying the progression of
the disease, in preselected and connected vascular trees. This led to the subsequent
establishment of important biomarkers of progression to DR, both heamodynamic
and geometric ones, within a non-progressors’ diabetic group, a progressors’ diabetic
group and a DR group. The second is that, for the first time, high performance clas-
sifiers are created and proposed, along with the corresponding feature subsets, solely
relying on the above biomarkers, for predicting different stages of the disease’s pro-
gression, not only between subjects with diabetes and DR, but also between non-
progressors’ diabetics and progressors’ diabetics.
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Lastly, the results in chapter 5 (the third major contribution), where the proposed
and improved method for estimating the CRVE and CRAE is described, were con-
firmed on a larger scale in this chapter as well. The CRAE and CRVE features, esti-
mated according to the proposed method, ranked second and third respectively, in the
entire feature selection process across all the combinations , as can be seen in table
6.29. This explicitly points out what was previously suggested, that any improvement
in the estimation of CRVE, CRAE and AVR can have a big impact in more effectively
and robustly studying the progression of the disease.
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Chapter 7
Conclusion
This thesis presents a novel, comprehensive and complete study of multiple geomet-
ric and haemodynamic biomarkers that have not been evaluated before. In addition it
presents a new, alternative and more accurate method for summarising the calibre of
the parent vessel trunk, with an application to the estimation of the CRVE, CRAE and
AVR. A summary of the main contributions and achievements is given in this chap-
ter. The previous chapters provided detailed and comprehensive information about
the background of DR, previous studies, utilised and implemented methods and tech-
niques, as well as the full results of the studies and the validation process.
7.1 Summary of Work
This thesis presents three novelties, which all define some important contributions for
the early detection and screening of diabetic retinopathy. Firstly, a complete frame-
work for the more efficient and meaningful analysis of the retinal biomarkers is pre-
sented, which was shown to produce more accurate and representative results. This
was also validated with the different classification models, where indeed most of the
significant or close to the significance level (0.05) features that were identified during
thematched-segments progressors’ group analysis, were also part of the feature subsets
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in the classification process. Until now, the studies in literature were focusing on re-
cruiting a healthy or diabetic cohort and comparing it against an advanced retinopathy
one, e.g. in (Kifley et al., 2007; Daxer, 1993; Yau et al., 2010; Nguyen et al., 2008a).
However, this study concluded that the alterations are happening much earlier, during
the last years of the diabetic eye, still on a stage that the interventions and treatment
plans from the clinicians can possibly be adjusted for the optimum management and
control of the disease.
Secondly, for the first time, a series of haemodynamic features were estimated and
evaluated as candidate biomarkers of the progression of the disease, which were shown
to make a difference in the statistical analysis and the classification process indeed.
Despite the limitations of the boundary conditions that were adopted for their estima-
tion, their importance was highlighted, suggesting that more appropriate, advanced
and representative boundary conditions would possible make even greater difference.
In addition, the performance of the classification models provided us with some strong
findings with possible clinical importance. These strongly suggest that accurately and
reliably predicting the progression of the disease, both from the non-progressors’ to the
progressors’ stage and also from the progressors’ stage to the onset of DR, is something
that can be achieved with the proper adoption of various geometric and haemodynamic
features, subject to the inclusion of large representative datasets.
Thirdly, the new method for summarising the calibre of the parent vessel trunk and
the subsequent improved estimation of the CRVE, CRAE and AVR, will definitely
make a difference in studying the progression of any retinal disease, not only DR.
This was clearly and succinctly shown, both statistically and in practise inside the
classification models. This led the estimations of the CRAE and CRVE according to
the proposedmethod, not only to rank higher than the similar estimations that are based
on the other method in literature (Knudtson et al., 2003), but also to rank second and
third among the entire investigated features across all the combinations (Table 6.23).
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7.2 Future Work
The work presented in this thesis could be continued and extended in a variety of
ways. Firstly and most importantly, given the complex, diverse and multiple effects
that diabetes has to the whole body, and also the millions of people that face its con-
sequences worldwide, additional and more representative data are needed. One of the
main problems that I had to deal with in all of these studies, was to find the necessary
and clean data needed for conducting all of the experiments. However, after showing
in practise how all these biomarkers of progression, e.g. CRVE, CRAE, blood flow
rate, vessel angles and widths, fractal dimension etc., are capable of differentiating
between different stages of diabetes and the onset of DR, additional data for building
more efficient classifiers are definitely needed. Moreover, despite not being the scope
of this thesis, it is definitely paramount to automate some of the processes involved,
such as artery/vein identification, in order to be able to apply all these analyses in a
larger scale. Stressing the last thing even further, this is a crucial and sensitive step,
because errors in this part pollute the available data, creating outliers that are difficult
to identify, because both types of vessels can take very small and very large values.
Therefore setting a threshold is not an option. That would be a fatal error that it was
avoided in this thesis, by carefully, manually labelling and selecting the vessels, sup-
porting one of the main objectives of presenting a robust, accurate and complete study.
Last but not least, the range of the period that the data were obtained from could also be
extended, in order to investigate the within subjects progression (progressors’ group)
what happens even before the three years from the onset of DR. According to what
was observed in this thesis, the changes possibly start even earlier, which means that
interventions and treatment plans could be even more effective.
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7.3 Epilogue
The motivations and objectives of this thesis were given in chapter 1. Detecting di-
abetic retinopathy early, when still no lesions have appeared, can be a life-changing
feat. In this thesis it was clearly shown that, subject to extending the studies to include
more subjects, in order to get a more representative sample of the alterations, DR can
be identified early. Clinicians could possibly be driven by that, in order to monitor the
patients more closely and even try to decelerate the progression of DR.
This thesis focused on presenting a framework, evaluating candidate biomarkers
and improving the estimations of some of them, in order to show that the alterations in
the retinal vasculature, as a consequence of diabetes and DR, occur prior to the onset of
DR, which are distinct enough to be able to detect different stages of the progression.
Finally, the thesis introduces some novel fundamental ideas and a framework for being
adopted by future studies, in order to lead to even more accurate and representative
analyses, inferences and verdicts.
206
Appendix A
Results of the Non-Significant
Features
Table A.1: Analysis of the non-significant main features for category 1
Feature
name
AICa BICa (p-(χ2)/
p-(s))b
ICC Ω2 Fc (VR/VE)d Group Means(SD)
(Y3, Y2, Y1, DR)
BetaA 35.4/
36.4
20.5/
21.7
0.15/
0.154
0.45 0.657 0.21
nested:0.356
0.015/
0.031
1.25(0.17),1.32(0.15)
1.27(0.16),1.31(0.17)
Lambda1A 623.5/
624.8
612.8/
611.2
0.28/
0.29
0.372 0.604 0.137
nested:0.365
0.0024/
0.0033
0.914(0.057),0.923(0.052)
0.908(0.057),0.926(0.052)
ThetaA 2578/
2575
2603/
2589
0.536/
0.538
0.487 0.648 0.13
nested:0.43
223/
736.9
154.1(41),153.6(41.2)
154.9(43.1),148.2(38.4)
Adj.GammaA 689.6/
689.2
675.4/
664.3
0.137/
0.137
0.463 0.685 0.203
nested:0.396
0.001/
0.002
0.812(0.08),0.825(0.07)
0.846(0.07),0.817(0.08)
Width_child2A 170.4/
168.2
195.3/
182.4
0.29/
0.29
0.667 0.763 0.529
nested:0.171
0.11/
0.062
3.16(0.43),3.19(0.47)
3.197(0.46),3.125(0.43)
Angle.BC_A 2531/
2529
2556/
2543
0.265/
0.271
0.754 0.708 0.161
nested:0.481
262.5/
582.5
127.4(41.7),121.1(40.5)
126.9(38.7), 120.2(35.5)
Lambda1V 1677/
1672
1657/
1640
0.35/
0.35
0.335 0.574 0.183
nested:0.295
0.001/
0.003
0.906(0.062),0.914(0.067)
0.902(0.072),0.909(0.065)
ThetaV 182.4/
177.8
214.2/
196
0.71/
0.71
0.353 0.608 0.248
nested:0.264
0.025/
0.05
137.1(32.9),136.3(28.8)
137.1(34.5),134.7(33)
Adj.GammaV 1929/
1927
1909/
1897
0.06/
0.06
0.351 0.611 0.171
nested:0.345
0.0008/
0.0024
0.763(0.067),0.765(0.071)
0.768(0.071),0.761(0.073)
Width_child2V 734/
734
766/
765
0.125/
0.127
0.521 0.708 0.366
nested:0.275
0.104/
0.101
3.198(0.531),3.219(0.513)
3.277(0.574),3.22(0.475)
Lacunarity 474.3/
469.8
465.3/
451.8
0.688/
0.681
0.79 0.832 0.787 0.0045/
0.0012
0.16(0.082),0.17(0.073)
0.171(0.059),0.174(0.078)
a: Full versus Restricted (null) model, b: chi-squared p-value and p-value based on Satterthwaite’s approximation, c: Random
effect variance (for subjects and, when applicable, the nested factor), divided by the total variance under the full model, d: Vari-
ance of Subjects/Variance of Residuals
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Table A.2: Analysis of the non-significant features of the different areas for category 1
Feature
name
AICa BICa (p-(χ2)/
p-(s))b
ICC Ω2 Fc (VR/VE)d Group Means(SD)
(Y3, Y2, Y1, DR)
AVmid_AVbeg 82.1/
78.6
75.5/
64.7
0.57/
0.58
0.514 0.612 0.51 0.013/
0.013
0.032(0.166),0.0013(0.176)
0.038(0.127),-0.0016(0.179)
AVend_AVbeg 85.3/
82.56
78.2/
68.2
0.375/
0.383
0.627 0.713 0.628 0.019/
0.011
0.0452(0.176),-0.004(0.17)
-0.0071(0.155),0.0062(0.193)
AVend_AVmid 67.9/
64.8
60.1/
50.5
0.413/
0.433
0.521 0.624 0.52 0.0169/
0.0155
0.0133(0.167),-0.006(0.165)
-0.046(0.154),0.008(0.224)
ellipse1ch1V 259.4/
257.2
273.7/
264.4
0.283/
0.302
0.334 0.467 0.339 0.53/
1.02
4.33(1.12),3.9(1.31)
4.47(1.3),4.35(1.22)
ellipse1ch2V 249.5/
247.7
263.8/
254.9
0.241/
0.253
0.387 0.519 0.394 0.567/
0.871
4.87(1.22),4.35(1.15)
4.72(1.04),4.43(1.36)
ellipse1ThetaV 616.3/
613.6
630.6/
620.7
0.355/
0.375
0.298 0.426 0.299 6.263/
9.577
81.29(12.78),84.89(11.93)
84.28(9.97),86.56(10.87)
ellipse1parA 285.9/
281.5
300.2/
288.6
0.678/
0.693
0.698 0.762 0.692 2.393/
1.065
6.71(1.81),6.65(1.85)
7(1.89),6.68(1.87)
ellipse1ch1A 293.8/
289.5
308.1/
289.5
0.642/
0.658
0.676 0.745 0.67 2.445/
1.2
5.57(2.07),5.54(1.78)
5.91(1.89),5.8(1.87)
ellipse1ch2A 292.2/
289.5
306.5/
296.6
0.35/
0.37
0.593 0.686 0.594 1.852/
1.264
5.44(1.85),5.10(1.51)
5.71(1.9),5.26(1.75)
ellipse1ThetaA 634.1/
628.5
648.4/
635.6
0.93/
0.95
0.3 0.39 0.285 46.2/
115.8
85.99(12.64),85.77(15.22)
87.39(12.31),86.71(10.22)
ellipse2parV 362.1/
359.4
376.1/
366.6
0.352/
0.361
0.704 0.774 0.705 6.51/
2.72
7.74(3.19),8.17(2.93)
8.68(3),8.12(3)
ellipse2ch2V 275.9/
274.4
290.2/
281.4
0.231/
0.249
0.944 0.96 0.94 10.07/
0.57
6.64(3.2),6.42(3.31)
6.87(3.32),6.8(3.19)
ellipse2ThetaV 601.7/
596.7
616/
603.9
0.798/
0.81
0.755 0.807 0.748 154.1/
51.67
83.31(14.38),85.17(13.93)
83.83(14.5),85.04(14.54)
ellipse2parA 281.5/
277
295.8/
284.1
0.698/
0.71
0.721 0.781 0.715 2.47/
0.982
7.19(2.23),6.91(1.6)
7.17(1.84),6.94(1.69)
ellipse2ch1A 258.1/
254.3
272.4/
261.5
0.53/
0.542
0.697 0.765 0.694 1.7/
0.75
5.62(1.55),5.55(1.32)
5.93(1.74),5.7(1.61)
ellipse2ThetaA 600.2/
597.7
614.5/
604.9
0.326/
0.335
0.528 0.635 0.531 71.07/
62.72
86.43(12.21),85.24(8.95)
83.96(11.41),81.99(13.24)
ellipse3parV 406.1/
400.9
420.3/
408.1
0.846/
0.854
0.533 0.621 0.521 6.085/
5.583
15.31(3.36),14.95(2.37)
14.72(4.29),15.21(3.34)
ellipse3ch1V 321.6/
317.5
335.9/
324.6
0.599/
0.616
0.8 0.845 0.795 5.73/
1.462
11.89(2.47),11.42(2.73)
11.47(2.8), 11.62(2.69)
ellipse3ch2V 351.9/
349.6
366.2/
356.8
0.291/
0.3
0.62 0.71 0.622 4.284/
2.599
11.33(2.37),10.51(2.5)
11.02(2.31),10.53(3.20)
ellipse3ThetaV 581.9/
581.8
596.2/
594.4
0.115/
0.128
0.393 0.539 0.41 38.06/
54.91
78.4(10.61),79.82(8.1)
81.94(8.22),83.7(11.21)
ellipse3parA 351.7/
347.8
366.1/
354.9
0.568/
0.585
0.503 0.603 0.498 2.864/
2.885
11.91(3.37),11.3(2.03)
11.24(1.64),11.51(2.18)
ellipse3ch1A 371.1/
370
385.4/
377.2
0.176/
0.193
0.53 0.645 0.539 4.169/
3.551
10.16(4.08),8.97(1.67)
9.13(2.26),9.21(2.49)
ellipse3ch2A 325.1/
325/3
339.3/
332.4
0.1/
0.11
0.583 0.694 0.598 2.831/
1.9
9.94(2.13),8.91(2.31)
9.38(2.05),9.11(2.18)
ellipse3ThetaA 571.97/
567.95
586.27/
575.1
0.58/
0.597
0.472 0.575 0.466 40.51/
46.41
86.07(11.1),85.89(8.74)
88.46(8.79),86.2(8.4)
AVR_LEON 294.5/
289.9
285.6/
272.2
0.31/
0.34
0.445 0.549 0.44 0.0038/
0.0049
0.691(0.081),0.712(0.084)
0.718(0.091),0.723(0.092)
AVR_KNUD 302.1/
301.1
294.1/
283.9
0.1/
0.112
0.443 0.562 0.448 0.0036/
0.0044
0.688(0.081),0.704(0.082)
0.702(0.094),0.723(0.093)
a: Full versus Restricted (null) model, b: chi-squared p-value and p-value based on Satterthwaite’s approximation, c: Ran-
dom effect variance (for subjects and, when applicable, the nested factor), divided by the total variance under the full model, d:
Variance of Subjects/Variance of Residuals
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Table A.3: Analysis of the non-significant tortuosity features for category 1
Feature
name
AICa BICa (p-(χ2)/
p-(s))b
ICC Ω2 Fc (VR/VE)d Group Means(SD)
(Y3, Y2, Y1, DR)
mean_phi 2494/
2489
2481/
2464
0.665/
0.668
0.538 0.631 0.537 3.7x10−4/
3.2x10−4
0.222(0.03),0.223(0.024)
0.223(0.026),0.225(0.028)
median_phi 2222/
2218
2209/
2193
0.488/
0.491
0.551 0.644 0.553 6.6x10−4/
5.3x10−4
0.139(0.032),0.138(0.033)
0.14(0.037),0.143(0.035)
75th_phi 1739/
1734
1726/
1708
0.823/
0.812
0.491 0.589 0.489 1.3x10−3/
1.4x10−3
0.347(0.052),0.35(0.04)
0.346(0.052),0.35(0.056)
sd_phi 2758/
2754
2746/
2728
0.72/
0.719
0.339 0.447 0.337 1.1x10−4/
2.2x10−4
0.24(0.019),0.242(0.017)
0.24(0.018),0.241(0.018)
mean_tau 3550/
3546
3537/
3520
0.6544/
0.656
0.506 0.603 0.505 4.5x10−5/
4.4x10−5
(3.71(0.98),3.76(0.85)
3.72(0.99),3.8(0.93))x10−2
median_tau 4687/
4684
4674/
4658
0.371/
0.372
0.652 0.728 0.653 8.34x10−6/
4.43x10−6
(11.1(3.6),11(3.1)
10.9(3.7),11.3(3.7))x10−3
75th_tau 3641/
3637
3628/
3611
0.593/
0.596
0.554 0.645 0.553 4.43x10−5/
3.57x10−5
(35.4(9),35.2(7.8)
35.1(9.2),36(9.4))x10−3
mean_psi 3633/
3629
3621/
3603
0.575/
0.573
0.539 0.632 0.538 4.29x10−5/
3.7x10−5
(4.47(0.92),4.49(0.86)
4.45(0.89),4.55(0.88))x10−2
median_psi 4276/
4272
4263/
4246
0.493/
0.495
0.708 0.772 0.707 2.23x10−5/
9.2x10−6
(16.9(5.7),16.7(5.2)
16.9(5.8),17.3(5.4))x10−3
75th_psi 3254/
3250
3241/
3224
0.716/
0.718
0.606 0.687 0.604 1.1x10−4/
7.16x10−5
(51.4(13.6),51.9(12.7)
52.1(13.3),52.6(13.9))x10−3
sd_psi 3104/
3098
3091/
3073
0.389/
0.388
0.275 0.383 0.273 4.6x10−5/
12.3x10−5
(7.25(1.3),7.25(1.2)
7.2(1.3),7.3(1.3))x10−2
Tort.blend 989/
986
977/
961
0.41/
0.42
0.576 0.664 0.575 7.4x10−3/
5.52x10−3
1.009(0.114),1.016(0.103)
1.012(0.114),1.024(0.122)
Tort_ellipse1 146/
141
138/
125
0.86/
0.87
0.131 0.108 0.112 0.0023/
0.0112
0.072(0.087),0.081(0.098)
0.089(0.098),0.082(0.076)
Tort_ellipse2 74.1/
73.9
66.5/
58.3
0.118/
0.129
0.191 0.336 0.203 0.0055/
0.0216
0.061(0.129),0.145(0.249),
0.091(0.149), 0.055(0.086)
a: Full versus Restricted (null) model, b: chi-squared p-value and p-value based on Satterthwaite’s approximation, c: Ran-
dom effect variance (for subjects and, when applicable, the nested factor), divided by the total variance under the full model, d:
Variance of Subjects/Variance of Residuals
Table A.4: Analysis of the non-significant haemodynamic features for category 1
Feature
name
AICa BICa (p-(χ2)/
p-(s))b
ICC Ω2 Fc (VR/VE)d Group Means(SD)
(Y3, Y2, Y1, DR)
wssparentA 793.5/
787.7
795.2/
788.4
0.865/
0.857
0.859 0.897 0.855 923/ 156.3 54.04(30.19),56.24(29.8)
51.96(25.67),52.81(24.56)
pressureA 527.1/
524.1
542.1/
531.6
0.41/
0.396
0.158 0.272 0.156 3.03/ 16.3 2.72(1.05),3.61(1.65)
2.91(1.18),3.36(1.15)
vparentaA 492.8/
487.6
507.8/
495.1
0.858/
0.852
0.888 0.918 0.885 40.05/
5.20
16.28(7.85),16.89(7.1)
16.11(6.28),16.33(6.12)
ReparentA 855.4/
850.7
870.5/
858.2
0.755/
0.745
0.91 0.934 0.907 51.78/
16.58
259.94(61.13),265.82(57.58)
260.2(53.03),262.62(50.17)
wsschild1A 703.3/
700.4
718.3/
707.9
0.374/
0.392
0.663 0.752 0.662 12.18/ 8.7 25.83(11.34),29.47(14.56)
25.54(13.05),28.75(13.14)
vchild1A 434.5/
431.33
449.5/
438.8
0.418/
0.436
0.689 0.771 0.687 8.173/
3.714
8.56(3.26),9.12(3.91)
8.17(3.22),9.02(3.57)
Rechild1A 862.1/
860.7
877.1/
868.2
0.21/
0.226
0.634 0.735 0.638 28.29/
21.28
147.8(32.9),147.1(38.7)
135.7(37.8),147.9(33.8)
wsschild2A 681/
677.3
876.9/
872.2
0.521/
0.538
0.764 0.828 0.761 167.8/
52.54
32.3(13.5),35.08(18.41)
31.58(13.15),32.83(15)
vchild2A 369.8/
367.6
384.8/
375.1
0.282/
0.299
0.781 0.845 0.783 5.802/
1.604
8.65(2.63),9.38(3.19)
8.94(2.52),8.89(2.71)
PinQoutA 610/
606
625.9/
614.1
0.646/
0.66
0.788 0.845 0.785 9.234/
4.828
25.07(9.92),24.37(11.17)
23.66(11.87),24.67(9.46)
pressureV 369.9/
368.1
384.1/
375.2
0.241/
0.263
0.562 0.571 0.569 2.221/
1.931
1.79(1.41),2.36(2.02)
2.39(1.55),1.22(1.13)
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a: Full versus Restricted (null) model, b: chi-squared p-value and p-value based on Satterthwaite’s approximation, c: Ran-
dom effect variance (for subjects and, when applicable, the nested factor), divided by the total variance under the full model, d:
Variance of Subjects/Variance of Residuals
Table A.5: Analysis of the non-significant main features for category 2
Feature
name
AICa BICa (p-(χ2)/
p-(s))b
ICC Ω2 Fc (VR/VE)dGroup Means(SD)
(Y3, Y2, Y1, DR)
AlphaA 505.3/
501.6
486.7/
468.9
0.498/
0.499
0.388 0.324 0.144
nested:0.091
0.0052/
0.0278
0.801(0.136),0.82(0.145)
0.808(0.125),0.807(0.127)
BetaA 192.3/
187.2
226.4/
206.4
0.846/
0.815
0.567 0.247 0.067
nested:0.091
0.005/
0.062
1.302(0.193),1.311(0.202)
1.323(0.197),1.303(0.209)
LambdaA 1509/
1505
1490/
1472
0.461/
0.461
0.391 0.341 0.152
nested:0.096
0.0018/
0.0093
0.858(0.103),0.899(0.065)
0.883(0.042),0.881(0.054)
Lambda1A 1867/
1862
1848/
1828
0.71/
0.87
0.645 0.241 0.054
nested:0.098
0.0004/
0.0064
0.922(0.068),0.92(0.071)
0.926(0.062),0.921(0.065)
Lambda2A 1570/
1566
1551/
1532
0.61/
0.6
0.419 0.319 0.132
nested:0.094
0.0014/
0.0085
0.813(0.079),0.822(0.091)
0.822(0.091),0.815(0.093)
ThetaA 1156/
1155
1189/
1175
0.108/
0.109
0.687 0.369 0.081
nested:0.172
0.018/
0.167
145.6(45.1),152.4(49.7)
149.5(48.5),153.9(46.1)
Adj.GammaA 2070/
2065
2051/
2031
0.865/
0.866
0.574 0.246 0.067
nested:0.091
0.0004/
0.0051
0.844(0.079),0.841(0.079)
0.85(0.074), 0.828(0.079)
Width_allA 1384/
1383
1417/
1402
0.159/
0.161
0.236 0.609 0.399
nested:0.12
0.16/
0.192
3.422(0.619),3.534(0.643)
3.496(0.652),3.486(0.625)
Width_parentA 1948/
1942
1985/
1967
0.474/
0.475
0.284 0.559 0.334
nested:0.13
0.231/
0.369
3.727(0.821),3.841(0.839)
3.791(0.848),3.796(0.814)
Width_child1A 1582/
1580
1621/
1617
0.236/
0.237
0.229 0.628 0.413
nested:0.12
0.211/
0.238
3.488(0.714),3.583(0.726)
3.561(0.729),3.549(0.729)
Angle.BC_A 9216/
9213
9250/
9232
0.444/
0.445
0.77 0.347 0.055
nested:0.176
90.02/
1278.9
116.40(43.81),119.1(47.39)
117.19(45.5),121.42(46.33)
AlphaV 934.2/
932.3
910.8/
891.9
0.198/
0.199
0.273 0.175 0.088
nested:0.033
0.004/
0.037
0.713(0.209),0.728(0.198)
0.735(0.205),0.734(0.207)
BetaV 413.2/
412.8
454.1/
436.1
0.136/
0.137
0.497 0.215 0.07
nested:0.07
0.005/
0.061
1.201(0.208),1.217(0.257)
1.232(0.212),1.219(0.203)
LambdaV 3421/
3419
3397/
3378
0.188/
0.189
0.248 0.181 0.096
nested:0.032
0.0015/
0.0138
0.834(0.129),0.844(0.121)
0.848(0.125),0.847(0.127)
Lambda1V 5629/
5623
5605/
5583
0.758/
0.759
0.591 0.15 0.037
nested:0.054
0.0002/
0.005
0.915(0.067),0.916(0.068)
0.919(0.061),0.915(0.063)
Lambda2V 3750/
3749
3725/
3709
0.075/
0.076
0.323 0.223 0.106
nested:0.052
0.0015/
0.0119
0.757(0.102),0.768(0.092)
0.773(0.101),0.769(0.104)
ThetaV 2328/
2327
2369/
2351
0.129/
0.13
0.108 0.104 0.067
nested:0.008
0.0101/
0.1391
137.2(39.1),138.6(38.4)
137.1(38.5),133.6(38.6)
Adj.GammaV 5990/
5989
5967/
5948
0.179/
0.18
0.521 0.21 0.064
nested:0.071
0.0004/
0.0049
0.778(0.056),0.783(0.061)
0.787(0.063),0.773(0.059)
Width_allV 4698/
4697
4738/
4722
0.074/
0.075
0.125 0.421 0.341
nested:0.048
0.175/
0.312
3.587(0.71),3.636(0.685)
3.671(0.706),3.638(0.692)
Width_parentV 6310/
6306
6351/
6330
0.581/
0.582
0.149 0.392 0.299
nested:0.051
0.275/
0.595
4.009(0.956),4.042(0.924)
4.07(0.941), 4.047(0.943)
Width_child1V 5645/
5642
5686/
5665
0.336/
0.337
0.122 0.375 0.293
nested:0.04
0.205/
0.465
3.723(0.84),3.759(0.797)
3.794(0.825),3.759(0.836)
a: Full versus Restricted (null) model, b: chi-squared p-value and p-value based on Satterthwaite’s approximation, c: Ran-
dom effect variance (for subjects and, when applicable, the nested factor), divided by the total variance under the full model, d:
Variance of Subjects/Variance of Residuals
Table A.6: Analysis of the non-significant main features for category 3
Feature
name
AICa BICa (p-(χ2)/
p-(s))b
ICC Ω2 Fc (V_R/
V_E)d
Group Means(SD)
(Y3, Y2, Y1, YO)
AlphaA 60.7/
61.1
50.7/
43.5
0.092/
0.102
0.2 0.145 0.247
nested:0.07
0.0078/
0.0215
0.740(0.163),0.805(0.171),
0.82(0.161),0.842(0.142)
BetaA 5.99/
4.76
12.81/
4.05
0.189/
0.205
0.04 0.341 0.07
nested:0.09
0.005/
0.061
1.259(0.23),1.35(0.234),
1.38(0.24),1.321(0.212)
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LambdaA 169.8/
168.1
158.2/
151.2
0.088/
0.097
0.277 0.457 0.264
nested:0.072
0.0025/
0.0065
0.855(0.095),0.872(0.056),
0.891(0.069),0.895(0.044)
Lambda1A 202.6/
197.9
192.5/
180.4
0.138/
0.139
0.346 0.334 0.069
nested:0.170
0.0004/
0.0049
0.846(0.079),0.856(0.082),
0.863(0.081),0.839(0.077)
Lambda2A 193/
190.1
180.1/
175.4
0.231/
0.236
0.188 0.431 0.116
nested:0.173
0.0008/
0.005
0.806(0.083),0.819(0.083),
0.815(0.061),0.821(0.055)
ThetaA 69.39/
67.55
86.97/
67.55
0.244/
0.259
0.234 0.4 0.173
nested:0.118
0.022/
0.09
143.7(34.1),143.9(33.1),
144.9(33.2), 158.6(40.6)
Adj.GammaA 236.9/
235.1
226.9/
217.6
0.241/
0.258
0.05 0.334 0.05
nested:0.206
0.0005/
0.0033
0.813(0.055),0.824(0.056),
0.835(0.053),0.819(0.051)
Width_parentA 105.1/
104.4
121.9/
115.1
0.085/
0.093
0.467 0.589 0.409
nested:0.116
0.1/
0.116
4.074(0.505),3.85(0.523),
3.838(0.457),3.912(0.402)
Width_child1A 93.58/
92.28
111.1/
102.3
0.195/
0.21
0.496 0.585 0.397
nested:0.144
0.087/
0.101
3.834(0.413),3.669(0.454),
3.689(0.474),3.669(0.421)
Width_child2A 89/
83.71
106.6/
93.75
0.871/
0.877
0.373 0.442 0.348
nested:0.031
0.062/
0.11
3.277(0.465),3.254(0.382),
3.304(0.371),3.325(0.437)
Width_allA 69.23/
66.48
86.81/
76.52
0.355/
0.372
0.505 0.58 0.447
nested:0.092
0.076/
0.079
3.73(0.415),3.593(0.403),
3.611(0.387),3.635(0.364)
Angle.BC_A 875.6/
872.5
893.2/
882.5
0.411/
0.424
0.211 0.26 0.212
nested:0.0002
185.7/
689.9
112.42(34.42),112.34(37.64),
110.94(35.01),123.99(38.99)
AlphaV 96.49/
92.91
83.44/
70.08
0.489/
0.498
0.464 0.596 0.398
nested:0.144
0.021/
0.024
0.581(0.206),0.622(0.234),
0.631(0.218),0.613(0.218)
BetaV 43.05/
41.93
29.99/
19.1
0.181/
0.188
0.251 0.433 0.04
nested:0.274
0.0021/
0.0345
1.121(0.112),1.173(0.124),
1.164(0.142),1.147(0.116)
LambdaV 267.6/
263.9
254.6/
241.1
0.523/
0.531
0.436 0.57 0.376
nested:0.133
0.0077/
0.0101
0.751(0.132),0.775(0.145),
0.782(0.137),0.771(0.141)
Lambda1V 435.3/
430.5
422.2/
407.7
0.745/
0.751
0.206 0.536 0.045
nested:0.426
0.0005/
0.018
0.816(0.057),0.831(0.053),
0.825(0.076),0.822(0.054)
Lambda2V 344.9/
343.8
331.9/
320.9
0.186/
0.194
0.397 0.419 0.399
nested:0.014
0.0051/
0.0076
0.681(0.098),0.715(0.109),
0.718(0.114),0.705(0.109)
ThetaV 9.89/
5.56
32.73/
18.61
0.642/
0.648
0.499 0.623 0.484
nested:0.048
0.044/
0.043
133.1(31.9),135.7(31.6),
136.5(31.4),131.4(30.4)
Adj.GammaV 514.6/
513.4
501.5/
490.3
0.211/
0.218
0.195 0.435 0.06
nested:0.217
0.0006/
0.0043
0.758(0.056),0.765(0.043),
0.767(0.056),0.761(0.054)
Width_parentV 394.2/
391.2
417.8/
404.3
0.51/
0.518
0.58 0.611 0.55
nested:0.057
0.4245/
0.3031
4.879(0.765),4.722(0.791),
4.844(0.853),4.818(0.827)
Width_child1V 416.9/
411.6
439.7/
411.6
0.854/
0.858
0.41 0.542 0.334
nested:0.148
0.223/
0.346
4.456(0.747),4.379(0.733),
4.467(0.861),4.435(0.818)
Width_child2V 194.4/
191.6
217.2/
204.6
0.36/
0.368
0.559 0.534 0.56
nested:0.015
0.1472/
0.1161
3.284(0.471),3.332(0.505),
3.415(0.499),3.331(0.401)
Width_allV 284.2/
279.8
307.1/
292.8
0.668/
0.675
0.559 0.598 0.521
nested:0.067
0.216/
0.171
4.206(0.571),4.144(0.588),
4.242(0.646),4.195(0.587)
Angle.BC_V 1792/
1788
1815/
1801
0.625/
0.632
0.422 0.551 0.377
nested:0.095
317.5/
444.5
123.6(36.37),122.1(32.8),
123.8(33.9),121.4(35.3)
Fractal 146.3/
144.1
141.1/
133.4
0.293/
0.323
0.641 0.732 0.645 0.0019/
0.0011
1.665(0.049),1.651(0.057),
1.64(0.059),1.643(0.055)
Lacunarity 127.5/
126.9
122.1/
116.2
0.139/
0.166
0.564 0.69 0.585 0.0024/
0.0017
0.149(0.031),0.167(0.078),
0.186(0.075),0.181(0.059)
a: Full versus Restricted (null) model, b: chi-squared p-value and p-value based on Satterthwaite’s approximation, c: Ran-
dom effect variance (for subjects and, when applicable, the nested factor), divided by the total variance under the full model, d:
Variance of Subjects/Variance of Residuals
Table A.7: Analysis of the non-significant features of the different areas for category 3
Feature
name
AICa BICa (p-(χ2)/
p-(s))b
ICC Ω2 Fc (VR/VE)dGroup Means(SD)
(Y3, Y2, Y1, YO)
AVmid_AVbeg 47.91/
46.66/
42.91/
36.54
0.196/
0.231
0.453 0.599 0.469 0.0091/
0.0102
0.052(0.155),0.0125(0.129),
0.042(0.155), 0.107(0.111)
AVend_AVbeg 36.35/
34.09
35.28/
34.08
0.291/
0.331
0.185 0.342 191 0.0041/
0.0175
0.068(0.121),0.138(0.139),
0.148(0.147), 0.061(0.174)
AVend_AVmid 61.52/
57.03
56.45/
47.17
0.618/
0.651
0.29 0.404 0.275 0.0034/
0.0091
0.005(0.122),0.003(0.116),
-0.041(0.084),-0.022(0.121)
ellipse1parV 111.4/
106.8
121.58/
111.89
0.712/
0.739
0.695 0.755 0.681 0.9497/
0.4448
7.205(0.894), 6.956(1.142),
7.275(1.117), 7.147(1.491)
ellipse1ch1V 61.08/
59.36
67.08/
62.34
0.232/
0.312
0.459 0.63 0.479 0.534/
0.578
4.936(1.083),4.695(0.972)
5.604(0.470),5.24(1.152)
211
ellipse1ch2V 124.84/
120.55
134.98/
125.61
0.635/
0.667
0.364 0.474 0.348 0.439/
0.821
5.152(0.946),4.716(0.907),
4.807(1.387),5.070(1.181)
ellipse1ThetaV 323.65/
323.51
333.78/
328.58
0.118/
0.146
0.2 0.408 0.229 38.55/
129.34
92.15(15.30),85.84(13.77),
80.31(9.74),88.71(12.35)
ellipse1parA 160.52/
152.01
165.21/
162.14
0.087/
0.094
0.113 0.51 0.231 0.532/
1.768
6.483(1.628),7.023(1.234),
7.321(1.312),6.898(1.345)
ellipse1ch1A 142.42/
141.72
151.85/
147.49
0.081/
0.105
0.73 0.819 0.754 2.686/
0.871
6.135(2.123),5.235(1.695),
5.983(1.881),6.193(1.819)
ellipse1ch2A 142.89/
141.25
153.02/
146.32
0.225/
0.261
0.241 0.413 0.241 0.4715/
1.3835
6.022(1.316),5.375(0.791),
6.318(1.897),5.505(1.208)
ellipse1ThetaA 298.61/
297.22
308.74/
302.29
0.202/
0.241
0.24 0.137 0.017 1.434/
82.75
80.83(10.66),85.78(10.42),
88.51(7.72),82.08(7.38)
ellipse2parV 197.15/
196.66
207.28/
201.72
0.138/
0.168
0.73 0.812 0.746 10.375/
3.523
8.143(3.414),7.769(3.515),
7.785(3.288),9.460(4.556)
ellipse2ch1V 119.5/
115.27
125.4/
124.56
0.063/
0.056
0.222 0.513 0.299 0.2866/
0.6703
6.027(0.596),6.151(0.902),
6.873(1.326),6.176(0.947)
ellipse2ch2V 168.57/
166.77
176.91/
173.63
0.051/
0.067
0.784 0.764 0.719 10.232/
3.987
6.322(3.646),7.716(3.477),
6.997(3.881),6.861(3.662)
ellipse2ThetaV 338.55/
336.5
348.68/
341.57
0.267/
0.305
0.254 0.416 0.262 65.29/
183.02
101.23(13.57),100.92(15.49),
94.07(15.96),91.74(17.71)
ellipse2parA 145.5/
143.6
155.6/
148.7
0.247/
0.285
0.4 0.549 0.411 0.9177/
1.3129
6.582(1.871),7.045(1.402),
7.411(1.312),6.525(1.315)
ellipse2ch1A 130.6/
127.5
140.8/
132.6
0.415/
0.455
0.213 0.351 0.210 0.2813/
1.054
5.88(0.821),5.276(1.013),
5.261(1.437),5.687(1.255)
ellipse2ch2A 124.11/
119.26
134.24/
124.33
0.762/
0.786
0.429 0.524 0.407 0.5303/
0.7707
5.19(1.377),4.934(0.958),
5.333(1.261),5.174(0.892)
ellipse2ThetaA 296.97/
289.41
302.05/
299.54
0.187/
0.198
0.410 0.683 0.521 47.82/
43.97
90.72(8.11),87.08(8.01),
83.45(13.61),85.17(7.18)
ellipse3parV 204.1/
201.1
214.2/
206.08
0.398/
0.438
0.414 0.351 0.209 1.746/
6.61
14.81(2.02),13.86(1.51),
12.91(4.49),14.11(2.61)
ellipse3ch1V 155.8/
151.36
161.49/
160.82
0.087/
0.089
0.29 0.565 0.37 0.922/
1.566
11.58(1.68),11.91(1.58),
11.01(1.34),11.16(1.516)
ellipse3ch2V 151.57/
148.19
158.98/
156.63
0.092/
0.121
0.547 0.721 0.607 1.849/
1.196
9.905(1.839),8.783(1.281),
8.974(1.855),9.19(1.914)
ellipse3ThetaV 291.64/
288.58
301.77/
293.65
0.4/
0.441
0.151 0.284 0.149 10.87/
61.89
76.35(6.68),77.52(7.96),
81.88(10.27),79.21(8.79)
ellipse3parA 166.4/
143.48
171.56/
153.61
0.152/
0.187
0.577 0.867 0.781 3.141/
0.808
12.55(2.01),11.34(2.03),
12.08(1.57),12.23(2.32)
ellipse3ch1A 183.09/
179.02
193.22/
184.09
0.586/
0.621
0.801 0.843 0.793 8.943/
2.331
8.496(4.071),7.784(2.595),
8.522(3.219),8.569(3.379)
ellipse3ch2A 164.37/
161.12
171.26/
169.44
0.067/
0.075
0.025 0.313 0.081 0.221/
2.509
10.93(2.11),9.56(0.98),
10.23(1.73),10.05(1.71)
ellipse3ThetaA 285.75/
284.32
295.9/
289.39
0.207/
0.243
0.071 0.233 0.085 5.25/
56.40
84.51(5.47),85.84(6.81),
82.12(6.81),85.98(8.87)
CRAE_LEON 458.98/
450.49
460.13/
464.79
0.059/
0.076
0.053 0.165 <0.000 <0.000/
14.89
18.94(3.19),18.74(3.13),
18.18(3.89),18.01(4.63)
CRVE_LEON 488.93/
483.23
497.29/
495.52
0.098/
0.121
0.067 0.132 <0.000 <0.000/
22.22
25.76(5.11),26.14(3.98),
26.72(5.23),26.08(5.01)
AVR_LEON 18.94/
15.34
20.09/
14.56
0.668/
0.682
<0.0000.019 <0.000 <0.000/
0.0571
0.735(0.321),0.716(0.234),
0.681(0.236),0.691(0.2)
CRAE_KNUD 409.26/
407.51
421.4/
416.4
0.052/
0.061
<0.0000.118 0.014 0.1295/
8.5214
18.46(2.01),18.24(2.82),
18.02(3.28),17.89(4.32)
CRVE_KNUD 542.38/
538.81
553.1/
549.53
0.084/
0.093
0.045 0.112 <0.000 <0.000/
44.63
25.45(5.01), 26.01(3.78),
26.31(5.11),25.87(4.87)
AVR_KNUD 55.11/
53.16
46.05/
40.82
0.067/
0.054
0.056 0.093 <0.000 <0.000/
0.026
0.731(0.311),0.701(0.245),
0.684(0.245), 0.691(0.201)
a: Full versus Restricted (null) model, b: chi-squared p-value and p-value based on Satterthwaite’s approximation, c: Ran-
dom effect variance (for subjects and, when applicable, the nested factor), divided by the total variance under the full model, d:
Variance of Subjects/Variance of Residuals
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Table A.8: Analysis of the non-significant tortuosity features for category 3
Feature
name
AICa BICa (p-(χ2)/
p-(s))b
ICC Ω2 Fc (VR/VE)d Group Means(SD)
(Y3, Y2, Y1, Y0)
mean_phi 432.19/
427.91
424.62/
412.78
0.631/
0.645
0.327 0.439 0.321 (1.82/
3.93)x10−4
0.218(0.021),0.216(0.022),
0.223(0.027),0.218(0.023)
median_phi 376.63/
373.97
369.06/
358.83
0.342/
0.359
0.383 0.506 0.384 (4.21/
6.74)x10−4
0.133(0.029),0.133(0.03),
0.145(0.036),0.138(0.035)
75th_phi 304.87/
300.66
297.3/
285.53
0.615/
0.629
0.285 0.397 0.279 (6.27/
16.1)x10−4
0.33(0.044),0.345(0.052),
0.345(0.052),0.34(0.044)
sd_phi 487.59/
483.77
480.02/
468.64
0.535/
0.548
0.166 0.268 0.162 (4.68/
24.22)x10−5
0.237(0.012),0.236(0.018),
0.24(0.018),0.234(0.019)
mean_tau 617.68/
612.13
610.11/
597
0.929/
0.933
0.518 0.606 0.506 (4.73/
4.61)x10−5
0.035(0.007),0.034(0.01),
0.035(0.01),0.035(0.01)
median_tau 822.32/
821.96
814.4/
807.19
0.095/
0.105
0.439 0.576 0.454 (4.07/
4.88)x10−6
0.011(0.003),0.0097(0.0025),
0.0112(0.0034),0.0109(0.0033)
75th_tau 671.16/
667.92
663.6/
652.79
0.431/
0.447
0.545 0.643 0.544 (2.91/
2.43)x10−5
0.0331(0.0056),0.0317(0.0065),
0.0332(0.0082),0.0340(0.0084)
sd_tau 406.01/
400.21
398.44/
385.07
0.978/
0.979
0.296 0.393 0.283 (2.16/
5.47)x10−4
0.081(0.021),0.078(0.031),
0.078(0.034),0.079(0.026)
mean_psi 652.47/
651.47
644.91/
636.34
0.172/
0.185
0.549 0.658 0.557 (3.63/
2.88)x10−5
0.044(0.005),0.041(0.008),
0.044(0.009),0.044(0.008)
75th_psi 616.6/
615.69
609.04/
600.56
0.179/
0.165
0.585 0.687 0.593 (6.02/
4.12)x10−5
0.0516(0.008),0.0488(0.0098),
0.0528(0.0127),0.0519(0.0091)
sd_psi 552.11/
548.14
544.54/
533.01
0.566/
0.582
0.407 0.517 0.402 (6.74/
10.02)x10−5
0.0724(0.0086),0.0691(0.0136),
0.0721(0.0145),0.0728(0.0141)
Tort.blend 161.55/
157.43
153.98/
142.4
0.612/
0.597
0.375 0.486 0.369 0.0042/
0.0072
0.988(0.091),0.974(0.1),
1.007(0.12),0.986(0.112)
Tort_ellipse1 78.78/
76.97
73.72/
66.83
0.242/
0.282
<0.0000.099 <0.000 <0.000/
0.0071
0.0223(0.0193),0.0827(0.1132),
0.0286(0.0191),0.0725(0.1207)
Tort_ellipse2 31.95/
27.56
26.89/
17.43
0.657/
0.689
<0.0000.04 <0.000 <0.000/
0.0242
0.0212(0.0181),0.0853(0.2152),
0.0882(0.2186),0.0342(0.0480)
Tort_ellipse3 71.88/
66.49
66.78/
56.36
0.885/
0.899
0.307 0.396 0.279 0.0028/
0.0072
0.0587(0.0549),0.078(0.1624),
0.0528(0.0716),0.0735(0.0749)
a: Full versus Restricted (null) model, b: chi-squared p-value and p-value based on Satterthwaite’s approximation, c: Ran-
dom effect variance (for subjects and, when applicable, the nested factor), divided by the total variance under the full model, d:
Variance of Subjects/Variance of Residuals
Table A.9: Analysis of the non-significant haemodynamic features for category 3
Feature
name
AICa BICa (p-(χ2)/
p-(s))b
ICC Ω2 Fc (VR/VE)d Group Means(SD)
(Y3, Y2, Y1, Y0)
wssparentA 107.89/
107.2
110.11/
109.35
0.082/
0.182
0.838 0.917 0.881 771.4/
104.1
79.85(35.11),65.78(26.22),
76.52(21.26),71.39(33.6)
pressureA 68.13/
64.36
71.04/
65.81
0.524/
0.654
0.347 0.483 0.295 3.096/
7.377
5.02(2.97),3.307(2.54),
4.402(3.3),2.336(1.208)
vparentaA 68.54/
67.75
70.66/
69.99
0.079/
0.136
0.832 0.915 0.877 27.99/
3.92
21.87(6.37),18.05(5.52),
21.48(3.92),20,29(6.46)
ReparentA 117.16/
116.46
119.37/
118.61
0.082/
0.123
0.814 0.905 0.861 1466.1/
234.7
307.1(43.54),278.56(44.38),
305.6(27.47),295.35(46.71)
wsschild1A 77.32/
76.71
80.23/
78.16
0.145/
0.167
0.664 0.81 0.71 27.52/
11.2
32.61(4.39),28.87(5.89),
31.76(6.27),34.85(7.83)
qchild1A 193.33/
189.45
191.87/
186.54
0.548/
0.531
0.287 0.424 0.231 (1.11/
3.69)x10−9
(8.01(0.925),7.79(0.761),
7.77(0.219),8.27(0.661))x10−4
vchild1A 42.45/
41.35
45.36/
42.81
0.178/
0.198
0.503 0.711 0.546 0.861/
0.715
10.15(0.727),9.28(1.42),
9.86(1.33),10.69(1.41)
Rechild1A 100.11/
98
103.02/
99.45
0.274/
0.301
<0.0000.276 <0.000 <0.000/
135.7
159.95(8.74),150.9(16.96),
154.73(11.65),166.57(6.52)
wsschild2A 83.64/
80.92
86.56/
82.37
0.351/
0.389
<0.0000.238 <0.000 <0.000/
34.4
39.29(3.86),36.14(4.67),
35.61(7.75),42.29(6.37)
qchild2A 193.82/
189.41
191.86/
186.5
0.552/
0.524
0.29 0.425 0.233 (1.25/
3.7)x10−9
(5.82(0.926),6.04(0.762),
6.13(0.219),5.56(0.665))x10−4
vchild2A 41.07/
37.56
43.98/
39.01
0.478/
0.516
0.277 0.442 0.235 0.2494/
0.8105
10.33(0.48),9.89(0.41),
9.84(1.33),10.72(1.42)
Rechild2A 90.93/
91.32
92.78/
93.83
0.094/
0.102
0.096 0.562 0.189 12.53/
53.5
132.63(29.28),140.16(26.13),
141.53(29.89),147.41(26.5)
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PinQoutA 90.66/
90.62
93.57/
92.01
0.113/
0.131
0.607 0.674 0.794 73.39/
35.35
16.56(9.20),24.05(6.43),
15.56(12.01),24.31(12.82)
wssparentV 86.08/
81.71
88.99/
83.16
0.653/
0.678
0.749 0.777 0.7 54.93/
23.51
17.97(5.74),19.86(5.3),
22.21(10.46),20.63(11.96)
pressureV 54.64/
54.03
57.15/
55.45
0.144/
0.167
0.078 0.378 0.012 0.039/
3.020
0.86(0.78),0.79(0.72),
0.71(0.49),1.12(0.98)
vparentaV 55.36/
50.83
58.27/
52.29
0.689/
0.734
0.759 0.783 0.708 4.377/
1.801
7.87(1.75),8.44(1.47),
9(2.8), 8.47(3.4)
ReparentV 112.33/
107.7
115.2/
109.15
0.712/
0.765
0.764 0.784 0.711 509.5/
206.9
175.22(20.37),181.84(15.61),
186.77(28.57),180.08(37.29)
wsschild1V 72.58/
69.04
75.47/
70.49
0.476/
0.497
0.419 0.553 0.376 6.065/
10.04
16.56(1.27),17.65(3.48),
19.97(3.56),17.39(6.15)
qchild1V 186.5/
181.93
185.04/
179.02
0.699/
0.713
0.746 0.768 0.759 (2.89/
0.98)x10−8
(6.7(2.51),6.54(2.162),
6.3(2.71),6.4(2.75))x10−4
vchild1V 44.71/
40.34
47.62/
41.7
0.653/
0.687
0.789 0.812 0.746 2.092/
0.709
6.023(0.498),6.324(1.516),
6.747(1.785),6.216(2.338)
Rechild1V 109.75/
104.08
112.65/
105.53
0.94/
0.943
0.937 0.933 0.911 1227.7/
118.7
112.08(26.06),114.24(32.53),
115.52(40.33),112(44.95)
wsschild2V 79.42/
74.47
82.33/
75.92
0.789/
0.823
0.951 0.951 0.934 125.56/
8.754
21.8(8.53),21.96(11.29),
20.10(11.74),21.51(14.09)
qchild2V 187.3/
180.95
184.15/
178.92
0.598/
0.623
0.756 0.779 0.771 (3.89/
1.18)x10−8
(5.72(2.51),5.91(2.17),
6.16(2.7),6.06(2.74))x10−4
vchild2V 43.48/
38.35
46.39/
39.81
0.834/
0.856
0.852 0.854 0.806 2.463/
0.591
6.61(1.06),6.64(1.57),
6.24(1.65),6.32(2.42)
Rechild2V 98.97.
93.61
101.88/
95.07
0.887/
0.928
0.681 0.687 0.593 111.36/
76.32
106.52(19.97),107.95(13.01),
105.77(9.45),103.32(9.64)
PinQoutV 83.75/
81.27
86.66/
82.72
0.318/
0.345
0.863 0.9 0.862 96.12/
15.37
26.88(9.28),27.7(9.26),
26.26(10.51),31.21(12.77)
a: Full versus Restricted (null) model, b: chi-squared p-value and p-value based on Satterthwaite’s approximation, c: Ran-
dom effect variance (for subjects and, when applicable, the nested factor), divided by the total variance under the full model, d:
Variance of Subjects/Variance of Residuals
Table A.10: Analysis of the non-significant main features for category 4
Feature
name
AICa BICa (p-(χ2)/
p-(s))b
ICC Ω2 Fc (VR/VE)d Group Means(SD)
(Y3, Y2, Y1, Y0)
AlphaA 163.4/
160
147.8/
133.44
0.326/
0.325
0.109 0.152 0.112
nested:<0.000
0.0044/
0.0349
0.767(0.181),0.763(0.206),
0.804(0.185),0.798(0.181)
BetaA 62.87/
59.81
90.44/
75.56
0.401/
0.406
0.015 0.01 <0.000
nested:<0.000
<0.000/
0.0673
1.285(0.202),1.345(0.214),
1.312(0.198),1.321(0.178)
LambdaA 556.65/
553.78
541.65/
526.4
0.377/
0.378
0.11 0.175 0.111
nested:0.013
0.0015/
0.0122
0.869(0.106),0.864(0.127),
0.878(0.109),0.875(0.101)
Lambda1A 828.76/
827.5
813.24/
799.87
0.23/
0.234
0.015 0.069 0.014
nested:0.018
(9.09/
623.6)x10−5
0.896(0.086),0.866(0.074),
0.845(0.084),0.85(0.071)
Lambda2A 600.9/
596.9
585.2/
569.4
0.576/
0.575
0.064 0.09 0.065
nested:<0.000
0.0007/
0.0113
0.819(0.103),0.832(0.121),
0.826(0.109),0.827(0.104)
ThetaA 436.16/
432.63
463.72/
448.38
0.48/
0.486
0.09 0.133 0.085
nested:0.01
0.016/
0.169
142.8(40.1),140.26(38.57),
149.4(47.4),149.6(47.6)
Adj.GammaA 909.68/
907.21
893.45/
879.65
0.316/
0.319
<0.0000.01 <0.000
nested:<0.000
<0.000/
0.0052
0.823(0.045),0.825(0.056),
0.833(0.052),0.838(0.061)
Width_parentA 765.28/
763.34
793.88/
778.83
0.373/
0.376
0.17 0.25 0.16
nested:0.032
0.075/
0.383
3.823(0.677),3.958(0.710),
4.004(0.717),3.96(0.623)
Width_child1A 735.51/
735.27
762.83/
751.25
0.101/
0.104
0.173 0.322 0.161
nested:0.073
0.071/
0.339
3.599(0.619),3.814(0.712),
3.766(0.668),3.762(0.659)
Width_child2A 550.21/
546.42
573.98/
565.75
0.121/
0.122
0.151 0.233 0.145
nested:0.023
0.038/
0.218
3.100(0.535),3.244(0.527),
3.297(0.463),3.285(0.496)
Width_allA 602.17/
601.77
629.33/
618.22
0.082/
0.081
0.189 0.302 0.176
nested:0.05
0.055/
0.242
3.508(0.56),3.672(0.578),
3.689(0.55),3.669(0.53)
Angle.BC_A 288.99/
285.55
316.55/
301.28
0.467/
0.474
0.046 0.071 0.0055/
nested:0.118
0.0056/
0.119
115.34(39.33),111.12(35.21),
119.23(44.53),117.87(40.04)
AlphaV 157.69/
154.94
144.53/
128.62
0.355/
0.354
0.159 0.179 0.161
nested:0.001
0.0079/
0.0415
0.647(0.222),0.668(0.223),
0.677(0.221),0.645(0.216)
BetaV 36.65/
31.33
62.92/
44.94
0.877/
0.88
0.054 0.066 0.052
nested:0.012
0.0034/
0.0593
1.141(0.145),1.159(0.122),
1.154(0.156),1.134(0.175)
214
LambdaV 706.57/
703.82
693.4/
677.5
0.354/
0.355
0.165 0.185 0.167
nested:0.051
0.0033/
0.0164
0.792(0.141),0.805(0.138),
0.811(0.14),0.791(0.139)
Lambda1V 1343/
1337
1330/
1311
0.927/
0.927
0.045 0.062 0.045
nested:<0.000
0.0002/
0.0059
0.836(0.058),0.836(0.059),
0.831(0.062),0.833(0.063)
Lambda2V 847.72/
844.22
834.56/
817.9
0.475/
0.476
0.146 0.158 0.147
nested:<0.000
0.0022/
0.0131
0.737(0.122),0.751(0.118),
0.751(0.122),0.734(0.127)
ThetaV 411.26/
409.12
437.58/
422.28
0.277/
0.279
0.129 0.152 0.131
nested:<0.000
0.0163/
0.1087
129.9(33.9),133.3(38.2),
134.9(35.1),127.7(32.6)
Adj.GammaV 1474/
1469
1461/
1442
0.875/
0.879
0.04 0.05 0.036
nested:0.043
0.0002/
0.0047
0.754(0.069),0.767(0.056),
0.774(0.034),0.773(0.063)
Width_parentV 1555/
1551
1582/
1565
0.515/
0.519
0.197 0.201 0.194
nested:<0.000
0.177/
0.735
4.456(0.97),4.436(0.875),
4.541(0.91),4.63(1.001)
Width_child1V 1465/
1461
1491/
1474
0.679/
0.682
0.2 0.208 0.197
nested:0.084
0.1553/
0.6311
4.156(0.901),4.141(0.809),
4.216(0.865),4.299(0.933)
Width_child2V 808.06/
805.76
404.03/
402.88
0.221/
0.222
0.188 0.216 0.195
nested:0.078
0.051/
0.208
3.204(0.523),3.262(0.517),
3.332(0.498),3.303(0.474)
Width_allV 1200/
1197
1226/
1210
0.349/
0.351
0.208 0.215 0.207
nested:0.092
0.1053/
0.4028
3.939(0.732),3.946(0.667),
4.031(0.678),4.077(0.731)
Angle.BC_V 286.56/
281.81
312.88/
294.97
0.741/
0.744
0.093 0.114 0.093
nested:<0.000
0.0092/
0.0891
115.93(36.15),118.12(36.92),
118.88(36.34),116.4(35.49)
a: Full versus Restricted (null) model, b: chi-squared p-value and p-value based on Satterthwaite’s approximation, c: Ran-
dom effect variance (for subjects and, when applicable, the nested factor), divided by the total variance under the full model, d:
Variance of Subjects/Variance of Residuals
Table A.11: Analysis of the non-significant main features for category 5
Feature
name
AICa BICa (p-(χ2)/
p-(s))b
ICC Ω2 Fc (VR/VE)d Group Means(SD)
(Prog, Non-Prog, DR)
AlphaA 234.19/
230.28
218.91/
208.15
0.352/
0.368
0.161 0.215 0.161
nested:<0.000
0.0068/
0.036
0.75(0.212),0.785(0.203)
0.792(0.184)
BetaA 133.85/
135.7
151.89/
148.98
0.054/
0.064
0.031 0.735 0.023
nested:0.463
0.0015/
0.037
1.253(0.171),1.317(0.162)
1.27(0.176)
LambdaA 881.51/
879.54
868.23/
857.40
0.362/
0.278
0.169 0.225 0.168
nested:<0.000
0.0025/
0.0125
0.836(0.117),0.878(0.101)
0.872(0.109)
Lambda1A 1306/
1304
1292/
1282
0.372/
0.391
0.072 0.109 0.073
nested:<0.000
(5.23/66.39)
x10−4
0.912(0.057),0.922(0.052)
0.927(0.044)
Lambda2A 950.77/
950.37
480.39/
478.18
0.111/
0.113
0.112 0.154 0.104
nested:<0.000
0.0013/
0.0115
0.803(0.116),0.832(0.111)
0.824(0.113)
ThetaA 806.5/
804.62
826.75/
819.78
0.053/
0.054
0.108 0.151 0.099
nested:<0.000
0.022/
0.198
147.61(50.47),143.73(43.48)
158.77(48.56)
Adj.GammaA 1429/
1427
1414/
1407
0.058/
0.071
0.031 0.742 0.022
nested:<0.470
(1.29/56.15)
x10−4
0.782(0.068),0.800(0.063)
0.788(0.068)
Angle.BC_A 6329/
6328
6350/
6343
0.076/
0.087
0.112 0.148 0.102
nested:<0.000
173/
1508
122.17(49.54),114.42(39.72)
125.73(44.77)
AlphaV 49.06/
47.76
78.98/
76.54
0.16/
0.167
0.576 0.703 0.081
nested:<0.000
0.0044/
0.0502
0.672(0.231),0.635(0.233)
0.699(0.234)
BetaV 95.45/
91.12
207.83/
204.34
0.23/
0.256
0.558 0.688 0.111
nested:<0.000
0.0077/
0.0619
1.141(0.163),1.182(0.141)
1.175(0.178)
LambdaV 677/54/
674.34
663.45/
660.34
0.601/
0.616
0.141 0.099 0.103
nested:<0.000
0.0023/
0.0204
0.806(0.149),0.797(0.155)
0.822(0.148)
Lambda1V 1525/
1522
1512/
1499
0.867/
0.869
0.048 0.077 0.054
nested:<0.000
(3.54/61.45)
x10−4
0.908(0.069),0.912(0.066)
0.912(0.074)
Lambda2V 853.44/
850.97
839.82/
828.28
0.465/
0.481
0.123 0.165 0.126
nested:<0.000
0.0022/
0.0156
0.724(0.123),0.717(0.109)
0.722(0.125)
ThetaV 577.06/
576.57
599.26/
590.68
0.105/
0.108
0.098 0.132 0.089
nested:<0.000
0.0123/
0.1257
135.91(37.66),125.55(32.26)
137.7(39.7)
Adj.GammaV 1661/
1659
1647/
1636
0.475/
0.491
0.09 0.123 0.094
nested:<0.000
(5.12/49.34)
x10−4
0.753(0.064),0.753(0.055)
0.762(0.068)
Fractal 628.32/
625.48
618.53/
609.16
0.559/
0.569
0.837 0.759 0.761 0.0029/
0.0009
1.652(0.058),1.65(0.054),
1.637(0.064)
Lacunarity 543.34/
539.6
533.56/
523.29
0.878/
0.882
0.806 0.717 0.722 0.0040/
0.0015
0.167(0.071),0.171(0.063),
0.176(0.078)
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a: Full versus Restricted (null) model, b: chi-squared p-value and p-value based on Satterthwaite’s approximation, c: Ran-
dom effect variance (for subjects and, when applicable, the nested factor), divided by the total variance under the full model, d:
Variance of Subjects/Variance of Residuals
Table A.12: Analysis of the non-significant features of the different areas for category 5
Feature
name
AICa BICa (p-(χ2)/
p-(s))b
ICC Ω2 Fc (VR/VE)dGroup Means(SD)
(Prog, Non-Prog, DR)
AVmid_AVbeg 88.74/
87.14
81.08/
74.35
0.303/
0.33
0.579 0.711 0.576 0.016/
0.011
-0.024(0.156),-0.109(0.168),
0.005(0.179)
AVend_AVbeg 84.54/
82.04
76.87/
69.22
0.471/
0.498
0.734 0.609 0.612 0.018/
0.011
0.011(0.166),0.094(0.146),
0.006(0.193)
AVend_AVmid 67.71/
63.88
60.04/
51.11
0.912/
0.918
0.502 0.64 0.524 0.018/
0.016
-0.013(0.161),-0.014(0.166),
0.01(0.223)
ellipse1parV 317.29/
311.13
323.9/
314.95
0.925/
0.931
0.666 0.525 0.544 0.9784/
0.8169
5.804(1.169),5.802(1.51),
5.946(1.508)
ellipse1ch1V 309.07/
305.19
321.84/
312.85
0.941/
0.944
0.405 0.254 0.274 0.408/
1.078
4.24(1.256),4.283(0.974),
4.353(1.227)
ellipse1ch2V 307.52/
304.12
320.29/
311.79
0.736/
0.751
0.361 0.517 0.377 0.579/
0.954
4.652(1.142),4.382(1.334),
4.431(1.36)
ellipse1ThetaV 725.17/
722.46
737.94/
730.12
0.523/
0.545
0.419 0.581 0.429 55.19/
73.23
83.49(11.53),82.24(10.56),
86.56(10.88)
ellipse1parA 361.6/
357.64
374.37/
365.30
0.977/
0.979
0.683 0.802 0.696 2.54/
1.11
6.789(1.829),6.819(2.135),
6.684(1.872)
ellipse1ch1A 362.96/
359.55
375.73/
367.21
0.745/
0.759
0.601 0.735 0.612 2.031/
1.285
5.679(1.895),5.208(1.05),
5.809(1.874)
ellipse1ch2A 375.47/
372.46
388.24/
380.12
0.611/
0.628
0.575 0.721 0.582 2.135/
1.529
5.42(1.756),6.069(2.613),
5.259(1.755)
ellipse1ThetaA 754.66/
750.82
767.43/
758.48
0.925/
0.931
0.284 0.443 0.301 49.15/
114.46
86.38(13.24),87.63(13.92),
85.71(10.22)
ellipse2parV 363.37/
359.63
376.14/
367.31
0.786/
0.794
0.667 0.786 0.677 5.904/
2.808
8.199(3.021),9.001(2.104),
8.12(3.005)
ellipse2ch1V 331.3/
329.32
341.07/
336.98
0.265/
0.279
0.275 0.429 0.279 0.404/
1.031
5.878(1.244),5.868(0.907),
5.368(1.197)
ellipse2ch2V 352.02/
348.39
364.79/
356.06
0.831/
0.841
0.285 0.449 0.289 0.414/
1.041
6.646(3.234),7.308(2.339),
6.804(3.195)
ellipse2ThetaV 725.48/
722.65
738.75/
731.21
0.716/
0.734
0.752 0.844 0.759 143.1/
45.3
84.11(14.05),79.99(6.39),
85.05(14.54)
ellipse2parA 363.37/
359.32
376.14/
367.98
0.878/
0.893
0.677 0.803 0.688 2.524/
1.144
7.094(1.883),6.686(2.362),
6.941(1.694)
ellipse2ch1A 333.3/
329.32
346.07/
336.98
0.895/
0.867
0.677 0.796 0.691 1.852/
0.831
5.704(1.531),5.781(1.935),
5.707(1.618)
ellipse2ch2A 352.02/
348.39
364.79/
356.06
0.831/
0.842
0.217 0.359 0.231 0.533/
1.768
5.557(1.6),5.295(1.366),
5.378(1.324)
ellipse2ThetaA 722.48/
719.44
735.25/
727.11
0.616/
0.634
0.525 0.664 0.538 72.98/
62.56
85.21(10.81),84.11(10.38),
81.99(13.24)
ellipse3parV 484.11/
480.27
496.88/
487.93
0.928/
0.929
0.409 0.568 0.429 4.357/
5.794
14.99(3.39),15.43(1.15),
15.21(3.34)
ellipse3ch1V 398.25/
394.56
410.79/
401.91
0.894/
0.901
0.818 0.891 0.825 5.756/
1.216
11.59(2.63),12.14(2.09),
11.61(2.71)
ellipse3ch2V 399.46/
395.75
412.23/
403.43
0.862/
0.871
0.835 0.891 0.842 6.26/
1.174
10.95(2.38),10.61(1.93),
10.53(3.21)
ellipse3ThetaV 691.42/
689.43
704.19/
697.1
0.365/
0.385
0.478 0.619 0.481 44.95/
48.38
80.05(9.02),83.14(8.13),
83.69(11.21)
ellipse3parA 437.58/
437.51
450.26/
445.24
0.129/
0.134
0.347 0.497 0.321 1.878/
3.981
11.48(2.44),9.77(2.57),
11.52(2.18)
ellipse3ch1A 449.64/
447.16
462.41/
454.82
0.467/
0.487
0.472 0.631 0.474 3.452/
3.829
9.425(2.866),8.124(2.098),
9.211(2.497)
ellipse3ch2A 401.39/
398.67
414.16/
406.34
0.527/
0.547
0.608 0.744 0.613 3.051/
1.923
9.413(2.175),8.367(2.361),
9.115(2.188)
ellipse3ThetaA 692.33/
688.45
705.1/
696.11
0.941/
0.944
0.467 0.632 0.484 45.63/
48.72
86.82(9.52),87.54(12.01),
86.21(8.39)
AVR_KNUD 293.4/
291.9
283.5/
275.4
0.291/
0.3
0.092 0.165 0.091 0.0012/
0.0121
0.698(0.088),0.726(0.159),
0.723(0.093)
a: Full versus Restricted (null) model, b: chi-squared p-value and p-value based on Satterthwaite’s approximation, c: Ran-
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dom effect variance (for subjects and, when applicable, the nested factor), divided by the total variance under the full model, d:
Variance of Subjects/Variance of Residuals
Table A.13: Analysis of the non-significant tortuosity features for category 5
Feature
name
AICa BICa (p-(χ2)/
p-(s))b
ICC Ω2 Fc (VR/VE)d Group Means(SD)
(Prog, Non-Prog, DR)
mean_phi 925.1/
924.6
915.1/
907.9
0.197/
0.199
0.434 0.532 0.419 (3.06/
4.23)x10−4
0.229(0.029),0.218(0.023),
0.227(0.027)
median_phi 799.7/
797.5
789.1/
780.9
0.406/
0.411
0.487 0.584 0.482 (7.02/
7.51)x10−4
0.147(0.043),0.135(0.032),
0.143(0.037)
75th_phi 650.1/
649.9
640.3/
632.7
0.213/
0.214
0.395 0.495 0.376 (1.02/
1.69)x10−3
0.361(0.056),0.338(0.046),
0.356(0.053)
mean_tau 1335/
1336
1325/
1319
0.107/
0.111
0.382 0.503 0.367 (3.66/
5.79)x10−5
0.041(0.011),0.036(0.009),
0.037(0.009)
median_tau 1780/
1778
1770/
1762
0.284/
0.294
0.405 0.512 0.397 (4.21/
6.41)x10−6
0.012(0.003),0.011(0.003),
0.012(0.004)
75th_tau 650.2/
649.2
640.2/
632.2
0.063/
0.06
0.361 0.484 0.348 (2.24/
4.19)x10−5
0.037(0.008),0.033(0.007),
0.036(0.009)
sd_tau 916.8/
915.1
906.8/
898.5
0.313/
0.317
0.305 0.415 0.294 (2.04/
4.88)x10−4
0.089(0.026),0.081(0.027),
0.083(0.024)
mean_psi 1364/
1363
1354/
1347
0.202/
0.205
0.374 0.488 0.369 (2.96/
5.05)x10−5
0.047(0.010),0.044(0.008),
0.046(0.009)
median_psi 1586/
1584
1576/
1568
0.297/
0.3
0.542 0.645 0.541 (1.74/
1.47)x10−5
0.018(0.007),0.016(0.005),
0.018(0.005)
75th_psi 1225/
1222
1215/
1205
0.669/
0.675
0.453 0.549 0.446 (7.71/
9.55)x10−5
0.055(0.015),0.051(0.011),
0.053(0.013)
sd_psi 1173/
1170
1163/
1154
0.638/
0.639
0.226 0.329 0.231 (4.39/
14.55)x10−5
0.075(0.015),0.072(0.012),
0.073(0.014)
Tort.blend 333.4/
334.9
322.1/
323.3
0.061/
0.06
0.379 0.481 0.344 0.0043/
0.0081
1.056(0.113),0.991(0.105),
1.031(0.115)
Tort_ellipse1 224.62/
222.89
215.8/
208.2
0.321/
0.339
0.018 0.03 0.008 <0.000/
0.011
0.051(0.085),0.081(0.114),
0.083(0.112)
Tort_ellipse2 111.22/
109.08
102.4/
94.38
0.395/
0.408
0.189 0.312 0.191 0.0049/
0.0213
0.057(0.152),0.099(0.184),
0.055(0.086)
Tort_ellipse3 336.6/
336.4
327.76/
326.89
0.148/
0.153
0.248 0.401 0.245 0.013/
0.004
0.067(0.096),0.054(0.069),
0.027(0.026)
a: Full versus Restricted (null) model, b: chi-squared p-value and p-value based on Satterthwaite’s approximation, c: Ran-
dom effect variance (for subjects and, when applicable, the nested factor), divided by the total variance under the full model, d:
Variance of Subjects/Variance of Residuals
Table A.14: Analysis of the non-significant haemodynamic features for category 5
Feature
name
AICa BICa (p-(χ2)/
p-(s))b
ICC Ω2 Fc (VR/VE)d Group Means(SD)
(Prog, Non-Prog, DR)
wssparentA 937.4/
934.5
950.4/
942.7
0.574/
0.591
0.823 0.902 0.826 862.1/
180.5
54.08(34.50),57.83(26.48),
52.81(29.16)
pressureA 655.4/
654.3
667.4/
666.3
0.089/
0.095
0.516 0.693 0.343 10.84/
20.68
3.403(4.688),3.741(3.942),
3.368(3.471)
vparentaA 603.2/
600.35
616.56/
608.23
0.543/
0.563
0.859 0.923 0.862 37.82/
6.06
16.42(7.04),17.34(5.06),
16.33(6.12)
ReparentA 1018/
1016
1032/
1024
0.521/
0.538
0.886 0.938 0.887 2540.6/
321.4
261.96(56.59),271.65(48.34),
262.63(50.17)
wsschild1A 811.9/
807.4
824.4/
815.4
0.765/
0.781
0.654 0.771 0.664 147.29/
74.26
26.93(14.72),30.12(13.23),
28.75(16.14)
vchild1A 509.9/
505.3
522.8/
513.7
0.708/
0.726
0.664 0.781 0.673 7.799/
3.788
8.618(3.44),9.997(3.195),
9.026(3.571)
Rechild1A 988.2/
985.3
1004/
996.1
0.665/
0.682
0.588 0.726 0.597 712.7/
480.8
143.62(36.44),158.04(33.54),
147.97(33.81)
wsschild2A 799.4/
796.9
814.5/
805.8
0.775/
0.789
0.711 0.818 0.721 154.9/
60.17
32.98(15.03),34.45(16.56),
32.83(15)
vchild2A 448.7/
445.6
461.4/
445.3
0.668/
0.684
0.741 0.841 0.748 5.389/
1.821
8.991(2.775),9.03(2.74),
8.892(2.72)
Rechild2A 923.88/
920.78
937.65/
928.65
0.638/
0.655
0.599 0.739 0.609 379.1/
244.3
127.46(26.73),128.34(25.93),
125.32(23.61)
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PinQoutA 734.44/
731.75
747.88/
739.31
0.71/
0.724
0.683 0.691 0.808 74.92/
33.51
24.38(10.85),22.42(9.85),
24.67(9.46)
wssparentV 672.05/
668.42
684.55/
675.92
0.832/
0.842
0.889 0.924 0.894 205.79/
24.39
24.01(12.8),23.34(12.12),
25.43(17.23)
pressureV 421.53/
420.45
434.03/
427.95
0.233/
0.263
0.177 0.311 0.181 1.09/
4.92
2.17(1.78),2.43(1.86),
2.21(1.87)
vparentaV 423.94/
420.21
436.44/
427.71
0.871/
0.879
0.884 0.923 0.889 12.73/
1.584
9.35(3.31),9.23(3.89),
9.59(4.19)
ReparentV 837.25/
833.44
849.8/
840.99
0.91/
0.916
0.881 0.923 0.886 1236.3/
158.4
188.91(33.54),184.98(34.53),
190.25(40.56)
wsschild1V 605.74/
602.71
618.24/
610.21
0.615/
0.633
0.882 0.926 0.884 93.55/
12.18
20.22(9.85),17.99(9.12),
22.69(10.82)
Rechild1V 756.28/
752.49
768.78/
759.99
0.902/
0.908
0.862 0.926 0.868 458.25/
69.48
110.55(21.36),113.46(31.32),
113.78(22.53)
wsschild2V 610.8/
606.43
623.11/
614.33
0.894/
0.901
0.913 0.857 0.863 88.61/
14.04
20.54(9.24),21.34(9.91),
22.25(10.48)
Rechild2V 749.88/
746.49
762.38/
753.87
0.739/
0.753
0.928 0.957 0.931 627.26/
46.78
112.14(25.94),112(20.13),
116.55(25.63)
PinQoutV 554.43/
551.1
566.92/
558.6
0.715/
0.732
0.794 0.873 0.801 36.83/
9.14
31.05(6.41),33.61(5.98),
30.51(7.06)
a: Full versus Restricted (null) model, b: chi-squared p-value and p-value based on Satterthwaite’s approximation, c: Ran-
dom effect variance (for subjects and, when applicable, the nested factor), divided by the total variance under the full model, d:
Variance of Subjects/Variance of Residuals
Table A.15: Analysis of the non-significant main features for category 6
Feature
name
AICa BICa (p-(χ2)/
p-(s))b
ICC Ω2 Fc (VR/VE)dGroup Means(SD)
(Y3, Y2, Y1, DR)
AlphaA 115.86/
113.24
102.97/
90.66
0.336/
0.344
<0.0000.417 <0.000
nested:0.226
<0.000/
0.0234
0.779(0.184),0.831(0.165),
0.791(0.145),0.813(0.156)
BetaA 125.04/
120.06
148.76/
133.62
0.795/
0.808
0.489 0.804 0.494
nested:0.142
0.065/
0.048
1.265(0.301),1.25(0.324),
1.33(0.256),1.351(0.231)
LambdaA 101.83/
96.01
88.27/
72.92
0.978/
0.981
0.789 0.965 0.795
nested:0.101
0.0671/
0.0087
0.807(0.103),0.818(0.106),
0.812(0.122),0.805(0.105)
Lambda1A 428.52/
424.15
414.97/
400.43
0.653/
0.684
0.04 0.586 0.043
nested:0.316
<0.000/
0.0052
0.902(0.067),0.902(0.061),
0.922(0.059),0.926(0.061)
Lambda2A 364.38/
360.76
350.82/
337.03
0.497/
0.521
0.164 0.865 0.149
nested:0.497
0.0016/
0.0039
0.815(0.106),0.851(0.095),
0.835(0.081),0.841(0.097)
ThetaA 301.68/
297.93
325.41/
311.49
0.523/
0.543
0.316 0.431 0.321
nested:<0.000
0.081/
0.171
1.236(0.351),1.247(0.371),
1.176(0.367),1.347(0.387)
Adj.GammaA 22.78/
17.04
46.52/
30.61
0.967/
0.974
0.326 0.992 0.381
nested:0.546
0.029/
0.0055
0.838(0.093),0.842(0.097),
0.839(0.097),0.829(0.095)
Width_parentA 587.68/
581.75
611.4/
595.31
0.995/
0.995
0.752 0.835 0.76
nested:<0.000
1.295/
0.409
3.408(1.346),3.255(1.55),
3.507(1.318),3.383(1.139)
Width_child1A 441.67/
436.48
465.4/
450.04
0.847/
0.853
0.435 0.991 0.445
nested:0.486
0.244/
0.037
3.506(0.764),3.613(0.724),
3.638(0.77),3.431(0.604)
Width_child2A 318.86/
315.35
342.45/
328.91
0.476/
0.492
0.446 0.738 0.443
nested:0.129
0.133/
0.128
3.072(0.516),3.3(0.609),
3.241(0.589),3.08(0.416)
Width_allA 414.74/
409.17
438.46/
422.72
0.934/
0.937
0.602 0.902 0.607
nested:0.173
0.349/
0.125
3.329(0.742),3.39(0.812),
3.462(0.792),3.297(0.608)
Angle.BC_A 2284/
2281
2307/
2294
0.432/
0.455
0.044 0.116 0.052
nested:0.008
99.36/
1787.47
128.64(54.54),129.45(50.65),
122.45(42.54),128.78(48.32)
AlphaV 88.68/
88.56
74.56/
64.93
0.111/
0.109
0.014 0.659 0.011
nested:0.407
<0.000/
0.021
0.732(0.212),0.713(0.197),
0.686(0.186),0.771(0.179)
BetaV 42.39/
42.27
66.05/
55.98
0.106/
0.117
0.05 0.459 0.025
nested:0.235
0.0018/
0.051
1.136(0.136),1.116(0.153),
1.081(0.182),1.166(0.174)
LambdaV 307.79/
307.71
294.11/
284
0.107/
0.129
0.023 0.662 0.022
nested:0.401
0.0003/
0.0081
0.846(0.125),0.835(0.123),
0.821(0.117),0.872(0.105)
Lambda1V 480.63/
476.89
467.03/
453.11
0.519/
0.522
<0.0000.479 <0.000
nested:0.279
<0.000/
0.0047
0.912(0.061),0.91(0.063),
0.892(0.086),0.908(0.075)
Lambda2V 326.45/
327.62
303.12/
304.56
0.067/
0.086
0.076 0.576 0.053
nested:0.297
0.0006/
0.0084
0.794(0.111),0.783(0.117),
0.753(0.116),0.816(0.105)
ThetaV 219.88/
220.56
234.45/
235.65
0.056/
0.067
0.045 0.218 0.026
nested:0.072
0.0039/
0.1349
145.75(43.5),136.4(36.18),
133.68(40.64),125.77(33.95)
218
Adj.GammaV 507.39/
507.3
493.34/
492.65
0.115/
0.154
0.051 0.428 0.028
nested:0.211
0.0001/
0.0043
0.779(0.065),0.773(0.07),
0.753(0.077),0.783(0.068)
Width_parentV 595.66/
593.48
619.45/
607.07
0.281/
0.317
0.307 0.345 0.282
nested:<0.000
0.269/
0.684
3.873(0.906),4.155(1.091),
4.306(0.996),3.783(0.718)
Width_child1V 515.45/
513.08
539.24/
526.68
0.304/
0.345
0.332 0.369 0.321
nested:<0.000
0.219/
0.466
3.63(0.8),3.871(0.924),
3.931(0.831),3.516(0.534)
Width_child2V 339.97/
334.89
363.76/
348.48
0.82/
0.864
0.293 0.322 0.304
nested:<0.000
0.093/
0.212
3.025(0.644),3.157(0.544),
3.155(0.468),3.034(0.396)
Width_allV 461.69/
458.37
485.47/
471.96
0.443/
0.491
0.362 0.385 0.348
nested:<0.000
0.192/
0.361
3.509(0.74),3.727(0.81),
3.797(0.706),3.444(0.502)
Angle.BC_V 2190/
2188
2212/
2204
0.056/
0.064
0.053 0.430 0.032
nested:0.205
36.42/
860.29
119.33(37.67),116.57(38.96),
122.01(45.67),108.87(35.23)
Fractal 103.45/
99.19
98.51/
89.06
0.656/
0.619
0.837 0.891 0.668 0.0027/
0.0013
1.676(0.085),1.669(0.031),
1.644(0.077),1.642(0.053)
Lacunarity 110.34/
109.43
85.12/
83.43
0.345/
0.355
0.745 0.456 0.653 0.0034/
0.0018
0.163(0.131),0.156(0.102),
0.177(0.098),0.164(0.065)
a: Full versus Restricted (null) model, b: chi-squared p-value and p-value based on Satterthwaite’s approximation, c: Ran-
dom effect variance (for subjects and, when applicable, the nested factor), divided by the total variance under the full model, d:
Variance of Subjects/Variance of Residuals
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